Cannabis Stocks Directory at Global Investor Ideas

Investors and traders – looking for a starting point to invest? Our free stock directory at Global Investor Ideas is a great resource to help your research begin.

For public companies – if your company is listed, you can request to update your description. Not listed? No problem! Simply email us today.

 

Psychedelic Stocks

 

 

1933 Industries Inc. (CSE:TGIF.C; OTCQB:TGIFF) Based in Las Vegas, Nevada, Friday Night Inc. is focused on the production and sales of medical marijuana and innovative cannabis products. The State of Nevada currently regulates and controls medical marijuana, and has announced its intention to do the same for recreational use as early as July, 2017.

22nd Century Group Inc. (NYSE MKT:XXII) is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants through genetic engineering and plant breeding. The Company’s primary mission is to reduce the harm caused by smoking. 22nd Century currently owns or exclusively controls more than 200 issued patents and more than 50 pending patent applications around the world. The Company’s strong IP position led to a licensing agreement with British American Tobacco (“BAT”), the world’s second largest tobacco company.

3 Sixty Risk Solutions Ltd. (CSE:SAFE) operating through its wholly-owned subsidiary, 3 Sixty Secure Corp., is a security service provider to the cannabis sector, transporting approximately $250 million of product every month. 3Sixty provides cannabis security consulting, guarding and secure transport security services to more than 500 customers and more than 60 licensed cannabis producers, including some of the world’s largest, such as licensed producers owned by Canopy Growth Corporation. 3Sixty has a staff of over 275 employees and employs a fleet of over 60 vehicles, which management believes provides a combined security footprint to approximately 30 million square feet of patrolled area.

3DX Industries Inc. (OTC: DDDX) is focused on the additive metal manufacturing segment within the manufacturing industry. 3DX has the capability of manufacturing a wide variety of products using its 3D metal printing system, 3D composite printing as well as more traditional methods of precision manufacturing. 3DX offers additive and subtractive manufacturing options as well as product design, engineering and assembly services to its customers. Cannabis: Has completed the development and design of a new and innovative product used for recovering excess heat from high energy grow lights. The part was designed specifically for the legalized cannabis markets including medical marijuana using the company’s 3D Metal printing — Binder Additive manufacturing process and is expected to be installed in select licensed facilities for real world testing in the coming months.

48North Cannabis Corp. (TSX:NRTH.V) is a TSXV Venture Exchange listed company whose wholly owned subsidiary DelShen Therapeutics Corp. (“DelShen”), is a licensed producer of medical cannabis in Canada. 48North grows unique genetics sourced from MariPharm B.V., a Netherlands-based phytopharmaceutical company with over 25 years of experience in the research and cultivation of cannabis for medical purposes. Its genetics are grown to exacting standards, ensuring patients can count on receiving the highest-quality cannabis products. DelShen is regulated by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) and the facility is located on 800-acres of owned land near Kirkland Lake, Ontario. DelShen’s license to produce cannabis was granted on Feb. 28, 2017, and pertains to the facility, a state-of-the-art, closed-box, 40,000-square-foot building with an additional

Abacus Health Products Inc. (CSE: ABCS) is engaged in the development and commercialization of over-the-counter (OTC) registered topical medications with active pharmaceutical ingredients and which contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD from the Cannabis sativa L plant. Abacus’ products are aimed at the rapidly growing markets for topical pain relief and therapeutic skincare and are based on proprietary patent-pending technologies developed by Abacus. Abacus’ formulations combine advanced science with organic and natural ingredients to provide safe relief. Abacus currently offers two lines of products: CBD CLINIC™, marketed to the professional practitioner market, and CBDMEDIC™, marketed to the consumer market. Abacus’ products are offered across the United States and are produced by a contract manufacturer in a cGMP compliant and audited manufacturing facility.

ABATTIS BIOCEUTICALS (OTC:ATTBF; CSE:ATT) is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The Company is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions, by supplying and partnering with companies to employ its mass cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. The Company also has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions.

ABcann Global Corporation (TSX:ABCN.V) was one of the first companies to obtain a production license under the Marijuana for Medical Purposes Regulations, which it received on March 21, 2014. It obtained a sales license on December 31, 2015. ABcann’s flagship facility, in Napanee, Ontario, contains proprietary plant-growing technology, including environmentally-controlled chambers capable of monitoring and regulating all variables in the growing process. This approach and the systems in place allow ABcann to produce organically grown and pesticide-free, high-yielding plants, which, in turn, can generate high-quality products that are consistent from batch to batch. ABcann is able to control environmental and nutrient demands, tailor-made for a particular strain of cannabis, without the variation that is typical when producing large quantities in less-controlled, larger rooms and greenhouse-type structures. ABcann’s modular approach to systems technology eliminates scale-up risk and allows ABcann to locate anywhere in the world and maintain consistency and quality of product. ABcann is expanding capacity in its current facility to approximately 30,000 sq ft and concurrently undertaking expansion into a new 150,000 sq ft facility in Napanee. ABcann is pursuing opportunities in Germany, Australia and other jurisdictions as well as exploring the development of multiple delivery vehicles.

Acology Inc (OTC:ACOL) markets and sells the TSOS Container™ (The Science of Storage).This container is the first-ever FDA approved polypropylene air-tight, water-tight, smell-proof delivery and storage container with a built-in grinder. It is manufactured from medical-grade No. 5 polypropylene resin, which is non-porous and non-leaching. These containers are portable and affordable. he Medtainer™ allows patients to store, grind and pour a variety of medications, including pills and all sizes and solidity, herbal medications and teas and even coffee and spices! The Medtainer™ can be ordered in with a certified child-resistant cap. Each Medtainer™ is water-proof and smell proof. Caregivers who are responsible for ensuring their patients medication regimens are universally pleased with the how easy and effective the Medtainer™ grind medications. It is an excellent solution for patients with dysphasia due to cognitive disorders or brain injuries, are in hospice or palliative situations and for anyone who would rather not swallow whole pills. The MedTainer™ was originally developed for geriatric and pediatric patients who had difficulty swallowing pills or needed an effective alternative to costly name-brand medications. The MedTainer™ has been sold and is being successfully used throughout the United States, Canada, Mexico and South America and Europe. Our association with the Medical Marijuana community was an unexpected windfall that has given Acology, Inc. the necessary funding to expand into the growing hospice and palliative care markets, and to help countless patients who are living at home or in small home-like settings and need help swallowing pills.

Acreage Holdings, Inc. (CSE:ACRG.U) is a vertically integrated, multi-state owner of cannabis licenses and assets in U.S. states where either medical and/or adult use of cannabis is legal. With one of the largest geographic footprints of any cannabis company, it currently owns and/or operates cultivation, processing and dispensary operations. Acreage is dedicated to building and scaling operations to create a seamless, consumer-focused branded cannabis experience.

Adastra Holdings Ltd. (CSE:XTRX) Founded in 2014, Adastra Holdings Ltd. built a successful reputation as a household name in cannabis concentrates among consumers and retailers alike. Adastra Labs Inc. was founded in 2018 and is an agricultural-scale cannabis extraction, distillation, and product manufacturer, located in Langley, BC. Operating out of its 13,500 sq. ft. Health Canada Licensed Standard Processing facility, now named Adastra Holdings Ltd., produces and distributes cannabis-derived products designed for medical cannabis and forward-looking therapeutic use. Recently, the Company announced its entry into psychedelics by applying for a Controlled Substances Dealer’s License, which is under review by Health Canada. As a leading supplier, Adastra Holdings Ltd. currently distributes its product line to 1400+ adult-use retailers and a web-based medical platform, CannMart Inc., seeking to provide consistent, quality concentrate products and alternative treatment options across the country to patients.

Advantis Corp (OTC:ADVT) develops products and works with developing companies to provide innovative healthcare products, holistic pain management solutions, and enhance the footprint in the evolving legal cannabis business. Advantis acquires ownership in developing companies that work within the nutraceutical and the alternative health care industries; consulting with these organizations to improve their product lines, expand their distribution channels through internal partnership agreements, and heighten brand value.

Aequus Pharmaceuticals Inc. (TSX:AQS.V) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus has grown its pipeline to include several commercial products in ophthalmology and transplant, and a development stage pipeline in neurology and psychiatry with a goal of addressing the need for improved medication adherence through enhanced delivery systems. As a complement to its focus in neurology, our most recent addition to the development pipeline was a long-acting form of medical cannabis, where there is a high need for a consistent, predictable and pharmaceutical-grade delivery of products for patients. Aequus intends to commercialize its internal programs in Canada alongside its current portfolio of marketed established medicines and will look to form strategic partnerships that would maximize the reach of its product candidates worldwide. Aequus plans to build on its Canadian commercial platform through the launch of additional products that are either created internally or brought in through an acquisition or license; remaining focused on highly specialized therapeutic areas.

AeroGrow International, Inc. (OTC:AERO) Headquartered in Boulder, Colorado, AeroGrow International, Inc. is the leader in the rapidly growing indoor gardening category. AeroGardens allow anyone to grow farmer’s market fresh herbs, salad greens, tomatoes, chili peppers, flowers and more, indoors, year-round, so simply and easily that no green thumb is required. With an AeroGarden… you can grow anything! In April 2013, AeroGrow entered into a strategic partnership with Scotts Miracle-Gro to continue to expand the indoor gardening market.

AFFINOR GROWERS (CSE:AFI; OTC:RSSFF) is focused on growing high quality crops such as romaine lettuce, spinach, strawberries and high quality medical Marijuana. Affinor is committed to becoming a pre-eminent grower, using exclusive vertical farming techniques.

Agrify Corporation (NasdaqCM:AGFY) is the most innovative provider of advanced cultivation and extraction solutions for the cannabis industry, bringing data, science, and technology to the forefront of the market. Our proprietary micro-environment-controlled Vertical Farming Units (VFUs) enable cultivators to produce the highest quality products with unmatched consistency, yield, and ROI at scale. Our comprehensive extraction product line, which includes hydrocarbon, ethanol, solventless, post-processing, and lab equipment, empowers producers to maximize the quantity and quality of extract required for premium concentrates.

Agrios Global Holdings Ltd (CSE:AGRO) is a data analytics driven agricultural technology, services and property management company, providing real property and equipment for lease and enhanced ancillary services to the agricultural and cannabis industries in the State of Washington. The Company’s mission is to enable licensed cultivators of cannabis and/or other agricultural crops to enhance both crop quality and yields through proprietary knowledge and the use of clean technology and tools.

Agritek Holdings Inc (OTC:AGTK) a fully reporting Company and pioneer within the medicinal marijuana space provides innovative patient and agricultural solutions seeks to be the leader in Compassionate Care Technology for the medicinal marijuana industry. Agritek Holdings provides real estate management and health and wellness product lines through its wholly-owned subsidiary, Agritek Holdings Inc. Agritek Holdings Inc. does not directly grow, harvest, or distribute or sell cannabis or any substances that violate United States law or the Controlled Substances Act, nor does it intend to do so in the future.

Aion Therapeutic Inc. (CSE: AION)- Formerly Osoyoos Cannabis Inc. is an early-stage cannabinoid extraction company based in Oliver, BC. Aion has applied for a standard processing license under the Cannabis Act for its 10,410 ft2 facility and that application is currently in the review stage. The Company will offer contract tolling extraction, sale of bulk oil and development of both proprietary Aion Cannabis branded and white labelled products once licensed to do so.

AKANDA CORP. (Nasdaq:AKAN) is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to high quality and affordable products. The Company is building a seed-to-patient supply chain, connecting patients in the UK and Europe with diverse products including cannabis products cultivated at its competitively advantaged grow operation in the Kingdom of Lesotho and with other trusted third-party brands. Akanda’s initial portfolio includes Bophelo Bioscience & Wellness, a GACP qualified cultivation campus in the Kingdom of Lesotho in Southern Africa, and CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK.

Akerna Corp (NasdaqGS:KERN) is a global regulatory compliance technology company. Akerna’s service offerings include MJ Platform®, Leaf Data Systems®, solo sciences tech platform and Ample Organics. Since its establishment in 2010, Akerna has tracked more than $18 billion in cannabis sales. Akerna is based in Denver.

Aleafia Health Inc. (TSXV: ALEF.V; OTCQX: ALEAF) is one of Canada’s leading, vertically integrated medical cannabis companies with a unique patient-focused, medical cannabis healthcare solution. Led by a distinguished and experienced corporate leadership team, Aleafia Health Inc. is pioneering a patient-centric experience that includes personalized services before, during and after treatment. Aleafia’s 22 cannabis clinics are staffed by licensed, practicing physicians. Aleafia Health Inc. has realized sustained patient acquisition growth and retention, underscoring the success of Canada’s first “patient-centric” cannabis-based health network.

ALGAE DYNAMICS CORP (OTCQB: ADYNF) is engaged in the development of unique health products and nutraceuticals that utilize hemp, cannabis and algae oils. We have engaged two Canadian universities to provide research into the use of extracts from cannabis oil, which we plan to use to develop products that combine the significant health benefits of Omega-3s derived from algae oil and extracts from cannabis oil. Our research is focused on the use of cannabis oil in the context of cancer, and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health.

Algae.Tec (ASX: AEB.AX) is a specialist producer, focused on developing technology that captures waste carbon dioxide to produce commercial quantities of a range of plant derived products for supply to three key markets: Medicinal cannabis, Algae-based nutraceuticals and Animal feed and aquaculture markets.

Alkaline Water Company Inc, The (TSX:WTER.V; CSE:WTER.C; NasdsaqCM: WTER) Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkakline88®, is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88® delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts our trademarked label ‘Clean Beverage.’ Quickly being recognized as a growing lifestyle brand, Alkaline88® launched A88 infused™ in 2019 to meet consumer demand for flavor-infused products. A88 infused™ flavored water is available in seven unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the Company launched A88CBD Infused™ brand, featuring a broad line of topical and ingestible products. These products are made with lab-tested full-spectrum hemp and include salves, balms, lotions, essential oils, bath-salts, CBD infused drinks, beverage shots, tinctures, capsules, gummies, and powder packs.

Alliance Growers Corp. (CSE:ACG; OTCQB: ALGWF) is a cannabis company dedicated to building shareholder value through its 4 Pillars business strategy. The company was incorporated in 2014 and is publicly traded on the CSE under the symbol ACG. The company’s head office is in Vancouver, BC and its interest in a marijuana production facility in Kelowna, BC.

Alternate Health Corp. (CSE:AHG; OTC:ATEHF) is a diversified healthcare company that uses its expertise in technology to revolutionize patient care and service delivery in both traditional and complementary medical fields. With investments in research, education and cutting edge technology, Alternate Health is a leader in software applications and processing systems for the medical industry using proprietary technology platforms. Through its subsidiaries, Alternate Health offers services ranging from medical practice and controlled substance management software to blood analysis and toxicology labs, to clinical research and continuing education programs. Alternate Health’s goal is to continue to lead the medical industry with data-driven results in patient care and product development.

Alternet Systems, Inc. (OTC: ALYI) is focused on offering varied, environmentally sustainable, energy storage solutions for targeted markets, including consumer electric vehicles and military applications. The first product category is lithium battery-powered motorcycles, to be followed by motorbikes. ALYI also recently brought Clarkson University Professor David Mitlin on board to lead a hemp energy storage initiative. Mitlin has successfully used hemp bast – the fiber left over from processing hemp – to construct carbon nanosheets that compete with, and in some respects, outperform the supercapacitor performance derived from more typical graphene nanosheets. Mitlin holds a US patent for his proprietary hemp energy storage technology.

American Cannabis Company, Inc. (OTC:AMMJ) offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. Through our two vertically integrated businesses, American Cannabis Consulting and American Cultivator Company, a group purchasing organization, we support our clients from concept to creation to commercialization to on-going operations.

American Green Inc (OTC:ERBB) Founded back in 2009 as one of the first publicly-traded medical marijuana-related companies in the world, American Green is proud to have the largest certified shareholder base which now numbers well over 50,000. The Company is keenly focused on developing, retailing, branding, and establishing commercial cultivation solutions under its proprietary American Green name along with our partners who are licensed retail medical marijuana dispensaries. American Green believes that the renewal of the legalized cannabis industry in the United States will aid in getting our economy back on its feet through increased employment in all related sectors — retail, real estate, contracting, farming and more. Additional revenues, fueled by taxing cannabis sales, and the decreased cost of housing prisoners who are no longer in prison for possession of cannabis should contribute to the renewal. Hard work and a clear vision propel American Green into the future. The centerpiece of our company is ZaZZZ, our unique automated vending solution designed specifically around American Green’s licensed proprietary patent technology.

American Premium Water Corporation (OTC:HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of Nano technologies paired without cannabidiol (CBD) to treat health disorders and enhance quality of life. The company’s portfolio includes the LALPINA Hydro and LALPINA CBD brands (www.lalpinahydrocbd.com), Gents (www.gentsco.com), Vanexxe (www.vanexxe.com) and plant + body essentials (www.plantbodyessentials.com). American Premium Water strives in providing only the highest quality CBD sources for its products, with quality control being one of our first and foremost focuses. The Company aims for this standard not only for compliance reasons, but also to provide our customers the highest quality product possible.

Americann Inc (OTC:ACAN) is a publicly traded company that plans to develop and lease sustainable, state-of-the-art medical cannabis cultivation properties. The Company has over 1,000,000 square feet of facilities in the planning and design stages of development. The Company has designed a proprietary line of cannabis infused products which will be branded and licensed to companies in regulated markets. AmeriCann, Inc. is a Certified B Corp, an acknowledgment of the company’s commitment to social and environmental ethics, transparency and accountability. AmeriCann became the first public cannabis company to earn this respected accreditation.

Amfil Technologies Inc. (OTC: AMFE) focuses primarily on the acquisition of income generating private companies and optimizing their operations under the Amfil Technologies umbrella. Amfil is focused on growing shareholder value by allowing investors access to self-sustaining small to medium sized businesses with proven profitable strategies, and identified as having substantial potential for future growth. Amfil seeks to achieve long-term financial returns consisting of regular dividend income, benefiting from preferential tax treatment, and expecting modest mid-to-long term capital growth. Amfil Technologies primarily invests in small to mid-sized companies with above average service capacity, growth potential or existing market share. GROzone: The GROzone systems are a triple function sanitization unit capable of naturally eliminating 99.9% of gaseous and aqueous pathogens developed for the Medical Marijuana Industry.

AMP Alternative Medical Products Inc. (CSE:XCX) is licensed to import European Union – Good Manufacturing Practice (EU-GMP) medical cannabis from Europe and elsewhere into Germany. AMP sources, stores, transports, delivers, and sells medical cannabis products to pharmaceutical distributors or pharmacists directly, the only point-of-sale for medical cannabis to German patients with a physician’s prescription.

Anebulo Pharmaceuticals, Inc. (NasdaqGS:ANEB) is a clinical-stage biotechnology company developing novel solutions for people suffering from cannabinoid overdose and substance addiction. Its lead product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within one hour of administration. Clinical trials completed to date have shown that ANEB-001 is rapidly absorbed, well tolerated and leads to weight loss, an effect that is consistent with central cannabinoid receptor type 1 antagonism.

Applied BioSciences Corp. (OTCQB: APPB) is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the medical, health and wellness, nutraceutical, and media industries.

Arkados Group, Inc. (OTC:AKDS) through its subsidiaries, is a global provider of scalable and interoperable Internet of Things solutions focused on industrial automation and energy management. We execute our business as a software developer and energy services firm focused on developing unique, cutting-edge solutions that enable machine to machine communications with specific applications for building and machine automation. Arkados, Inc., our technology subsidiary, has developed the Arktic™ software platform, a scalable and interoperable cloud-based system for sensing, gathering, storing, analyzing data as well as reporting critical information and implementing command and control. Our applications currently focus on measurement and verification and predictive analytics and are expanding to include building and city automation. Arkados Energy Solutions, our services subsidiary, is a general contractor providing energy conservation services to commercial building owners and managers. These services include energy assessments, LED lighting retrofits, oil-to-natural gas boiler conversions and solar PV system installations. The companies combine to provide solutions to building owners that increase return on investment, reduce operational cost and save energy. Arkados® is a registered trademark of Arkados Group, Inc. Cannabis: April 2017: beta site agreement with Yuma Way LLC, a Colorado-based cannabis grower, to utilize the Arktic™ Smart Building solution to help to optimize conditions in their greenhouse facility in order to increase revenues and reduce operating expenses.

Arena Pharmaceuticals, Inc. (NasdaqGS:ARNA) a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. One of the products under development is APD371, an agonist of the cannabinoid receptor 2 that is in Phase I single-ascending dose trial for the treatment of pain. The company also manufactures drug products under a manufacturing services agreement for Siegfried AG

Ascent Industries Corp. (CSE: ASNT) In Canada, Ascent (through its wholly-owned subsidiaries) is a Licenced Producer under the Access to Cannabis for Medical Purposes Regulations of Health Canada, with licences to cultivate cannabis and produce cannabis extracts. In addition, the Company is a Licenced Dealer under the Controlled Drugs and Substances Act (Canada), with the ability to produce, package, sell, send, transport and distribute medically focused cannabis products in Canada to other licenced entities and internationally in jurisdictions where medical cannabis is legal. In the United States, the Company holds licences in Oregon (for processing and for distribution of cannabis to any licenced entity in the state) and in Nevada (for cultivation and for production, processing and wholesale distribution of cannabis). In Europe, Agrima ApS, a Danish company and wholly-owned subsidiary of Ascent, has submitted licence applications for a Wholesaler Dealers Licence and Controlled Drug Licence in Denmark, and applications for the approval of eight products to the Danish Medical Cannabis Pilot Program.

Asia Green Biotechnology Corp. (CSE:ASIA) – formerly Asia Cannabis Corp – is an early-stage international agri-technology company centred on the planting, growing, and harvesting of new and valuable strains of hemp and related crops in commercial quantities in South Asia.

Aurora Cannabis Inc. (NasdaqGS:ACB; TSX:ACB.TO) is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Providing customers with innovative, high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched.

AusCann Group (ASX:AC8.AX) researches, develops, cultivates, produces, and sells clinically validated cannabis medicines to patients in Australia. The company has a strategic partnership with Tasmanian Alkaloids Pty Ltd. AusCann Group Holdings Ltd is headquartered in Carabooda, Australia.

Australis Capital Inc. (CSE: AUSA; AUSA.WT) identifies and invests in the cannabis industry predominately in the United States, a highly regulated, fragmented, rapidly expanding and evolving industry. Investments may include and are not limited to equity, debt or other securities of both public and private companies, financings in exchange for royalties or other distribution streams, and control stake acquisitions. Australis Capital adheres to stringent investment criteria and will focus on significant near and mid-term high-quality opportunities with strong return potentials while maintaining a steadfast commitment to governance and community. Australis Capital’s Board, Management and Advisory Committee members have material experience with, and knowledge of, the cannabis space in the U.S., extensive backgrounds in highly regulated industries, adherence to stringent regulatory compliance, public company and operational expertise

Auxly Cannabis Group Inc. (TSX:XLY.V) is a collective of entrepreneurs with a passion for the cannabis industry past, present and future. Our mandate is to facilitate growth for our partners by providing them with financial support and sharing our collective industry experience. Our partners all have different visions, voices and brand values, and all share a common goal-to build a world-class industry based on ethics, diversity, quality and innovation.

Axim Biotechnologies Inc (OTC:AXIM) focuses on the research, development and production of cannabis-based pharmaceutical, nutraceutical and cosmetic products. Our flagship products include CanChew®, a CBD-based controlled release chewing gum, and MedChew Rx, a combination CBD/THC gum that is undergoing clinical trials for the treatment of pain and spasticity associated with multiple sclerosis. We prioritize the well-being of our customers while embracing a solid fiscal strategy.

Ayr Wellness Inc. (CSE: AYR.A, AYR.WT, AYR.RT) is a vertically-integrated cannabis company in the United States focused on recreational and wellness applications, with an initial anchor portfolio of vertically-integrated operations in the Eastern and Western United States.

Bang Holdings Corp (OTC:BXNG) through its subsidiary Bang Digital Media, provides brand management, cannabis related digital content and influencer-based marketing for the cannabis industry. While major media providers restrict online marijuana advertising, Bang Holdings’ marketing networks allow cannabis companies to directly reach cannabis and cannabis equipment consumers. Since launching its first digital channel 4TwentyToday across multiple digital platforms in 2014, Bang Digital Media’s network has grown to reach more than a million engaged enthusiasts and has generated hundreds of millions of content views. Bang’s expanded network of cannabis-friendly social influencers reaches an additional twenty million subscribers.

BANGI (OTC:BNGI) which means “marijuana” or “hemp” in the African dialect Swahili, is a diversified investment vehicle that acquires and leases specialized real estate assets, such as cannabis farms. The Corporation combines hard asset security and long-term appreciation potential

BC Bud Corporation, The (CSE: BCBC) is a house of brands created by industry professionals who are passionate about the user experience and ever-changing consumer demand. Founder-led and based in British Columbia; we take the heritage of BC Bud seriously

BC Craft Supply Co. Ltd. (CSE:CRFT) is a vertically integrated, prohibition-era brand house firmly rooted in BC’s craft cannabis industry, which boasts an international reputation. With proven capabilities in cannabis cultivation, genetic research and development, product processing, and retail, Pasha is uniquely positioned in the new legal cannabis market through its network of hundreds of craft cannabis suppliers under the Pasha umbrella. Pasha subsidiary, Medcann Health Products Ltd., is a Health Canada licensed cultivator and processor with a licence to sell medical cannabis products in Canada. Pasha and BC Craft are also developing a craft cannabis campus, which is dedicated to bringing craft quality into the newly legal cannabis market in Canada. BC Craft is driven to assist craft growers in obtaining security clearance and licensing to grow as micro-cultivators, specializing in education and compliance to bring growers into the regulated cannabis supply market. Of particular importance is reflecting that we do in fact have a Health Canada license.

Bedrocan Cannabis Corp (TSX:BED.V) is the global leader in medicinal cannabis research and product innovation and has been producing and supplying government-regulated medicinal cannabis for 13 years. Bedrocan’s strains of pharmaceutical-grade cannabis are used by patients in seven countries, including Canada. The company is committed to clinical research, with ISO 9001-rated production processes and product development, on an international scale. Bedrocan is one of only two companies currently supplying pharmaceutical-grade medicinal cannabis in Canada.

Beleave Inc. (CSE:BE; OTC:BLEVF) is a biotech company who’s wholly-owned subsidiary Beleave Kannabis Corp. is licensed to cultivate and sell medical cannabis and produce cannabis oils and extracts pursuant to Health Canada’s Access to Cannabis for Medical Purpose Relations. Beleave has developed a network of medical cannabis clinics under the Medi-Green banner and has applied for various patents to broaden its strong research focused foundation.

Belgravia Hartford Capital Inc. (CSE:BLGV) is focused on the provision of clearly value-added services to the international Cannabis industry. This includes the production of specialized organic fertilizers for Cannabis Sativa plants, and the organization and development of blockchain technology software for seed to sale tracking and quality attestation of intermediate and consumer products. The wholly owned subsidiary of Belgravia, ICP Organics, is a research and development company incorporating agronomic and health perspectives in the Cannabis space. Blockchain technology, with its ability to provide robust and immutable histories of product tracking and also low cost integrated data bases for the Cannabis industry, is an ideal value-added approach to generating profitable Cannabis production and distribution activities. Belgravia is also developing a royalty-streaming subsidiary.

Bellatora Inc. (OTC: ECGR) purpose is to provide superior and innovative vaporizer products and eLiquids offering tobacco and marijuana smokers a healthier lifestyle alternative, while not polluting the environment for others. The freedom to vape. The liberty to enjoy. An established American marketer, manufacturer, and distributor of electronic vaporizers and eLiquids, Bellatora’s line up of premium quality electronic vaporizers, cigars, cigarillos, and cigarettes as well as eLiquids used in electronic vaping devices, provide significantly lower health risks, as well as product discreteness, and controlled active ingredient concentrations from tobacco and marijuana products.

BellRock Brands Inc., (CSE:BRCK.U) Formerly Dixie Brands Inc. is a multi-state cannabis CPG company that reaches over 113 million Americans across California, Colorado, Florida, Illinois, Maryland, Nevada, Michigan and Oklahoma, with a portfolio of cannabis brands.

Benchmark Botanics Inc. (CSE:BBT) is a public company that has recently acquired a Health Canada approved access to medical cannabis for medical purposes (ACMPR) producer: Potanicals Green Growers, Inc. The production center is based out of the beautiful Peachland, BC with a corporate office in Richmond, BC, Canada. Our advanced production technology and international strategic partnerships are our competitive advantage.

Better Choice Company (OTC:BTTR) Formerly Sport Endurance – At the foundation of Better Choice Company, Inc., is the belief that good health practices and nutrition contribute to, and promote, a higher quality of life. Better Choice, an animal health and wellness CBD company, has acquired TruPet LLC, an online seller of ultra-premium, all-natural pet food, treats and supplements, with a special focus on freeze dried and dehydrated raw products, and Bona Vida, Inc., an innovative emerging CBD platform, focused on developing a portfolio of brand and product verticals within the animal and human health and wellness space.

Better Plant (CSE:PLNT) (OTC: VEGGF) Formerly Yield Growth – develops and acquires intellectual property and other assets related to plant-based products and therapeutics. Through its integrated business model, Better Plant develops, manufactures, markets, sells and distributes plant-based products. It has 14 patent applications to protect its Intellectual Property, and over 200 proprietary wellness formulas at various stages of commercialization, including over 20 proprietary products that are now for sale via eCommerce or brick-and-mortar retail stores. It operates websites and oversees eCommerce and Amazon sales for over 200 JUSU plant based products for body, baby and home. Its majority-owned subsidiary NeonMind Biosciences Inc. is launching a line of coffees infused with health optimizing medicinal mushrooms including reishi, cordyceps, lion’s mane and turkey tail mushrooms. NeonMind is also engaged in research into developing a psilocybin (psychedelic mushroom) based product for weight loss and has applied for a Section 56 Exemption to begin preclinical trials to study its pending psychedelic medicine patents.

BetterLife Pharma Inc. (CSE: BETR) Formerly Pivot Pharmaceuticals Inc.- is an emerging biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Pivot’s wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions Inc. (“PGS” or “Pivot Green Stream”), conducts research, development and commercialization of cannabinoid-based nutraceuticals and pharmaceuticals.

Bettermoo(d) Food Corporation (CSE: MOOO)- Formerly Happy Gut Brands Limited- is an innovative beverage company focused on delivering high quality products through online and in-store retail platforms. Happy Gut Brands utilizes social media to deliver educational experiences for their customer base while demonstrating – pioneering beverage technologies. Happy Gut Brands wholly owned subsidiary Happy Tea provides high-quality CBD beverages developed to assist in alleviating stress, decreasing anxiety and minimizing inflammation to support enhanced daily routines. Happy Gut brands other wholly owned subsidiary, bettermoo(d), is a purpose driven plant-based, alternative dairy brand based in Vancouver, British Columbia, Canada, driven by the motto, “What A Cow Eats and A Human Needs”. Inspired by rich and creamy milks and cheeses from the Alps regions of Europe, bettermoo(d) dairy alternatives are infused with a proprietary blend of herbs, similar to those eaten by pasture-raised cows in these regions, prior to the introduction of mass factory farming of cows for milk.

BevCanna (CSE:BEV, OTC:BVNNF) develops and manufactures cannabinoid-infused beverages and consumer products for in-house brands and white label clients. With decades of experience creating, branding and distributing iconic brands that have resonated with consumers on a global scale, the team demonstrates an expertise unmatched in the emerging cannabis beverage category. Based in British Columbia, Canada, BevCanna has a 292-acre outdoor cultivation site in the fertile Okanagan Valley and the exclusive rights to a pristine spring water aquifer, as well as a world-class 40,000-square-foot, HACCP certified manufacturing facility, with a current bottling capacity of up to 72M bottles.

Beyond Medical Technologies Inc. (CSE:DOTC) Formerly Micron Waste Technologies Inc. is a leading organic waste technology company based in Canada. Micron Waste has developed and commercialized an on-site treatment system that can turn organic waste into clean water. Their research & development team has already produced solutions to handle organic waste generated by food distributors, quick service restaurants, and marijuana cultivators.

Bhang Inc. (CSE: BHNG) is committed to delivering exceptional sensory experiences to consumers at every point in their cannabis journey through its award-winning portfolio of brands. Bhang is a trusted cannabis house of brands with an extensive portfolio of over 100 cannabis, hemp-derived CBD and terpene products, including chocolates, pre-rolls, vapes, gums, beverages, gummies and mouth sprays, among others, that are sold by its licensees and/or by Bhang directly. Since 2010, Bhang has mastered the art of harnessing mutually-beneficial partnerships to bring safe, consistent and delicious products to consumers.

BioHarvest Sciences Inc. (CSE:BHSC) Formerly Canna-V-Cell Sciences Inc. produces and sells a food-based Nutraceutical product called ViniaTM which contains the whole range of piceid resveratrol in natural state . The product is made by growing plant cells from red grapes in bioreactors utilizing the Issuer’s platform technology which allows the growing of specific cells instead of the whole plant. The Issuer is also completing research to adapt its platform technology to growing of cannabis cells under a cannabis research license in Israel.

BioHemp International (OTC:BKIT) is a Company focused on rolling up a distribution platform for CBD providers to become the leading consolidation force in the CBD industry.

Biome Grow (CSE:BIO) is structured to be a centrally run business with cannabis production and distribution assets that are designed for certain Canadian provinces where there is a competitive advantage over large, national incumbent cannabis producers. Biome currently has four wholly-owned subsidiaries including: Highland Grow Inc., a licensed producer in Nova Scotia under Canada’s ACMPR; P-209 Inc., a company incorporated under the laws of the Province of Ontario and in the late stages of applying for a license under the ACMPR; The Back Home Medical Cannabis Corporation, a company incorporated under the laws of the Province of Newfoundland and Labrador and in the late stages of applying for a license under the ACMPR; and, Weed Virtual Retail Inc., a company incorporated under the laws of the Province of Ontario in the business of operating a new virtual reality technology platform focused exclusively on the medical and recreational cannabis markets.

Blue Diamond Ventures Inc. (OTC:BLDV) seeks to partner with individuals and companies that share a common synergy, mission, and vision to enable products/services that are produced, delivered and consumed utilizing fewer natural resources, providing a sustainable alternative to traditional products on the market today. As a diversified customer centric Management / Holding Company; Blue Diamond Ventures, Inc. seeks opportunities in various markets and is driven by critical thinking and the scientific method. Now-Brands, LLC – (40% Owned by Blue Diamond Ventures, Inc.) Producers of Olde Imperial Mystic Hemp Flavored Vodka; Cannabis Clean, LLC – (20% Owned by Blue Diamond Ventures, Inc.) Providers of Cannabis based cleaning and Special Grow Room Treatments.

Blue Line Protection Group Inc (OTC:BLPG) is a leading security, transportation and risk mitigation solutions provider for financial institutions servicing the legal cannabis industry. Blue Line provides consulting, armed security, compliance and investigations, transportation and secure vaulting services to banks, businesses and government entities who need to protect their assets, licenses and clients. Blue Line serves banks and credit unions by providing currency processing and transportation solutions, and its risk mitigation services help financial institutions serving cash-intensive industries comply with federal “know your customer” mandates.

Bluma Wellness Inc. (CSE:BWEL) owns and operates a vertically-integrated, licensed medical cannabis company in the State of Florida doing business as “One Plant Florida”. One Plant Florida cultivates, processes, dispenses and retails medical cannabis to qualified patients in the State of Florida through multiple retail dispensaries and an innovative next-day door-to-door e-commerce home delivery service, thereby offering convenient access for its customers and meeting the demands of an evolving retail landscape. Bluma plans to continue expanding its cultivation and distribution operations as the Florida market grows and may enter into other US states where the production, distribution and use of cannabis is permitted under state law.

BLVD Centers Corporation (CSE:BLVD) has operations in the US inpatient (detox and residential) and outpatient rehabilitation market and serves clients with addictive and co-occurring disorders, and offers a line of marijuana lifestyle management supplements. While BLVD continues to focus on its traditional services it is exploring the possibility of expanding its addition treatment services and product offering in the marijuana space in some capacity to be determined.

Body and Mind Inc. (CSE:BAMM) through its wholly owned subsidiary, Nevada Medical Group LLC, cultivates and retails flower, oil extracts, and edible cannabis related products, from its 20,000 square foot facility located in Clark County , Nevada. The products are distributed under the “Body and Mind” brand which has become successfully recognized on industry related websites such as Weedmaps.

Botanix Pharmaceuticals Ltd. (ASX:BOT.AX) mission is to improve the lives of patients battling acne, psoriasis and atopic dermatitis, by providing new treatment options for conditions that currently are inadequately addressed or are treated with therapeutics that are burdened with side effects profiles. We are harnessing the untapped potential of a synthetic active pharmaceutical ingredient known as cannabidiol which is currently being studied for the treatment of epilepsy, pain, arthritis and schizophrenia amongst other indications. Botanix is preparing for the first human trials utilizing synthetic cannabidiol in a proprietary drug delivery system (Permetrex™) for direct skin delivery of the therapy.

BoxScore Brands, Inc. (OTC: BOXS), a company that develops, markets, and distributes cannabis related and other alternative wellness products including ice cream electronic kiosks in North America, recently announced the addition of consumer goods industry veteran Michael P. Flanagan. The Company is also announcing a new strategic direction focused on opportunities within CBD and other alternative wellness products.

Braingrid Limited (CSE: BGRD) is a global technology company that provides an affordable, versatile and quick-to-install data acquisition and sensor integration platform for cannabis cultivators. Capturing real-time data needed to increase revenues, reduce costs and risks, and connecting cultivators to their grow on a microclimate level, Braingrid is also developing systems utilizing data science, machine learning and AI to deliver “smart” controls and building management solutions for the precision agriculture and energy efficiency sectors.

BREEDIT CORP (OTC:BRDT) through its Israeli subsidiary, BreedIT Ltd http://www.ibreedit.com, is the developer of highly sophisticated agro-breeding solutions for plant breeders and researchers. BreedIT’s proven iBreedIT® – the Intelligent Decision Support System (IDSS) for breeders which was developed by a team consisting of among the world’s leading breeding specialists for optimizing the breeding processes, services the plant breeding needs of corporations, research and government institutions. BreedIT’s IDSS provides advanced solutions for generating and disseminating knowledge aimed at assisting breeders to plan, manage and analyze their breeding data and to perform research activities quickly and effectively. Founded in 2013, BreedIT Corp has offices in New York, New York and in Rehovot, Israel.

Bud Genius, Inc (OTC:RIGH) An early leader in an industry that many are speculating will grow, Bud Genius is one of the first established analytical cannabis laboratories in the United States. Bud Genius was launched to bring vendors together with doctors, patients, and dispensaries that require certified products held to demanding standards. Bud Genius has a vision to expand across the US and abroad serving as the beacon of quality for medical cannabis and adult-use marijuana through the formation of regional laboratories.

BYND Cannasoft Enterprises Inc. (CSE: BYND) owns and markets a proprietary customer relationship management (CRM) software product, known as “Benefit CRM” which enables small and medium-sized businesses to optimize their day-to-day business activities. BYND plans to roll out the next generation of its Benefit CRM software, which will be cloud based in the next few months. BYND has recently begun development of an entirely new, innovative CRM platform, designed specifically to serve the needs of the medical cannabis industry. BYND has also obtained a primary growing license for growing medical cannabis in Israel and hopes to begin construction of a farm facility in late Q2 or Q3 of this year. Once the cannabis farm becomes operational, Cannasoft intends to work with strategic partners to develop and market new, proprietary cannabis infused products for sale throughout Israel and for export.

C21 Investments Inc. (CSE:CXXI; OTCQX: CXXIF) is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets, leveraging industry-leading retail revenues with high-growth potential multi-market branded consumer packaged goods. The Company owns Silver State Relief and Silver State Cultivation in Nevada, and Phantom Farms, Swell Companies, Eco Firma Farms, and Pure Green in Oregon. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. Based in Vancouver, Canada

Calyx Bio-Ventures Inc. (TSX:CYX.V) In addition to Calyx’s portfolio of proprietary intellectual property with applications in crop enhancement, its wholly-owned subsidiary, Cannigistics Agri-Solutions Corp., is a software development company that has created a software platform tailored to advanced indoor agriculture. The Cannigistics software platform is designed to enhance the efficiency and effectiveness of indoor agricultural operations, and positions Cannigistics to be the industry leader in agri-software solutions by providing businesses with advanced controls over all aspects of their operations. Recent upgrades have also generated interest in the software platform from outside the agriculture industry which could potentially provide additional areas of growth for the Company.

Canabo Medical Inc. (TSX:CMM.V; OTC:CAMDF) wholly owns and operates Cannabinoid Medical Clinics, or CMClinics, Canada’s largest referral-only clinics for medical cannabis. After opening in 2014, Canabo now has ten clinic locations, including Toronto, Barrie, Ottawa, Hamilton, Halifax, St. John’s, and Edmonton, with a number of additional clinics planned for opening in 2017. The principal business carried on and intended to be carried on by Canabo is the operation of strictly referral-only medical clinics for evaluating the suitability of, prescribing, and monitoring cannabinoid treatments for patients suffering from chronic pain and disabling illnesses. Clinics operated by Canabo are staffed by physicians and qualified health care practitioners specifically trained to assess patient suitability for cannabinoid treatment, recommend treatment regimes, and monitor treatment progress. Canabo sees patients only on a physician-referral basis. The Access to Cannabis for Medical Purposes Regulations (“ACMPR”) requires that medical cannabis must be prescribed by a health care practitioner; however, no cannabinoid products or medical cannabis are sold at Canabo’s medical clinics.

Canada Coal Inc. (TSX:CCK.V) has signed a non-binding Letter of Intent (“LOI”) with Honu Inc., a licensed marijuana grower and producer of marijuana concentrates and edible marijuana products in the State of Washington.

Canadian Cannabis Corp. (OTC:CCAN) Using an education and research focused platform targeted at healthcare providers and patients, Canadian Cannabis Corporation (CCC) will provide high quality medical marijuana to help manage a range of specific medical conditions, as well as help patients obtain their monthly prescription in a simple, seamless and transparent way.

CanaFarma Hemp Products Inc. (CSE: CNFA) is a full-service company operating in the hemp industry offering a full range of hemp-related products and services. These products and services include growing top-quality hemp, providing hemp-processing services, and offering hemp-based products to consumers utilizing a direct-to-consumer marketing approach.

Canbiola, Inc. (OTCQB: CANB) is a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps and concentrate. Canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure CBD products are legal in all 50 states.

Canbud Distribution Corporation (CSE: CBDX) is an early stage Canadian science and technology based vertically integrated global cannabis and hemp cannabinoids (“CBD”) clone to consumer company. The Corporation, through its subsidiaries, holds three industrial hemp licenses for the purposes of supplying the global market with medicinal and wellness cannabidiol and other cannabinoid-based products on leased lands located in McKellar, Ontario, Kettleby, Ontario and Lakefield, Ontario. Each hemp licence allows the growing and harvesting of hemp CBD flowers for processing into CBD and other cannabinoids extracts.

Cann Group Limited (ASX:CAN.AX) is the first Australian company to secure the necessary licences to undertake research and to cultivate cannabis for human medicinal and research purposes under the Australian Government’s new medicinal cannabis regulatory system. Cann is building an Australian based business intended to take advantage of opportunities relating to the emerging medicinal cannabis industry.

Cannabics Pharmaceuticals Inc (OTC:CNBX) a U.S based public company, is dedicated to the development of Personalized Anti-Cancer and Palliative treatments. The Company’s R&D is based in Israel, where it is licensed by the Ministry of Health for its work in both scientific and academic research as well as current clinical studies underway at Rambam Hospital. The Company’s scientific focus is on identifying and harnessing the therapeutic properties of specific natural Cannabinoids. Cannabics’ vision is to create individually tailored therapies for cancer patients, utilizing advanced screening systems and personalized bioinformatics tools.

Cannabis Growth Opportunity Corporation (CSE:CGOC) is an investment corporation which seeks to provide shareholders long-term total return through capital appreciation by investing in an actively managed portfolio of securities of public and private companies operating in, or that derive a significant portion of their revenue or earnings from, products or services related to the cannabis industry.

Cannabis Sativa Inc. (OTC:CBDS) is engaged through its recently acquired subsidiary, Kush, in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. CBDS also offers the Skin Garden line of cosmetic products through its subsidiary, Wild Earth Naturals, which are designed to use organic and natural ingredients, including hemp seed oil, to benefit inner wellbeing as well as outward appearance.

Cannabis Science Inc. (OTC:CBIS) takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers and neurological conditions.

Cannabis Strategic Ventures Inc. (OTC: NUGS) is one of the largest publicly traded marijuana cultivators in the United States. The Company is Los Angeles-based that incubates, develops and partners with category leaders within the cannabis and ancillary sectors. The Firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing Cannabis consumer brands.

Cannabis Suisse Corp. (OTCMKTS:CSUI) is a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company’s facilities for producing cannabis are based in Zurich. The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.

Cannabix Technologies (CSE:BLO; OTC: BLOZF) is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana. Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions. Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the recent use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous. The device is currently in prototype development and the Company is rapidly developing this technology.

CannaGrow Holdings, Inc (OTC:CGRW) has entered the Medical/Recreational Cannabis Industry as a Lessor, Liaison, and Consultant to licensed Growers providing them with turnkey Growing Facilities in the State of Colorado. The Company intends to expand this business model within this industry as business opportunities evolve whereby providing for the highest return to its shareholders. CannaGrow Holdings, Inc. does not and will not, until such time as Federal law allows, grow, harvest, distribute or sell marijuana or any substance that violate the laws of the United States of America.

CANNAMERICA BRANDS CORP. (CSE:CANA) is a U.S. marine veteran founded and operated portfolio of cannabis brands with licensing agreements in the states of Colorado, Nevada and Maryland. The Company aims to maximize the value of its brands by employing strong brand management teams, marketing and licensing the brands through various distribution channels, including dispensaries, wholesalers and distributors, in the United States and internationally. The Company’s core strategy is to enhance and monetize the global reach of its existing brands, and to pursue additional strategic acquisitions to grow the scope and diversity of its brand portfolio.

CannaOne Technologies (CSE:CNNA) was founded by a team of developers who recognized the tremendous opportunity of the emergence of the commercialized cannabis industry and its growth. This realization inspired the development of proprietary technologies that provide custom solutions for global markets. CannaOne’s goal is to meet the needs of an industry that is in flux and continuously shaping form. Our mandate is to apply in-depth research that encompasses all facets of a cannabis business to deliver digital tools that encourage the flourishment of the industry from the ground up. CannaOne’s first consumer product, BloomKitTM, is a robust proprietary business to business software platform with high functionality for cannabis businesses operating online or in a retail environment.

CannaPharmaRX, Inc. (OTC:CPMD) is focused on the acquisition and development of state-of-the-art cannabis grow facilities in Canada. CPMD is in discussion with other companies regarding potential acquisitions. CannapharmaRx’s business strategy is to become a leader in high quality and low-cost production of cannabis through the development, acquisition, and enhancement of existing facilities. CannapharmaRx is committed to operating high-quality facilities utilizing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis.

Cannara Biotech Inc. (CSE:LOVE) is building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility located in Farnham, less than 45 minutes from downtown Montreal. Leveraging Quebec’s low electricity costs, Cannara will produce high-grade indoor cannabis and derivative products for the Canadian and international markets. Working with partners from various industries, Cannara will generate licensing revenues, rental revenues and revenue streams from joint-venture arrangements leveraging this highly valuable property.

Cannassure Therapeutics Ltd. (TASE: CSURE.TA) is a subsidiary of Solbar Food Technologies Ltd., a 57 year-old producer of plant based raw materials and solutions for the food and food additives industries. Cannassure holds all the approvals required for establishing a vertically integrated medical cannabis operation and is working in all these areas from breeding, cultivation, extraction, storage, packaging and distribution.

Cannasys, Inc. (OTC:MJTK) is a leading technology solutions, marketing, and branding company in the regulated cannabis industry. Its core products are delivered “software as a service” to facilitate point-of-purchase transactions, customer relationship marketing solutions, and regulated cannabis laboratory information management systems. CannaSys plans to develop, acquire, and build strategic relationships with other businesses in order to bring additional solutions to market in both established and developing medical and recreational cannabis states.

Cannvas MedTech Inc. (CSE:MTEC) is a leading business technology company within the cannabis space. The company designs and builds customer-centric solutions that enable its partners to harness the power of data to truly understand their customers, industry, and key business drivers.

Cannex Capital Holdings Inc. (CSE:CNNX) through its wholly-owned subsidiaries, provides a range of comprehensive and flexible growth options for licensed cannabis cultivators, processors and/or dispensaries domestically and internationally, including providing turn-key real estate with operational infrastructure as well as long term advisory and consulting services. Cannex has acquired BrightLeaf Development LLC (“BLD”), a limited liability company that, through subsidiaries, holds real estate assets, property leases, brands and intellectual property, and material supply agreements with Superior Gardens LLC (d/b/a Northwest Cannabis Solutions), Washington State’s and the Pacific Northwest’s largest full-line cannabis producer/processor, and also 7Point Holdings LLC, another Washington State licensed cannabis producer/processor. Cannex is managed by a team of experienced industry and capital markets experts who are committed to aggressive, cost-effective growth and is based in Vancouver, British Columbia. Cannex is currently undertaking an expansion initiative to support the acquisition and development of additional assets, in Canada and internationally, that is expected to serve and support the growing legal medical and recreational cannabis markets. Cannex is also exploring several international opportunities in countries that have legal and strongly regulated medical and recreational cannabis sectors.

Cannibble Food-Tech Ltd. (CSE:PLCN) is a food tech company that develops and manufactures food mix products that are enhanced variously with hemp seeds, hemp protein, CBD, and THC, where legal to do so. Cannibble has developed proprietary formulas for powder-based edibles that are subsequently enhanced with active cannabinoids, which are marketed under our brand name “The Pelicann”. Cannibble has developed over 100 product SKUs, of which 32 have been manufactured to date.

CanniMed Therapeutics Inc. (TSX:CMED.TO) is a Canadian-based, international plant biopharmaceutical company and a leader in the Canadian medical cannabis industry, with 15 years of pharmaceutical cannabis cultivation experience, state-of-the-art, GMP-compliant plant production processes, including 281 points of quality control, and world class research and development platforms with a wide range of pharmaceutical-grade cannabis products. In addition, the Company has an active plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. CanniMed Ltd., a wholly-owned subsidiary of the Company, was the first producer to be licensed under the Marihuana for Medical Purposes Regulations, the predecessor to the current Access to Cannabis for Medical Purposes Regulations. Prairie Plant Systems Inc., a wholly-owned subsidiary of the Company, was the sole supplier to Health Canada under the former medical marijuana system for 13 years, and has been producing safe and consistent medical marijuana for thousands of Canadian patients, with no incident of diversion.

CannLabs Inc (OTC:CANL) is a respected authority and advisor to commercial, governmental and educational entities focused on the Cannabis industry. The company leverages its propriety scientific, testing processes, cloud-based business intelligence and data/analytics as well as consulting services to garner revenues from legalized Cannabis states and their constituents. Through Carbon Bond Holdings Inc. and the state certified labs it has relationships with, CannLabs delivers best practices around products, services and business intelligence focused on the Cannabis industry. CannLabs customers include states that currently have legalized medical or recreational Cannabis along with their associated growers, dispensaries, manufacturers of edibles, and residential consumers seeking information on cannabis.

CannPal Animal Therapeutics (ASX: CP1.AX) a pet pharmaceutical company, focuses on research, development, and commercialization of regulatory approved medicines using compounds derived from the cannabis plant for cats, dogs, and horses in Australia.

Canntab Therapeutics Limited (CSE: PILL) is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. Canntab has developed in-house technology to deliver standardized medical cannabis extracted from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. Simply put, Canntab’s mission is to put the “Medical” into medicinal cannabis!

CannTrust Holdings Inc. (NYSE:CTST; TSX:TRST.TO) since its inception in 2014, has led the Canadian market in producing pharmaceutically standardized product. As a federally regulated licensed producer, CannTrust™ brings more than 40 years of pharmacy and healthcare experience to the medical cannabis industry. CannTrust currently operates a 50,000 square foot state-of-the-art hydroponic facility in Vaughan, Ontario and is upgrading a 430,000 square foot cultivation facility in the Niagara region. CannTrust™ is committed to research and innovation, as well as contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis. Our product development teams along with our exclusive, global pharma partner, Apotex Inc., are diligently innovating and developing products that will make it easier for patients to use medical cannabis. We support ongoing patient education about medical cannabis and have launched a compassionate use program to support patients with financial needs.

Canopy Growth Corp (NasdaqGS:CGC; TSX:WEED.TO) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics. Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.

Canopy Rivers Inc. (TSX:RIV; OTC:CNPOF) is a unique investment and operating platform structured to pursue opportunities in the emerging global cannabis sector. The Company is managed by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks; but what makes Canopy Rivers truly unique is the Company’s strategic partnership and cornerstone investment from Canopy Growth Corporation (TSX:WEED, NYSE:CGC). Canopy Rivers works collaboratively with Canopy Growth to identify strategic counterparties seeking financial and/or operating support and affiliation with the Canopy Growth group of companies. The result is an ecosystem of complementary companies operating throughout the cannabis value chain. As the portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves, which the company believes results in an ideal environment for innovation, synergy, and value creation for Canopy Rivers, Canopy Growth, and across the entire Rivers ecosystem.

Cansortium Inc. (CSE:TIUM-U) is a US Based, vertically integrated cannabis company with a global mission: deliver the highest standards of cannabis care from nursery to lab to shelf. We maintain the highest standards in science, compliance, empathy, and the genetics of both plant and human. In providers, patients, education, and ever-shifting laws.

Captiva Verde Land Corp. (CSE:PWR) is a sustainable real estate company that invests in land assets that contain green residential communities, disruptive manufacturing facilities, organic food production and Cannabis operations.

Captor Capital Corp. (CSE:CPTR) is a Canadian investment firm. The company follows a strategy of acquiring profitable, established companies and organizations with growth potential that require capital to scale. Captor currently has investments in a number of companies and industries, including Millennial Esports in the technology sector, I-5 Holdings in the cannabis sector, and URU Metals in the natural resources sector.

Cara Therapeutics, Inc. (NasdaqGM:CARA) is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body’s peripheral nervous system and have demonstrated initial efficacy in patients with moderate-to-severe pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics.

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) is focused on producing pharmaceutical cannabidiol (CBD) products and developing innovative therapies for heart disease, including acute myocarditis and other causes of heart failure. The Company’s lead product, CardiolRx™, is designed to be one of the safest and most consistent CBD formulations on the market. CardiolRx is pharmaceutically produced, cGMP certified, and is THC free. The Company plans to commercialize CardiolRx in the billion-dollar market for medicinal cannabinoids in Canada and is also pursuing distribution opportunities in Europe and Latin America. In heart failure, Cardiol is planning an international clinical study of CardiolRx in acute myocarditis, a condition caused by inflammation in heart tissue, which remains the most common cause of sudden cardiac death in people less than 35 years of age. The Company is also developing proprietary nanotechnology to uniquely deliver pharmaceutical CBD and other anti-inflammatory drugs directly to sites of inflammation in the heart that are associated with heart failure. Heart failure is the leading cause of death and hospitalization in North America with associated healthcare costs in the U.S. alone exceeding $30 billion

Cartel Blue (OTC:CRTL) is a Los Angeles, California based eco-friendly apparel company that utilizes high-quality fabrics and designs with contemporary and edgy marketing strategies in conjunction with popular and unique celebrities in the film, television and music industries. The company manufactures and markets cotton/hemp jeans and tops for both men and women in the United States of America. Its newest division EOC (Evolution of Consciousness) Underground is a collection of men’s and women’s eco-friendly hemp/cotton t-shirts, hoodies, tote bags, and soon to be added jeans, shorts, scarves, vests, and jackets.

CB Scientific (OTC:CBSC) through its subsidiaries, designs, develops and manufactures Life Science Analytical Tools and Devices, Medical Delivery Systems, laboratory services, personal analytical kits and devices and CBD hemp oil and nutraceutical formulations for growers, care takers, dispensaries and companies worldwide. CB Scientific is continuing to develop new technologies specifically for cannabis (hemp) analytics. CB Scientific believes every product sold to patients as “Medical Quality” should be inspected for health benefits, safety, consistency, purity, potency and packaged properly for distribution. CB Scientific has worked with many of the cannabis industry leaders in the country and have also been featured in cannabis industry publications including High Times Magazine, Culture and many trade publications, on-air interviews and panel discussions across the United States. CB Scientific’s focus has been the education and safety of consumers combined with innovation to put power into the hands of the patients.

CB2 Insights (CSE:CBII; OTCQB:CBIIF) s a global leader in clinical operations, technology & analytics solutions and research and development services with a mission to mainstream medical cannabis into traditional healthcare. Providing immediate market access through its wholly-owned clinical network across 12 jurisdictions, proprietary data-driven technology solutions and comprehensive contract research services designed for those in both the medical cannabis and traditional life sciences industries, CB2 Insights is able to support its partners across the entire data and research spectrum. CB2’s Clinical Operations business unit leverages extensive experience to develop clinical models with standard operating procedures, advanced workflows, training and ongoing management support. CB2 also owns and operates its own speciality clinics including the brands Canna Care Docs and Relaxed Clarity which assess nearly 100,000 patients seeking medical cannabis treatment to provide immediate market access to US-based product manufacturers for clinical trial and research programs. The Company has built both electronic data capture (EDC) and clinical data management software (CDMS) which work to support its partners of any size to execute their data and clinical strategies. CB2 also offers comprehensive contract research organization (CRO) services including full scale clinical trial management, trial design, monitoring and other key research functions used by licensed producers, multi-state operators and traditional pharmaceutical companies entering the medical cannabis space.

CBD Global Sciences, Inc.,(CSE:CBDN) is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle which currently owns two product categories, branded under the name AETHICS (www.aethics.com) and CANNAOIL (www.cannaoilshop.com), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals. CBD Global Sciences hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online

CBD Unlimited, Inc. (OTC:EDXC) Formerly ENDEXX Corp. (OTC:EDXC) develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.3% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving. In the interest of providing conformity with federal and state mandates, the company has incorporated the “Gorilla-Tek” platform into its business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink regulated, and restricted products maintained under federal/state/local compliance. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is tremendously efficient as it provides up-to-the-minute accounting and product details. Gorilla-Tek increases productivity, while reducing costs for retailers and costs in time for customers

CENTR Brands Corp. (CSE: CNTR) (FSE: 303) develops and markets non-alcoholic beverages for the North American market. The Company’s initial focus is on the creation and launch of a global brand for the cannabidiol (CBD) infused beverage market. The Company’s first product, named CENTR, is a sparkling, low-calorie, CBD beverage.

Chapmans Limited (ASX: CHP.AX) is a venture capital firm specializing in early- stage, mature investments, special situation companies, growth capital investments in public and private companies. CANNABIS: MJ Life Sciences Pty Ltd – MJLS is an Australian special-purpose company established with the aim of becoming a leading global medicinal cannabis holding and investment company. MJLS is a direct investor in Caziwell Inc., owner of the established North American medicinal cannabis brand and business Aunt Zelda’s, with convertible note rights of up to 49.99% in Caziwell Inc. Chapmans views the opportunity to invest directly in MJLS, and have direct exposure to its future investments in the rapidly growing global medicinal cannabis sector, as being strategically advantageous and consistent with it’s high conviction and capital growth investment philosophy.MJLS expects to secure further compelling medicinal cannabis assets in the near term and list on the ASX by IPO or RTO in 2018 .

Charlestowne Premium Beverages Inc (OTC Pink: FPWM) formerly 1st Prestige Wealth Management – is a company that develops, produces, markets, and distributes alcoholic beverages worldwide. The Company’s portfolio showcases spirit brands such as Papa Vodka, Crocodile Tears Vodka, Proprietor’s Reserve Whiskey, and Lord Proprietor’s Special Reserve Whiskey. Charlestowne Premium also has Wholesaler and Import permits from the Alcohol and Tobacco Tax and Trade Bureau – the governing body for spirits in the U.S. under the Department of the Treasury. Cannabis: hope to carve a niche within the CBD infused beverage landscape.

Charlotte’s Web Holdings, Inc. (CSE: CWEB; TSX:CWEB.TO) is a market leader in the production and distribution of innovative hemp-based, CBD wellness products. Through its vertically integrated business model, CWEB strives to improve customers’ lives and meet their demands for stringent product quality, efficacy and consistency.

Chemesis International Inc. (CSE:CSI) is a licensed producer and manufacturer of medical and recreational cannabis in California and Puerto Rico, currently operating a 20,000 square foot, expandable state of the art manufacturing facility in Cathedral City, California and a 120,000 square foot cultivation and manufacturing facility in Puerto Rico. Chemesis International Inc. seeks to be an active participant in the U.S. and international cannabis markets.

Chemistree Technology Inc. (CSE:CHM) is an exciting new company, focusing its efforts on social media, branding, licensing and marketing technology. In addition to marketing events, brands and any other activities in the cannabis industry, the company will continue to identify other avenues for growth for social media marketing services, as well as brand marketing, product marketing, and more general services like financing and corporate consulting. The Company believes the cannabis industry offers a tremendous opportunity for growth. The reason for this is simply that marketing of cannabis companies, their products as well as information about the industry itself is in its infancy. Initially, the Pacific Northwest is the Company’s main target geography, but this is expected to expand from British Columbia and Washington into Oregon, and eventually California.

China Food & Beverage Company (OTC:CHIF) is a U.S. holding company whose strategy is the acquisition of companies in the medical cannabis industry, as well as the formation of joint venture partnerships and strategic alliances.

Choom Holdings Inc. (CSE:CHOO) Formery Standard Graphite Corp – was created for and inspired by the Choom Gang; a group of high school buddies in Honolulu during the early 1970’s who loved to smoke weed—or as they called it, “choom”. Now, after four decades, Choom™ is bringing the spirit of Hawaii to the Okanagan and Canada. We’re planting our flag in the rapidly growing legal cannabis industry in Canada with our own brand of high-grade handcrafted herb.

Christina Lake Cannabis Inc. (CSE:CLC) is a Licensed Producer of cannabis under the Cannabis Act which also received a Research and Development License from Health Canada on May 20, 2020. CLC’s facility consists of a 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, as well as research facilities, and a facility dedicated to processing and extraction. CLC cultivates cannabis using strains specifically developed for outdoor cultivation and expects to produce 22,500 kg or more from its 32-acre facility before developing its adjacent 99-acre expansion property, which will bring its cultivation footprint to over 4.35 million square feet or over 88,000 kg of low-cost, high-quality, sun-grown cannabis annually.

Chuma Holdings (OTC:CHUM) and our wholly-owned subsidiaries provide turnkey financing and support solutions to the rapidly evolving and growing legal cannabis industry. We provide “seed to sale” key business services including financing, compliance consulting, dispensary solutions, banking and payment processing solutions, and marketing and sales consulting. Chuma’s experienced team has over thirty-five years combined experience in the lawfully organized cannabis industry in California, and we are currently generating revenue from existing financing and service solutions. We are planning on expanding throughout California and bringing our array of services to each new state that legalizes the use of cannabis.

Citation Growth Corp (CSE:CGRO) Formerly LIHT Cannabis Corp. – pursues commercial ventures in the medical and approved use categories in the marijuana space in the United States and Canada.

City View Green Holdings Inc., (CSE:CVGR) (OTCQB: CVGRF) Formerly Icon Exploration Inc. – wholly-owned subsidiary has made application for a Cannabis licence under the Cannabis Act. The Company’s aim is to become a vertically integrated cannabis company focused on seed to retail. The Company’s business will incorporate growing, extraction, production and retail. Once legalized, the Company also expects to produce edible products, distillates and water-soluble products for the beverage market. In addition, the Company’s subsidiary owns a 19.9% stake in a private retail-focused cannabis company with access to retail store licences in Alberta and other retail opportunities across Canada.

Clean Power Capital Corp. (CSE:MOVE) is an investment company, that specializes in investing into private and public companies opportunistically that may be engaged in a variety of industries, with a current focus in the health and renewable energy industries. In particular, the investment mandate is focused on high return investment opportunities, the ability to achieve a reasonable rate of capital appreciation and to seek liquidity in our investments.

Clever Leaves Holdings Inc. (Nasdaq: CLVR) is a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids. Its operations in Colombia produce cannabinoid active pharmaceutical ingredients (API) and finished products in flower and extract form to a growing base of B2B customers around the globe. Clever Leaves aims to disrupt the traditional cannabis production industry by leveraging environmentally sustainable, ESG-friendly, industrial-scale and low-cost production methods, with the world’s most stringent pharmaceutical quality certifications.

CLS Holdings USA Inc (OTCQB:CLSH; CSE:CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states. CLS stands for “Cannabis Life Sciences,” in recognition of the Company’s patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company’s business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.

Codebase Ventures Inc. (CSE:CODE) Formerly 360 Blockchain Inc – is led by technology and business experts who invest early in great ideas in sectors that have significant upside, including the cannabis sector. We operate from the understanding that technology is always evolving, bringing early opportunities for strategic investments that can deliver the exponential returns to our shareholders. We seek out and empower the innovators who are building tomorrow’s standards with platforms, protocols and innovations – not just products. We invest early, support those founders, take their ideas to market and work tirelessly to help them realize their vision.

Columbia Care Inc. (CSE:CCHW) is one of the largest and most experienced cultivators, manufacturers and providers of medical and adult use cannabis products and related services with licenses in 19 jurisdictions in the US and the EU. Columbia Care has completed more than 1.6 million sales transactions since inception and working in collaboration with renowned and innovative teaching hospitals and medical centers globally, continues to be a patient-centered health and wellness company setting the standard for compassion, professionalism, quality, care and innovation in the rapidly expanding cannabis industry.

Compass Diversified Holdings LLC (NYSE:CODI) owns and manages a diverse family of established North American middle market businesses. Each of its current subsidiaries is a leader in its niche market. CODI maintains controlling ownership interests in each of its subsidiaries in order to maximize its ability to impact long term cash flow generation and value. The Company provides both debt and equity capital for its subsidiaries, contributing to their financial and operating flexibility. CODI utilizes the cash flows generated by its subsidiaries to invest in the long-term growth of the Company and to make cash distributions to its shareholders. Hemp: The manufacture and marketing of branded, hemp-based food products Manitoba Harvest: Headquartered in Winnipeg, Manitoba, Canada – Manitoba Harvest is a pioneer and global leader in branded, hemp-based foods. The company’s hemp products are among the fastest growing in the natural foods industry and are currently carried in about 7,000 retail stores across the U.S. and Canada. Virtually all of the company’s products are made on-site at their world-class manufacturing facility that has achieved the highest level of global certification in food safety and quality (BRC Grade A+). A vital component of the company’s vision is to promote health and wellness, and foster positive change for communities and the environment.

Constellation Brands (NYSE: STZ; NYSE:STZ-B) a Fortune 500® company, is a leading international producer and marketer of beer, wine and spirits with operations in the U.S., Mexico, New Zealand, Italy and Canada. Based in Victor, N.Y., the company believes that industry leadership involves a commitment to brand building, our trade partners, the environment, our investors and to consumers around the world who choose our products when celebrating big moments or enjoying quiet ones. Founded in 1945, Constellation has grown to become a significant player in the beverage alcohol industry with more than 100 brands in its portfolio; about 40 wineries, breweries and distilleries; and approximately 9,000 talented employees. We express our company vision: to elevate life with every glass raised. Cannabis: November 2017 – Constellation Brands (NYSE:STZ) (NYSE:STZ.B), a leading beverage alcohol company, today announced that it has signed an agreement to acquire a minority stake in Ontario, Canada-based Canopy Growth Corporation, a well-respected public company and leading provider of medicinal cannabis products. This investment and relationship is consistent with Constellation Brands’ long-term strategy to identify, meet and stay ahead of evolving consumer trends and market dynamics, while maintaining focus on its core total beverage alcohol business. Constellation has no plans to sell any cannabis products in the U.S. or any other market unless or until it is legally permissible to do so at all government levels.

Corbus Pharmaceuticals Holdings, Inc. (NasdaqGM:CRBP) is a clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company’s lead product candidate, JBT- 101, is a novel synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation, and fibrotic processes. In November 2016, Corbus reported positive topline data results from a Phase 2 study in diffuse cutaneous systemic sclerosis, showing clear signal of clinical benefit with JBT-101. The Company recently completed a Phase 2 study of JBT-101 for the treatment of cystic fibrosis with topline data expected to be announced before the end of the first quarter of 2017. Additionally, JBT-101 is being evaluated in a Phase 2, 12-month open label extension study in systemic sclerosis, a Phase 2 study in skin-predominant dermatomyositis, with a 12-month open label extension study in dermatomyositis and another Phase 2 study in systemic lupus erythematosus planned to commence in the first quarter of 2017.

CordovaCann Corp. (CSE:CDVA) is a Canadian-domiciled cannabis-focused consumer products company. CordovaCann primarily provides services and investment capital to the processing and production vertical markets of the cannabis industry.

Core One Labs Inc. (CSE:COOL) Formerly Lifestyle Delivery Systems Inc. filmstrip technologies produce an oral delivery system that can be used for energy elixirs, herbal remedies and a smokeless alternative option to medical and recreational users of cannabis. The Company’s technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking but also a new way to accurately meter the dosage and assure the purity of the product. The Company will license the technology to licensees, who will in turn manufacture the strips where the legal use of marijuana is allowed.

Corix Bioscience Inc. (OTCQB: CXBS) is the developer of proprietary cannabis and industrial hemp strains using tissue cell cultures to propagate living plants, with plans to patent strains to be used in the pharmaceutical medical industries. Our methods allow us to create and breed new and existing plant strains from tissue cells free from any pathogens or disease. We grow these plants to maturity and extract the oils. The oils are the “medicine” part of the plant. Our sales are focused at the medical industry and are developing brand named products to be released in early 2018. Company headquarters are in Phoenix, AZ with our laboratory and processing facility in Carson City, NV and grows in Genoa, NV. We are currently looking at expanding our footprint into Washington, Oregon, California and Arizona. The Company’s mission is to create clean products in medical grade facilities that are truly better for people and the environment.

Creative Edge Nutrition, Inc. (OTC:FITX) are in the “New Age Beverage Industry under the category Functional Beverages/Energy Products”. It is our intended plan to focus on our energy drink products and nutritional market targeting active lifestyles and well-being with a line of energy drinks such as beverages, our delicious tasting energy bars and more, including unique legal cannabinoids infused product lines. It is our goal to reward your commitment as shareholders with accurate and timely information and strategic partnerships that are not only transactional but transformational in nature. The company will implement a distribution and sales strategy that will be impactful and provide immediate measurable results.

Cresco Labs (CSE: CL) based in Chicago is a grower, processor and retailer of premium cannabis with operations in six states (Illinois, Ohio, Pennsylvania, Nevada, California and Arizona) and approval pending for acquisitions in three more states (New York, Massachusetts, Maryland). The company focuses on entering markets with outsized demand potential, significant supply constraints and high barriers to entry. Its speed-to-market – seven months from license to market – gives Cresco a competitive advantage as it replicates its model to expand its national footprint. Cresco’s ability to execute is complemented by a brand strategy that is tailored to all major consumer segments: everyday cannabis, medicinally focused, connoisseur grade, and chef inspired edibles by James Beard Award-winning pastry chef Mindy Segal

Creso Pharma (ASX: CPH.AX) develops and commercializes cannabis and hemp based nutraceutical products for human and animal health. It offers products for various age groups to accommodate a range of dietary requirements that are based non-animal derived gums, allowing buccal absorption of the cannabinoids. The company is also developing products based on BioLingus technology platform that uses micro-encapsulation technology for sublingual delivery of bio-active molecules such as proteins, peptides, and small molecules; and bioavailable enteric-coated tablets based on mesoporous silica gel.

Cronos Group, The (TSX:CRON.TO; NasdaqGM: CRON) Formerly PharmaCan Capital Corp. – is a company in the business of investing in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s MMPR. PharmaCan has a diversified portfolio of investments including investments in 3 of the 15 companies that are listed on Heath Canada’s website as licensed to produce and sell medical marijuana as well as another two of the eight companies that are listed on Health Canada’s website as licensed to produce medical marijuana.

CrowdGather, Inc. (OTC:CRWG) is an investor, acquirer, operator and owner of digital assets in the consumer and cannabis sectors. In 2016, CrowdGather intends to launch a crowdfunding portal at CrowdGather to assist cannabis and digital startups in procuring financing. The Company’s online publishing network is anchored by DIY community builder, Yuku.com while its cannabis holdings include long standing online communities WeedTracker and RapMusic.

CSA Holdings Inc (Canna Security America) (OTC:CSAX) provides security solutions to businesses in the cannabis industry in the United States. The company offers IP CCTV systems, intrusion alarm systems, perimeter alarm systems, and access control systems, as well as security consulting services. It also provides armed guards, armored transport, executive protection, background check, investigation, and risk assessment services.

CTT Pharmaceutical Holdings Inc. (OTCQB:CTTH) principal asset is a unique and novel patented drug delivery technology, an orally administered, fast dissolving thin film (the “Wafer”). This technology platform will target both the human and veterinarian (pet) markets for treatment of many diseases including pain management. The Oral Thin Film (Wafer) formulation is protected by several Canadian and US Patents. CTT’s oral fast dissolving drug delivery systems will consist of edible thin films (wafers) that dissolve without water, within a few seconds after placement in the mouth. The majority of drugs administered using our drug delivery system mirror injections in that they have the ability to enter the bloodstream quickly, are convenient and discrete, and can be administered anywhere. A faster absorption rate is achieved because the mouth contains a very thin mucosa and is extremely vascular. There is no bitter taste, no smoke inhalation as is the case with cannabis, and less degradation of medication (by bypassing the stomach) and most importantly lower dosage units are required given the efficacy of absorption. Patient compliance is improved, especially with those who have a fear of choking and/or are pediatric, geriatric or incapacitated patients who have difficulty swallowing. Most fast dissolving systems on the market today deliver anti-inflammatories, antihistamines and cough and breathing related medications. CTT believes that its Wafer technology will be one of the first to gain use in major markets such as pain management.

CURE Pharmaceutical Holding Corp. (OTC: CURR) is a fully integrated specialty pharmaceutical/bioscience company that leverages disruptive proprietary drug delivery technologies for a broad range of molecules serving the biopharmaceutical, veterinarian, medical foods and pharmaceutical cannabis markets. CURE develops its patented and proprietary delivery system (CureFilm™), the most advanced oral thin film on the market today, from its industry leading full service cGMP manufacturing facility. The Company’s mission is to deliver proven drugs in a fast and efficient manner and to improve quality of life.

Curaleaf Holdings, Inc. (CSE: CURA) (OTC: CURLF) s the leading vertically integrated multi-state cannabis operator in the United States. It is a high-growth cannabis company with a national brand known for quality, trust and reliability. The company is positioned in highly populated, limited license states, and currently operates in 12 states with 45 dispensaries, 12 cultivation sites and 11 processing sites. Curaleaf has the executive expertise and research and development capabilities to provide leading service, selection, and accessibility across the medical and adult-use markets, as well as the CBD category through its Curaleaf Hemp brand.

CV Sciences Inc. (OTC:CVSI) formerly CannaVest Corp, located in Las Vegas, Nevada, focuses on drug development activities on products containing cannabidiol (CBD) as the active pharmaceutical ingredient, and is engaged in the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™ brand.

Dakshidin Corporation (Whitechapel Holdings) (OTC Pink: DKSC) has positioned itself as an innovator in the emerging CBD and cannabis-derived products and services industry.

Datametrex AI Limited (TSX:DM.V; FSE:D4G) is focused on the collection of retail sales data, providing Government Agencies and Fortune 500 corporations with Artificial Intelligence solutions and implementing blockchain solutions for secure data transfers. The company is planning on integrating the DataTap environment to decentralized blockchains to further authenticate and validate the data collected. BLOCKCHAIN: Company’s wholly owned subsidiary, Nexalogy Environics Inc., has entered into a license and development agreement (the “Agreement”) with Revive Therapeutics Ltd. (“Revive”) (TSXV:RVV) (OTCQB:RVVTF) to develop the Artificial Intelligence (“AI”) component in Revive’s proprietary patient-focused program enabled by Blockchain technology dedicated to the medical cannabis industry.

Delivra Corp. (TSX:DVA.V) is a specialty biotechnology company that has a proprietary transdermal delivery system platform that can shuttle pharmaceutical and natural molecules, through the skin, in a targeted specific manner. Delivra manufactures and sells a growing line of natural topical creams with the proprietary transdermal delivery system platform under the LivRelief™ brand, for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and under the LivSport™ brand for sports performance. LivRelief™ products are available in pharmacies, grocery chains, and independent health food stores across Canada, and on-line at www.livrelief.com. LivRelief™ pain and nerve pain products are also available in the United States on Amazon and at www.livrelief.com/us. In parallel with its consumer products business, Delivra also has a mandate to license its patent-pending proprietary transdermal delivery technology platform to pharmaceutical companies globally, for the repurposing of pharmaceutical molecules transdermally to treat a broad range of conditions, along with licensing its over-the-counter products globally. Delivra is headquartered in Burlington, Ontario and has a research and development laboratory in Charlottetown, PEI. Cannabis: Completed a strategic partnership with Dosecann Inc. and ARA-Avanti RX Analytics Inc. to develop a unique suite of standardized and commercialized products for the medical cannabis market

Delota Corp. (CSE:LOTA) is an established vape and cannabis retailer that curates and sells vape and nicotine-related products, other smoking cessation products, cannabis products, and accessories where regulations permit. The Company currently operates 28 brick-and-mortar specialty vape stores in Ontario under the 180 Smoke Vape Store banner name, a leading Canada-wide specialty vape e-commerce platform (www.180smoke.ca), and five licenced dispensaries under the Offside Cannabis banner name in Ontario.

Delta 9 Cannabis Inc. (TSX:DN.TO) wholly-owned subsidiary, Delta 9 Bio-tech, is a licensed producer of medical marijuana pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) and operates an 80,000 square foot, expandable, state-of-the-art production facility in Winnipeg, Manitoba, Canada.

Dewmar Intl BMC Inc (OTC:DEWM) is a U.S. based, veteran-owned brand management services company that specializes in developing, acquiring and/or licensing new products and brands for successful launch or distribution in both national and international markets. The Company’s flagship brand, Lean Slow Motion Potion, is rated as one of the top 3 selling relaxation brands in the United States of the purported over 100 plus relaxation brands currently available in the world market. Furthermore, the Company is leveraging the explosion in the worldwide popularity of products derived from industrial hemp.

Diego Pellicer Worldwide Inc (OTC:DPWW) is a real estate and consumer retail development company that is focused on developing Diego Pellicer as the world’s first “premium” marijuana brand. Through the development and acquisition of premium, legally compliant real estate locations for cannabis growers and retailers, Diego Pellicer Worldwide provides a best-in-class platform for new business growth in the cannabis industry. Diego Pellicer does not grow or sell marijuana or marijuana infused products.

Digicann Ventures Inc. (CSE:DCNN) – Formerly Agra Ventures Ltd – is a growth-oriented and diversified company focused on the international cannabis industry. The company is dedicated to the cultivation, distribution and marketing of high-quality cannabis and cannabis-infused products worldwide. Digicann Ventures’ primary asset in Canada is Boundary Bay Cannabis located in Delta, BC, which is one of the largest cannabis greenhouse facilities focused on the cost-optimized cultivation of high-potency cannabis. Abroad, the company’s wholly owned subsidiary, Farmako GmbH, is focused on becoming Europe’s leading distributor of medical cannabis. Farmako currently has active product distribution operations in Germany and is fully licensed in the United Kingdom

DigiPath, Inc. (OTC: DIGP) is an independent cannabis testing and media firm that supports the cannabis industry’s best practices for reliable testing and delivers cannabis news coverage and education about the cannabis industry. DigiPath’s two business units are DigiPath Labs and TNM News Corp. DigiPath Labs™ is working to set the industry standard for testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures (SOP) to ensure product safety and efficacy. TNM News Corp. has pioneered a cannabis-focused news network, The National Marijuana News, which delivers news, interviews, and education on all things cannabis.

DionyMed Brands Inc. (CSE:DYME) is a multi-state cannabis brands and distribution platform, supporting cultivators, manufacturers and award-winning brands in the medical and adult-use cannabis markets. DionyMed sells branded products in every category from flower to vape cartridges, concentrates and edibles and serves more than 700 dispensaries and completes over 40,000 direct-to-consumer deliveries each

Discover Wellness Solution Inc. (CSE:WLNS) Formerly RMMI Corp is a Canadian company licensed, through its subsidiary, to cultivate, produce, process and sell cannabis in various forms. The Company’s vision is to enhance shareholder value by establishing cost leadership in hemp processing and CBD extraction coupled with a global distribution strategy.

Driven Deliveries, Inc. (OTC: DRVD), previously Results Based Outsourcing Inc. is the only publicly traded cannabis delivery service operating within the United States. Founded by experienced technology and cannabis executives, the Company provides on-demand marijuana delivery, in select cities where allowed by law. Driven provides the legal cannabis consumers the ability to purchase and receive their marijuana in a fast and convenient manner. By 2020, legal cannabis revenue in the U.S. market is projected to hit $23 billion. In leveraging consumer trends, and offering a proprietary, turnkey delivery system to its customers, management believes it is uniquely positioned to best serve the needs of the emerging cannabis industry and capture notable market share within the sector.

Earth Alive Clean Technologies Inc. (CNSX: EAC) aims to be a key player in world markets of environmentally sustainable industrial solutions. The company works with the latest innovations in microbial technology Co formulate and patent innovative products that can tackle the most difficult industrial challenges, once only reserved to environmentally harmful chemicals and additives. The company is focused on environmental sustainability in 1) dust control for the mining industry, and 2) the agriculture industry. Cannabis: Dr. Marijane, the Company’s specially formulated cannabis biofertilizer. Dr. Marijane is a 100% organic root probiotic that has been shown to increase cannabis yields by up to 28%. Scientific testing and validation of its performance began in 2014, and results have been repeatedly confirmed by several licensed commercial producers over the last year.

Earth Science Tech Inc (OTC:ETST) is a publicly traded unique Science based Biotechnology company focused on cutting edge Nutraceuticals, Bioceuticals, Phytoceuticals and Cosmeceuticals for the Health, Wellness and Alternative Medicine Markets to help improve the quality of life for Consumers Worldwide. ETST is also dedicated to providing Natural Alternatives to prescription medications through the use of its cutting edge Nutritional and Dietary Supplements. This may include products such as its High-Grade Hemp CBD (Cannabidiol) Oil, Vitamins, Minerals, Herbs, Botanicals, Personal Care Products, Homeopathies, Functional Foods and other products. These products may be in various formulations and delivery systems including (but not limited to) capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs. ETST is focused on researching and developing innovative Hemp extracts and to make them accessible Worldwide. ETST plans to be the premier supplier of the highest quality and purity of High Grade Hemp CBD (Cannabidiol) Oil. ETST’s primary goal is to advance different High Quality Hemp extracts with a broad profile of Cannabinoids and additional natural molecules found in Industrial Hemp and to identify their distinct properties. The company is dedicated in offering its consumers the finest and purest quality All Natural-Organic Hemp CBD Oil while never compromising on quality. ETST High Grade Hemp CBD (Cannabidiol) Oil is classified as “food based” and therefore perfectly permissible in all 50 states and more than 40 countries. Cannabinoids (Cannabidiol/CBD) are natural constituents of the Hemp plant and CBD is derived from Hemp stalk and seed. Hemp oil is a well-known dietary supplement and the naturally occurring CBD possesses no psychoactive qualities and presents a continuing stream of overwhelming evidence of significant Wellness benefits. With no psychoactive ingredient, Hemp CBD Oil is a ready-for-market Hemp-based Nutraceutical. The United States Food and Drug Administration (FDA) currently considers non-THC hemp based cannabinoids, including CBD, to be “food based” and therefore saleable. These new non-psychoactive CBD-rich hemp oil products that ETST has geared up to market and distribute are beyond reproach. CBD (cannabidiol), a naturally occurring constituent of the Industrial Hemp plant, promotes and supports the nutritional health of aging bodies in particular. Source: US Government Patent #6,630,507 “Cannabinoids as antioxidants and neuroprotectants.” ETST does not grow, sell or distribute any substances that violate United States Law or the controlled substance act. ETST does sell and distribute hemp based products.

EastWest Bioscience Inc. (TSX:EAST.V) is a vertically integrated wellness company with the infrastructure to become a global giant in the Hemp & CBD consumer health market. Since it was founded in 2016, EastWest continues to grow as a high-quality producer, manufacturer and distributor of multiple lines of premium hemp products. EastWest is strategically positioned in mainstream consumer markets with wholistic natural products and has developed distribution channels into mainstream stores and markets in Canada. The Company has a Health Canada licensed, GMP (Good Manufacturing Practices) certified manufacturing facility and produces premium brands offering natural products for a preventive care lifestyle. EastWest consumer product lines are divided into four distinct brands: 1) Natural Advancement – natural biopharmaceutical health supplements; 2) Earth’s Menu – all-natural hemp superfoods; 3) Natural Pet Science – pet food and pet supplements; and 4) Chanvre Hemp – all-natural health and beauty products. The organization will continue to focus on ongoing development of innovative, hemp-based consumer products through advanced science with clean, natural ingredients to complement its current product offerings.

Easton Pharmaceuticals (OTC:EAPH) is a specialty pharmaceutical company involved in various pharmaceutical sectors and others industries such as medical marijuana. The Company previously owned an FDA approved wound healing drug and currently owns topically-delivered drugs to treat cancer and other conditions that are in various stages of development with 3 of its OTC products to soon be ready for marketing and sale. Easton has completed an acquisition that grants a 40% ownership interest in Medicated Markets International LLC; a California Licensed Medical Marijuana Grower on 20 acres (3 acre growing area). Easton has also made additional investments into AMFIL Technologies and their groZONE anti-microbial airflow system, and has an exclusive option to purchase up to 49% in a medical marijuana grow-op business post granting of license from Health Canada, located in Ontario, Canada which has received a letter to build from Health Canada. The company’s gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of Cannabidiol extracts

Eco Science Solutions, Inc. (OTC:ESSI) is a technology-focused Company based in Hawaii, targeting the multibillion-dollar health, wellness and alternative medicine industry. From enterprise software, to consumer applications for daily use, the Company develops technical solutions that empower enthusiasts in their pursuit and enjoyment of building eco-friendly businesses and living healthy lifestyles. Eco Science’s core services span localized communications between consumers and business operators, social networking with like-minded enthusiasts, rich educational content, e-commerce, and rapid delivery of products, all catering to the health-and-wellness lifestyle.

Ecosphere Technologies, Inc (OTC:ESPH) s a technology development and intellectual property licensing company that develops environmental solutions for global water, energy, industrial and agricultural markets. We help industry increase production, reduce costs, and protect the environment through a portfolio of unique, patented technologies: technologies like Ozonix®, the Ecos PowerCube® and the Ecos GrowCube™, which are available for sale, as well as exclusive and nonexclusive licensing opportunities across a wide range of industries and applications throughout the world. Our technologies and products are available through multiple brands and subsidiaries that include Sea of Green Systems, Ecosphere Development Company and Fidelity National Environmental Solutions. Marijuana: Ecosphere Development Company, LLC. (“EDC”) is a wholly owned subsidiary of Ecosphere Technologies that was organized to develop and lease turnkey, high tech Agricultural Centers in locations around the United States that are geographically, politically and economically well positioned. EDC’s first project is located in Southeastern Washington State, where water and natural resources are plentiful, with over 300 days of sunshine per year.

Eden Empire Inc. (CSE:EDEN) is in the business of investments and operations in the cannabis sector and engaging in retail cannabis sales in Canada and the United States.

Elev8 Brands, Inc. (OTC: VATE) mission is simple: craft the highest-quality, organic hemp products for consumers in search of a healthier, happier lifestyle. Everyone needs to get the proper amount of healthy proteins to keep them feeling better and more energetic. We source only the best organic hemp protein powders-naturally full of powerhouse amino acids and Omegas-3, 6, and 9-so we can infuse your daily coffee and tea with an abundance of minerals, vitamins, antioxidants, and fiber. Mother Nature creates this pure hemp with a rare, perfect balance for optimal nutrition and exceptional taste. Elev8 Hemp takes these raw, natural products and transforms them into delicious CBD-infused beverages that will become your new favorite daily drink. CBD-infused coffees and teas are our specialty, and we take our mission very seriously. Let us do what we do best and let achieving a healthier lifestyle be as simple as remembering your morning cup.

Elixinol Global Limited (OTC: ELLXF) (ASX: EXL.AX) co-founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and extracting premium-quality hemp, Elixinol is one of the few CBD hemp extract brands with complete seed-to-sale control over its products. Elixinol also conducts rigorous third-party laboratory testing and quality control. Elixinol distributes hemp-derived CBD products in 40 countries globally including North and South America, throughout Europe, Asia, and the Pacific Region under its own label as well as bulk CBD and wholesale CBD.

ELIXXR Ltd. (TSX:ELXR.V) (OTCQB:ELXIF) formerly -LGC Capital – is a leading cannabis investment firm with a focus on the legal global cannabis market. Through its growing portfolio of investment companies, ELXR is building a transversal integrated organization of interconnected legal cannabis companies with cultivation, processing and distribution in Australia, Jamaica, Switzerland, Italy, and Canada serving domestic and export markets.

Emblem Corp. (TSX:EMC.V; OTC:EMMBF) formerly Sabre Capital is licensed under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) to cultivate and sell medical marihuana. Emblem carries out its principal activities producing marihuana from its facilities in Paris, Ontario pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.

Emerald Health Therapeutics Inc. (CSE:EMH) is a cannabis company that is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.

Empower Clinics Inc. (CSE:CBDT) -formerly Adira Energy Ltd. – is a growing network of physician-staffed health clinics focused on helping patients improve and protect their health. Our mission is centered around physician-guided treatment for the relief of chemo-therapy side-effects, seizures, PTSD, and a multitude of chronic pain conditions. We understand that each patient is unique, and we’re here to provide personalized guidance toward the optimal product for their individual need.

Encompass Compliance Corp (OTC:ENCC) is the most comprehensive provider of workplace drug, alcohol & marijuana compliance services. The company provides organizations with policies, procedures and training for supervisors and employees to manage their drug and alcohol testing programs. In addition Encompass provides claim defense services for your safety, risk and legal teams as well as information and content that supports your Human Resource and Drug Compliance Program Managers.

Enertopia (CSE.TOP; OTC:ENRT) is focused on providing opportunities for people to maintain or increase their quality of life. With the advances in medical research, changing laws and increasing public awareness around Medical Marijuana and other health remedies, people finally have options to live their life their way. Enertopia’s mandate is to provide education and opportunities for people in search of self-care and healing.

EnWave Corporation (TSX:ENW.V; FRANKFURT:E4U.F) a Vancouver-based advanced technology company, has developed Radiant Energy Vacuum (“REV™”) — an innovative, proprietary method for the precise dehydration of organic materials. REV™ technology’s commercial viability has been demonstrated and is growing rapidly across several market verticals in the food and pharmaceutical sectors. EnWave’s strategy is to sign royalty-bearing commercial licenses with industry leaders in multiple verticals for the use of REV™ technology. The company has signed twenty-three royalty-bearing licenses to date, opening up eight distinct market sectors for commercialization of new and innovative products. In addition to these licenses, EnWave has formed a Limited Liability Partnership, NutraDried LLP, to develop, manufacture, market and sell all-natural cheese snack products in the United States under the Moon Cheese® brand. Cannabis: EnWave is driven to innovate and continuously commits resources to strengthen its intellectual property portfolio which is the cornerstone for the Company’s licensing-royalty business model. This patent application expands the application of EnWave’s Radiant Energy Vacuum (“REV™”) technology to the rapidly growing global medicinal and recreational cannabis market sector.

Epazz, Inc. (OTC: EPAZ) is a leading cloud-based software company that specializes in providing customized cloud applications to the corporate world, higher-education institutions, and the public sector. Epazz BoxesOS™ v3.0 is the complete business web-based software package for small- to mid-size businesses, Fortune 500 enterprises, government agencies, and higher-education institutions. BITCOIN: Epazz a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions, announced today that the company’s new cannabis bitcoin payment system, ZenaPay, has joined the Tappx mobile-marketing community to promote its apps in the Tappx community and assist in ZenaPay’s launch.

eSense-Lab (ASX: ESE.AX) a life sciences company, specializes in the commercialization of the phytochemical profiling of plants. Its technology combines genetics, mRNA, protein expression, and phytochemical profiles to generate a comprehensive model of rare or high value plants. The company’s product is reconstructed cannabis Terpene Profiles. esense-Lab Ltd. was incorporated in 2016 and is based in Nes Tziona, Israel.

ETFMG Alternative Harvest ETF (NYSE Arca:MJ) is one of the first of its kind available to U.S. investors allowing them access to a unique sector in this rapidly evolving market. MJX is designed to replicate the Prime Alternative Harvest Index, which tracks companies likely to benefit from the increasing global acceptance of various uses of the cannabis plant. This includes treatments from innovative medicinal breakthroughs involving the plant’s unique properties – the result of years of significant research by the global biotech and pharmaceutical community.

Eureka 93 Inc. (CSE: ERKA) Formerly LiveWell Canada Inc. – is one of the largest CBD extraction operations in North America, dedicated to producing the highest quality CBD products for our customers. Our first processing facility is in Eureka, Montana, off U.S. Route 93, in the rugged Pacific Northwest. Surrounded by soaring mountains, pristine lakes and dense forests, the name Eureka93 reflects the purity and creativity that goes into all our products and solutions.

Eve & Co Incorporated (TSXV:EVE,OTC:EEVVF) through its wholly-owned subsidiary Natural MedCo Ltd., holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil. Natural MedCo Ltd. was Canada’s first female-founded licensed producer of medicinal marijuana and received its cultivation licence from Health Canada in 2016. Eve & Co is led by a team of agricultural experts and has a licensed 1,000,000 square foot greenhouse located in Strathroy, Ontario.

EVE Investments (ASX: EVE.AX) is a venture capital firm specializing in startup investments in technology sector. The firm prefers to invests in Australia. Hemp: Eve Investments holds a 50% interest in Meluka Health. Meluka Health is a wellness and nutrition company that develops and sells its naturally derived, organic and ecologically pure products created using its old growth Australian Melaleuca tea tree plantation which are worldly acclaimed for their medicinal activity. Meluka Health is currently focused on producing high quality organic medicinal honey and the development of a bee health tonic. Products – Hemp Seed Honey – incorporating the health benefits of hemp seed which has a concentrated balance of proteins, essential fats, vitamins and enzymes combined with a relative absence of sugar, starches and saturated fats and combined with Meluka Honey to deliver an exception flavour profile; Medicinal cannabis honey – a premium medicinal honey product produced by by Bees harvesting on cannabis plants

Eviana Health Corporation (CSE: EHC) was established for the marketing of proprietary formulations of natural skincare and therapeutic products (cosmeceuticals and nutraceuticals). The Company is now completing the final stages that will enable it to deliver customized consumer skin care products. The Company holds an – 3 – option to acquire a 100% equity interest in Eviana Inc., an Ontario corporation that holds certain assets in Serbia relating to the cultivation of industrial hemp plant oil for the pharmaceutical, nutraceutical and cosmeceutical industry. Pursuant to this option, the Company has access to a significant grower/supplier of a critical ingredient in topical skin care cream. The Company plans to build on its presence as a cosmeceutical, nutraceutical and pharmaceutical centered business focusing on the market for natural hemp strains of cannabis sativa for bio-chemical cosmeceutical and nutraceutical merchandise and cannabinoid-based topical creams and products.

EVIO Inc (OTC:EVIO) Formerly – Signal Bay, Inc. – is a life sciences company focused on analyzing cannabis as a means for improving quality of life. The Company provides analytical testing services, advisory services and performs product research in its accredited laboratory testing facilities. The Company’s EVIO Labs division operating coast-to-coast provides state-mandated ancillary services to ensure the safety and quality of the nation’s cannabis supply.

EVITRADE Health Systems Corp. (CSE:EVA) offers a physiologically interactive computing platform that integrates medical devices and artificial intelligence applications into a fully automated, personal health management system for hypertension, arrhythmia, diabetes, and obesity. The current focus is a telehealth platform for the normalization of cardiometabolic power in terms of blood pressure, blood glucose, and body weight – and the monitoring of the physiological response to medical solicitations, mainly medication, diet, exercise, and lifestyle changes. HEMP: recently announced that the Company’s subsidiary, Western Agri Supply Solutions Corp. has entered into a joint venture with Belt Energy and Biomass, a Nevada hemp focused operator.

Evogene Ltd. (NYSE:EVGN) is a leading biotechnology company for the improvement of crop productivity for the food, feed and fuel industries. The Company operates in three key market segments: improved seed traits (addressing yield increase, tolerance to environmental stresses and resistance to insects and diseases); innovative ag-chemicals (developing novel herbicide solutions for weed control); and ag-biologicals. Evogene has collaborations with world-leading seed and ag-chemical companies.

Exactus Inc. (OTCQB: EXDI) is pursuing opportunities in hemp derived Cannabidiol, which is more commonly referred to as CBD. Industrial hemp is a type of cannabis plant containing less than 0.3% THC (tetrahydrocannabinol), which is the psychoactive component of the cannabis plant. Industrial hemp is cultivated for the plant’s seed, fiber, and extracts. After 40 years of prohibition, the Agricultural Improvement Act of 2018, known as the 2018 Farm Bill, legalized hemp on the federal level. Hemp production will be regulated by the United States Department of Agriculture (USDA) and the states. As a result, Hemp has generally been removed from the Controlled Substances Act (CSA) and the Drug Enforcement Administration (DEA). A potential risk of growing hemp in the United States is that the entire crop must be destroyed if it tests at a THC percentage greater than 0.3%.

EXMceuticals Inc. (CSE: EXM) Formerly Orofino Minerals Inc – is a cannabis company with a head office in Vancouver, British Columbia and operations in the Democratic Republic of Congo and Uganda. EXM’s activities are focused on the sustainable cultivation of cannabis and hemp, and the production of pharmaceutical grade, psychotropic and non-psychotropic cannabis and hemp ingredients for the pharmaceutical, therapeutical and nutraceutical industries. EXM is in the process of obtaining additional licenses and establishing operations across multiple sites in Africa, including Ethiopia, Malawi, Zambia and Burundi. In addition, EXM is in the process of obtaining a license in Portugal for the establishment of a research laboratory, a nursery, and a center for processing and distribution. EXM proposes to export the extracted ingredients to international markets.

Falcon Technologies, Inc (OTC PINK: FLCN) is a company focused on the marketing, sale, and distribution of CBD products and other products derived from industrial hemp.

FinCanna Capital Corp. (CSE:CALI) is a royalty company for licensed medical cannabis, with a focus on California. FinCanna, led by a team of finance and industry experts is building its portfolio of investments in scalable, best-in-class projects. FinCanna’s flagship investment is with Cultivation Technologies Inc. (“CTI”) to provide funding for its fully-entitled, large-scale indoor medical cannabis facility to be developed in Coachella, Southern California. This Coachella Campus will be a state-of-the-art facility that will include cultivation, extraction, manufacturing, testing and distribution.

Fire & Flower Holdings Corp. (TSXV: FAF.V) is a leading independent adult-use cannabis retailer poised to capture significant market share in Canadian provinces that allow private retail. The company provides customers with expertly curated product selection and a best-in-class, education-driven customer experience. Fire & Flower’s leadership team combines extensive experience in the legal cannabis industry with deep retail expertise. The company is at the forefront of the new adult-use cannabis industry in Canada.

First Harvest Corp (OTC:HVST) is a platform for tech, media and gaming with a focus on the cannabis industry and emerging growth sectors. This platform spans mobile gaming, digital and social media, e-commerce sales and education. First Harvest’s platform connects mainstream advertisers to pro-legalization supporters of medical and therapeutic cannabis.

Flora Growth Corp. (NasdaqCM:FLGC) s a cannabis company that works to leverage natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the world’s largest outdoor cannabis cultivation facilities, Flora strives to market a higher-quality premium product at below market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive.

Flower One Holdings Inc. (CSE:FONE) is a company with strategic investments in the cannabis sector through its wholly-owned subsidiaries. FONE’s wholly-owned subsidiaries are located in Nevada where it is currently converting the largest commercial scale greenhouse in the State. The 430,000 square foot facility will be used for cannabis cultivation as well as the processing, production and high-volume packaging of dry flower, cannabis oils, concentrates and infused products.

FluroTech Ltd. (TSX:TEST.V) is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech’s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples derived from cannabis plants. Using the technology that was developed at the University of Calgary in conjunction with the University of Alberta, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ and consumable testing kits

ForeverGreen Worldwide Corporation (OTC:FVRG) develops, manufactures and distributes an expansive line of all natural whole foods and products to North America, Australia, Europe, Asia, Africa and South America, including their new global offerings, PowerStrips, SolarStrips and BeautyStrips. They also offer Azul and FrequenSea(TM), whole-food beverages with industry exclusive marine phytoplankton, the Versativa line of hemp-based whole-food products, immune support and weight management products, Pulse-8 powdered L-arginine formula, TRUessence(TM) Essential Oils and Apothecary, 24Karat Chocolate(R) and an entire catalog of meals, snacks, household cleaners and personal care products

Freedom Leaf Inc. (OTC: FRLF) The Marijuana Legalization Company™ is a fully reporting and audited, Publicly Traded company. Freedom Leaf is one of the leading go-to resources in the cannabis, medical marijuana, and industrial hemp industry. It is involved in mergers and acquisitions in the marijuana industry, including incubation of new marijuana-related companies and spin offs. In addition, the company flagship publication, Freedom Leaf Magazine, The Good News in Marijuana Reform, produces a portfolio of news, print and digital media, websites, and web advertising, for the ever-changing industry. Freedom Leaf Inc. does not handle, grow, sell, or disperse marijuana or related products.

Frelii Inc. (OTCQB: FRLI) is a biotech company that uses human DNA gene sequencing and artificial intelligence (AI) to assess more than 3.2 billion markers on the human genome. The results are aligned and leveraged against its AI, as a means of creating a very strong and powerful data platform for use by the Health & Wellness, Healthcare, Medical Cannabis and Pharmaceutical industries. Frelii’s technology generates accurate and profoundly valuable insight into an individual’s DNA. The company provides DNA Kit Packages and customized reporting for consumers, patients and healthcare providers to ensure the ideal treatment, drugs and dosing are a prime “fit” to the individual. Cannabis – May 2019 – announced that it has signed a contract and licensing agreement with Optivida Health (Optivida), one of the nation’s leaders in advanced hemp extract for the consumer market. Optivida will leverage Frelii’s proprietary DNA Kit Packages™ to ensure Optivida customers can realize the optimal benefits of which specific Optivida products best suit their unique DNA profile.

FSD Pharma Inc. (CSE:HUGE; NasdaqCM: HUGE) owns, through its wholly-owned subsidiary FV Pharma Inc., a license to produce marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR) which was originally granted on October 13, 2017. Headquartered at the former Kraft plant in Cobourg, Ontario, approximately an hour’s drive from Toronto, FSD Pharma’s management’s mission is to transform the facility into the largest hydroponic indoor cannabis facility in the world. FSD Pharma intends to target all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development.

FusionPharm, Inc. (OTC:FSPM) manufactures and sells a line of cultivation containers under the PharmPod brand name in the United States. Its PharmPods cultivation container system is used in the indoor plant cultivation. Fusion Pharm, Inc. also sells its PharmPod cultivation containers for use in cultivating various plants to businesses, universities, and individuals.

Future Farm Technologies Inc. (CSE: FFT: OTC:AGSTF) Formerly Arcturus Growthstar Technologies Inc. – business model includes developing and acquiring technologies that will position it as a leader in the evolution of Controlled Environment Agriculture (CEA) for the global production of various types of plants. Future Farm provides scalable, indoor CEA systems that utilize minimal land, water and energy regardless of climate, location or time of year and are customized to grow an abundance of crops close to consumers, therefore minimizing food miles and its impact to the environment. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generate yields up to 10 times greater per square foot of land. The contained system provides many other benefits including seed to sale security, scalability, consistency due to year-round production, cost control, product safety and purity by eliminating environmental variability. The Company is also in the business of designing and distributing LED lighting solutions utilizing the COB and MCOB technology. The Company is focused on delivering cost efficient lighting to North America via advanced e-commerce sites the Company owns and operates. LEDCanada.com which caters to B2B customers is a supplier of the newest and highest demand LED solutions. The Company also owns and operates COBGrowlights.com which caters to both large and small agriculture green houses and controlled cultivation centers.

FutureLand Corp. (OTC:FUTL) a Colorado company, is a cannabis and hemp specialty-zoned land leasing company formed to capitalize upon the emerging global cannabis market. FutureLand, focuses on target acquisition, zoning, license fulfillment, site plan preparation and financing of cannabis or hemp grow facilities throughout the United States. We give growers the opportunity to grow. We monetize through leasing the land, leasing the structures on the land, financing interest revenue and management fees associated with cultivation centers. FutureLand retains ownership of all the land and the structures. FutureLand leases to both medical marijuana, retail marijuana as well as industrial hemp growers. FutureLand does not currently grow, distribute or sell marijuana, but this is about to change.

FutureWorld Corp. (OTC:FWDG) a Delaware corporation, is a leading provider of advanced technologies and solutions to the global cannabis industry. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products and services, such as industrial Hemp. FutureWorld, through its subsidiaries, provides personal and professional THC and CBD test kits, pharmaceutical grade CBD oil solutions, SafeVape vaporizers, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal cannabis. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global cannabis and hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana.

Gaby Inc. (CSE: GABY) is a better-for-you foods company which creates powerfully nutritious foods that contain no additives or preservatives using unique ingredients in innovative ways. Well-known for its original and award-winning skinnypasta™, gabbypasta™ and noodi™ brands, GK has added a fourth brand, alto™, to represent its cannabis- and hemp-infused products – creating the cannabis sector’s first savory and nutritionally dense THC- and CBD infused edibles brand. With its existing infrastructure of major retailers and an extensive broker network, GK is uniquely positioned to service both mainstream grocery and licensed cannabis retailers throughout both legal and emerging markets across North America.

Gage Growth Corp. (CSE:GAGE) is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market. Through years of progressive industry experience, the firm’s founding partners have successfully built and grown operations with federal and state licenses, including cultivation, processing and retail locations. Gage’s portfolio includes city and state approvals for 19 “Class C” cultivation licenses, three processing licenses and 12 provisioning centers (dispensaries).

Gaia Grow Corp. (CSE:GAIA) is a licenced cultivator of industrial hemp. The Company’s business model leverages contract farming to utilize existing farmland and skilled farmers to cultivate industrial hemp, which it then sells to processors to be turned into hemp fibre and cannabidiol oil and concentrates. The Company expects to expand its operations to include retail cannabis stores in British Columbia.

Gala Global Inc (OTC:GLAG) is a publicly-traded company focused on the development and commercialization of cannabis derived products. The company is developing relationships with numerous groups within the cannabis and hemp industry as well as Indian Tribes looking to take advantage of the newly given opportunities by the federal government regarding cannabis on tribal lands. We are still in the process of developing a hemp fiber clothing line and a therapy line of nutraceutical CBD products. Gala Global, Inc., professional services group provides operational services and technologies that drive efficiencies in the medical and recreational cannabis market.

Galileo Life Sciences (OTC:MDRM) (formerly Modern Mobility Aids) is a company strategically focused on the production and distribution of premium medical marijuana in North America and advanced health and life science and services that nurture innovative solutions to enhance the quality of life for all. The Company also has a commitment to leading edge research and development in support of these rapidly growing alternative health and life sciences trends, technologies and services.

General Cannabis Corp (OTC:CANN) formerly Advanced Cannabis Solutions, Inc. – provides services to the regulated cannabis industry throughout the United States. We will lease growing space and related facilities (commercial real estate and equipment) to licensed marijuana business operators for their production needs. We are pursuing ancillary business products and services including customized finance, capital formation, banking, regulatory compliance consulting and advanced logistical support for grow operations. ACS does not grow, harvest, distribute or sell cannabis or any substances that violate United States law or the Controlled Substances Act, nor does it intend to do so in the future.

Generation Hemp Inc. (OTCQB:GENH) is a Dallas/Fort Worth based energy transition company that primarily operates in the hemp midstream sector with fee-based midstream hemp services. The Company continues to acquire proven hemp companies to build out its environmentally sustainable seed to sale model and into related verticals that offer significant shareholder value, including energy efficient Bitcoin cryptocurrency mining operations. With operations in Hopkinsville, Kentucky and Denver, Colorado, the company uses its proprietary technology to dry, clean, process and store hemp. In addition, Generation Hemp also owns and leases real estate to companies that need seed storage facilities located within the greater Denver area.

Gilla Inc. (OTC:GLLA) manufactures, markets and distributes E-liquid, which is the liquid used in vaporizers, E-cigarettes, and other vaping hardware and accessories. E-liquid is heated by the atomizer to deliver the sensation of smoking. Gilla aims to be a global leader in the manufacturing and distribution of E-liquid for the vapor industry. The Company provides consumers with choice and quality across categories and price points. Gilla’s product portfolio includes Coil Glaze, The Drip Factory, Surf Sauce, Siren, VaporLiq, Craft Vapes, Craft Clouds, Vape Warriors, Miss Pennysworth’s Elixirs, The Mad Alchemist, Replicant and Crown E-liquid brands. Marijuana: Gilla’s new brand of CBD E-liquid products will be marketed under the new label “Enriched” and www.enrichedvapor.com

Glass House Brands (OTC:GLASF) is one of the fastest-growing, vertically integrated cannabis companies in the U.S., with a dedicated focus on the California market and building leading, lasting brands to serve consumers across all segments. From its greenhouse cultivation operations to its manufacturing practices, from brand-building to retailing, the company’s efforts are rooted in the respect for people, the environment, and the community that co-founders Kyle Kazan, Chairman and CEO, and Graham Farrar, Board Member and President, instilled at the outset. Through its portfolio of brands, which includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness, Glass House Brands is committed to realizing its vision of excellence: outstanding cannabis products, produced sustainably, for the benefit of all.

Global Compliance Applications Corp. (CSE:APP; OTCQB:FUAPF) – Formerly Global Cannabis Application Corp. – is a global leader in designing and developing innovative blockchain technologies and machine learning solutions to improve real-world businesses. GCAC’s leading solution is Efixii, an Ethereum Layer 2 blockchain and EVM programming functionality that is on par with other Layer-2’s, such as Polygon. GCAC can quickly connect each participant from product producers, distributors, manufacturers and retailers through a series of value chain dApps that allows for data connectivity to drive better consumer experiences and sales. GCAC created clearESG to assist businesses in communicating their sustainability goals and earned attributes on the blockchain through a series of ESG (Environmental, Social & Governance) merit badges. As an interconnected supply chain solution, the Efixii solution pays tokens for attesting to a product’s value, or truthness, through a reward program. GCAC works in many agricultural industries providing a value-added blockchain offering through a cost-effective SaaS licensing model.

Global Health Clinics (CSE: MJRX) Global Health Clinics operates a two-part system of customer lead generation and conversion, through its network of pavilions and the ownership and operation of five medical clinics that aim to connect Canadians with ACMPR license producers by advancing the understanding of medical cannabis and its applications, and the provision of related services and products for patients suffering from illness from which they may find relief with medical cannabis, including facilitating access to qualified health care practitioners, independent medical cannabis evaluations and related advice. Through its pavilions, the company is developing a substantive consumer database of persons interested in both medicinal and recreational use

Global Hemp Group (CSE:GHG; CSE:GHG.WT; OTC:GBHPF) is focused on acquiring and/or joint venturing with companies across all sectors of the hemp and cannabis industries in an effort to build a “soil-to-shelf” portfolio of complementary companies that will enable GHG to capture cash flow, revenues and value from its acquisitions and establish a far greater collective valuation than GHG or the individual companies would have on their own. Initial revenues will be generated from its environmental impact solutions and hemp consulting businesses.

Glow LifeTech Corp. (CSE:GLOW) is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow LifeTech has rights to the groundbreaking, plant-based MyCell Technology® delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates, unlocking the full healing potential of natural active compounds.

Golden Developing Solutions, Inc. (OTC: DVLP) is developing an online retail business for cannabidiol (CBD), hemp oil and health/wellness-related products. The Company is also developing a high-capacity, high-quality CBD extraction and production facility. In addition, through the website of its joint venture partner, Pura Vida Vitamins (www.PuraVidaVitamins.com), as well as through wholesale and distribution channels, the Company offers a broad range of high-quality, price-competitive products, including traditional vitamins, supplements, and CBD-based tinctures, vapes and soft gels, among other products. Merchandise also includes hemp and CBD-related products and additional products focusing on health and lifestyle. Golden Developing Solutions is a development-stage company providing business services and/or products supporting the cannabis industry, in which company intends to make acquisitions in the near future. Currently, 29 states and the District of Columbia have passed laws permitting their citizens to use cannabis for medical and/or recreational purposes. Cannabis has shown encouraging signs as a treatment for various medical conditions and has become increasingly more acceptable to the public and society.

Golden Leaf Holdings Ltd. (CSE:GLH) is one of the largest cannabis oil and solution providers in North America. It’s a leading cannabis products company in Oregon built around recognized brands. GLH leverages a strong management team with cannabis and food industry experience to complement its expertise in extracting, refining and selling cannabis oil.

Goodbody Health Inc. (CSE: GDBY) Formerly Sativa Wellness Group Inc – is an established health and wellness company that operates within the United Kingdom and Europe as a trusted distributor and retailer of quality, accredited wellness products and diagnostic services to provides a unique ‘frontline’ healthcare service in the local community and enable customers to manage their health care digitally. It also has world-class ISO accredited CBD extraction and laboratory testing capabilities. It operates under the mantra ‘Know More. Live Better’ To provide healthcare testing services in the local community.

Goodness Growth Holdings, Inc. (CSE:GDNS.C; OTC:GDNSF) Formerly Vireo Health International, Inc., is one of America’s leading multi-state cannabis companies. Goodness Growth Holdings is a physician-led, science-focused organization, dedicated to providing patients with best-in-class quality cannabis-based products and customer experience. Goodness Growth Holdings cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. Goodness Growth Holdings currently has licenses and/or operations in Arizona, Maryland, Massachusetts, Minnesota, Nevada, New Mexico, New York, and Puerto Rico.

Graph Blockchain Inc. (CSE:GBLC) is a leading-edge private blockchain data management and business intelligence solutions provider. Graph leverages their proprietary integration of the AgensGraph Database engine with IBM’s Hyperledger Fabric to create a transparent and immutable ledger with near real-time transactional data processing and intuitive data visualization. In addition, Graph’s hybrid approach offers greater flexibility and scalability, benefiting industries with fast-paced and constantly changing environments. The company is currently focused on developing enterprise platforms for high-growth areas including the global logistics industry, the global trade sector, the cannabis health and wellness sector, and the electric vehicle charging space

Greater Cannabis Company, The (OTCQB:GCAN) is a biotechnology company focused on the development and commercialization of innovative Cannabinoid delivery systems. Greater Cannabis deploys its licensed, patented technology platform for use in the Cannabis industry. The Company’s conveyance platform can be utilized to deliver Cannabinoids without the harmful side effects found with other routes of Cannabinoid administration. The technology is versatile in that for the first-time patients can receive lower dosing, enhanced bioavailability, and controlled rapid and delayed release using a fully dissolvable, non-irritant oral eluting patch. Greater Cannabis’ mission is to bring our technology to the global market through partnerships with leading Cannabis and pharmaceutical companies, for the benefit of patients and consumers.

GREEN AND HILL INDUSTRIES (OTC:GHIL) is the owner of Ross’ Gold™ which plans to license it established brand through partnerships including government approved producers for medical cannabis strains called Ross’ Platinum, Ross’ Gold, Ross’ Silver and Ross’ Bronze with specific THC/CBD levels for specific ailments. The Company has an established international marquee with the celebrity of Olympic Gold Medal winner Ross Rebagliati who is a spokesperson for the benefits of medical cannabis, especially as it relates to sports training, injuries, pain management and stress. Ross’ Gold is building its brand to be a premium hemp product line and medical cannabis label internationally. The Company will have a line of Ross’ Gold retail products across Canada available in 2015 including glass smoking products, water pipes, bubblers, hand pipes, water pipe parts & accessories, and concentrate parts & accessories, as well as vaporizers through a licensing partnership The Company is also currently under a pre-development contract with a major production company for a television series tentatively titled Ross’s Gold.

Green Cures & Botanical Distribution Inc (OTC:GRCU) is revenue-generating company that wholesales and retails hemp-infused nutritional, botanical, sports, and body care products. The company is currently Web-based and focuses on online retailing. Green Cures & Botanical Distribution Inc., operates a diverse portfolio of products and services within the botanical and cannabis industry, as permitted by law. From concept to production and distribution, Green Cures & Botanical Distribution Inc., is continuously creating and introducing products that promote a healthy life style.

Green Growth Brands (CSE:GGB) – formerly Xanthic Biopharma Inc. – expects to dominate the cannabis and CBD market with a portfolio of emotion-driven brands that people love. Led by renowned retailer Peter Horvath, the GGB team is full of retail renegades with decades of experience building successful brands.

The Green Organic Dutchman Holdings (TSX:TGOD.TO) produces Farm Grown, Pharma Grade Organic Cannabis. The Company grows high quality, organic medical cannabis with sustainable, all natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product.

Green Thumb Industries Inc. (CSE:GTII; OTCQX: GTBIF) a national cannabis cultivator, processor and dispensary operator, is dedicated to providing dignified access to safe and effective cannabis nationwide while giving back to the communities in which they serve. As a vertically integrated company, GTI manufactures and sells a well-rounded suite of branded cannabis products including flower, concentrates, edibles, and topicals. The company also owns and operates a rapidly growing national chain of retail cannabis stores called RISE™ dispensaries. Headquartered in Chicago, Illinois, GTI has seven manufacturing facilities and licenses for 50 retail locations across seven highly regulated U.S. markets. Established in 2014, GTI employs more than 350 people and serves hundreds of thousands of patients and customers each year. GTI was named a Best Workplace 2018 by Crain’s Chicago Business.

GreenGro Technologies, Inc. (OTC:GRNH) is a world class provider of eco-friendly green technologies with specific domain expertise in indoor and outdoor agricultural science systems serving both the consumer and commercial farming markets. It brings together community and commerce through the growth and distribution of healthy, nutritious foods and vital medicines backed by science and technology. Customers include restaurants, community gardens, small and large scale commercial clients. Greengro Technologies also provides design, construction and maintenance services to large grow and cultivation operations and collectives in the medical and recreational marijuana sectors.

Greenlane Holdings, Inc. (NasdaqGS: GNLN) is one of the largest global sellers of premium cannabis accessories, CBD and liquid nicotine products. The Company operates as a powerful house of brands, third party brand accelerator and distribution platform for consumption devices and lifestyle brands serving the global cannabis, CBD, and liquid nicotine markets with an expansive customer base of more than 11,000 retail locations, including licensed cannabis dispensaries, and smoke and vape shops. Greenlane has an established track record of partnering with brands through all stages of product lifecycle, providing a range of services including product development, go-to-market strategy, sales and marketing support, market research, customer service, direct-to-consumer fulfillment, warranty repair, supply chain management, and distribution. In addition to owning and operating its own brands, Greenlane is the partner of choice for many of the industry’s leading players including PAX Labs, (Canopy-owned) Storz & Bickel, JUUL, Grenco Science, Firefly, DaVinci, Select, Sherbinski, Bloom Farms, Mary’s Nutritionals, Cookies and dozens of others. Greenlane’s house of brands is comprised of child-resistant packaging innovator Pollen Gear; VIBES rolling papers; the Marley Natural accessory line; the Keith Haring accessory line, Aerospaced & Groove grinders, and Higher Standards, which is both an upscale product line and an innovative retail experience with flagship stores at New York City’s famed Chelsea Market and Atlanta’s Ponce City Market. The company also owns and operates Vapor.com, an industry leading e-commerce platform which offers convenient, flexible shopping solutions directly to consumers

GreenStar Biosciences Corp. (CSE: GSTR; OTCPK: GTSIF) is a growth-oriented technology and services company that provides real estate, financial, management, IP and branding support to licensed cannabis businesses in the United States. GreenStar operates a growing portfolio of tenant partner companies in the United States. GreenStar applies refined strategies tested in the Washington State market to help partner companies reach their full potential. Based in Vancouver, BC, GreenStar intends to facilitate growth through acquisitions and development of additional assets, products and technologies in legal cannabis markets by leveraging its capital markets, branding and operational expertise.

Grow Condos Inc (OTC:GRWC) is a real estate purchaser, developer & manager of specific use industrial properties providing “condo” style turn-key grow facilities to support the cannabis industry. We own, lease, sell and manage multi-tenant properties. Like during the Gold Rush days in California, Grow Condos is focused on a pick-and-shovel approach to participating in the exploding marijuana industry. We finance the purchase and/or development of properties by offering to investors private placement sponsorships, debt instruments, or limited partnerships. We believe there is a significant investor demand for such opportunities. Currently we own and manage a 15,000 square foot warehouse in Eagle Point, Oregon, own and developing a property in Eugene Oregon and are currently looking into other acquisitions in Oregon, Colorado, Washington, California and Nevada with like-minded investors who want to share in the growth of this dynamic new industry.

Grow Solutions Holdings,Inc. (OTC:GRSO) is focused on the development/distribution of high-demand products and services for cultivation, processing, and consumption of cannabis.

Growblox Sciences, Inc. (GB Sciences Inc) (OTC:GBLX) is a biopharmaceutical research and development company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize our safe and consistent medicinal cannabis. The company is pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm to bring relief to patients in communities across the country.

GrowGeneration Corp (OTC:GRWG) owns and operates specialty retail hydroponic and organic gardening stores. Currently, GrowGen has 12 locations, which includes 10 locations in Colorado, 1 location in California and 1 location in Nevada. GrowGen carries and sells thousands of products, including organic nutrients and soils, advanced lighting technology and state of the art hydroponic equipment to be used indoors and outdoors by commercial and home growers. Our mission is to own and operate GrowGeneration branded stores in all of the major legalized cannabis states. Management estimates that roughly 1000 hydroponic stores are in operation in the U.S.

Growlife Inc. (OTC:PHOT) aims to become the nation’s largest cultivation service provider for cultivating organics, herbs and greens and plant-based medicines. Our mission is to best serve more cultivators in the design, build-out and expansion of their facilities with products of high quality, exceptional value and competitive price. Through a nationwide network of local representative, regional centers and its e-Commerce team, GrowLife provides essential goods and services including media (farming soil), industry-leading hydroponics equipment, plant nutrients, and thousands more products to specialty grow operations in 17 states. GrowLife is headquartered in Seattle, WA and was founded in 2012.

Grown Rogue International Inc. (CSE:GRIN) (OTC:GRUSF) is a vertically-integrated, multi-state Cannabis family of brands on a mission to inspire consumers to “enhance experiences” through cannabis. We have combined an expert management team, award winning grow team, state of the art indoor and outdoor manufacturing facilities, and consumer insight based product categorization, to create innovative products thoughtfully curated from “seed to experience.” The Grown Rogue family of products include sungrown, light dep and indoor premium flower, live rosin jars and terp diamonds, infused, indoor and sungrown pre-rolls, live resin and rosin carts, along with chocolate edibles created in partnership with a world-renowned Chocolatier.

GTEC (TSX: GTEC.V; OTCPK: GGTTF) was founded in 2017 to capitalize on opportunities in the nascent and rapidly growing legal cannabis industry. GTEC is a public corporation listed on the TSX Venture Exchange and based in Kelowna, British Columbia. GTEC is focused on growing premium quality craft cannabis in purpose-built indoor facilities. GTEC currently holds a 100% interest in GreenTec Bio-Pharmaceuticals Corp., Alberta Craft Cannabis Inc. Grey Bruce Farms Inc., Falcon Ridge Naturals Ltd., Tumbleweed Farms Corp., Zenalytic Laboratories Ltd., and Spectre Labs Inc.

Halo Collective Inc. (NEO:HALO)(OTC:HCANF) is a leading, vertically integrated cannabis company that cultivates, extracts, manufactures and distributes quality cannabis flower, oils and concentrates, and has sold approximately eight million grams of oils and concentrates since inception. Halo continues to evolve its business and scale efficiently, partnering with trustworthy leaders in the industry, who value the Company’s operational expertise in bringing top-tier products to market. Recently, the Company has entered into a non-binding letter of intent with Red Light Holland Corp. for the purpose of creating a joint venture to become a licensed psilocybin manufacturer to supply psilocybin products to licensed service centers in the State of Oregon.

Harborside Inc. (CSE:HBOR; OTCQX:HBORF) a vertically integrated enterprise with cannabis licenses covering retail, major brands, distribution, cultivation, nursery and manufacturing, is one of the oldest and most respected cannabis companies in California. Founded in 2006, Harborside was awarded one of the first six medical cannabis licenses granted in the United States. Today, the Company operates 14 dispensaries covering Northern and Southern California and one in Oregon, distribution facilities in San Jose and Los Angeles, California and integrated cultivation/production facilities in Salinas and Greenfield, California. The Company continues to play an instrumental role in making cannabis safe and accessible to a broad and diverse community of California and Oregon consumers.

Harvest Health & Recreation Inc. (CSE:HARV; OTCQX: HRVSF) is one of the first consistently profitable, vertically integrated cannabis companies with one of the largest footprints in the U.S. Harvest’s complete vertical solution includes industry-leading cultivation, manufacturing, and retail facilities, construction, real estate, technology, operational, and brand building expertise – leveraging in-house legal, HR and marketing teams, along with proven experts in writing and winning state-based applications. The company has more than 525 employees with proven experience, expertise and knowledge of in-house best practices that are drawn upon whenever Harvest enters new markets. Harvest’s executive team is comprised of leaders in finance, compliance, real estate and operations. Since its founding in 2011, Harvest has grown its footprint every year and now has more than 60 licenses in 12 states, with planned expansion into additional states by 2020. Harvest shares timely updates and releases as part of its regular course of business with the media and the interested public

Harvest One Cannabis Inc. (TSX:HVST.V) controls operations across the entire cannabis value chain through three business units, with Harvest One serving as the umbrella company over horticultural arm United Greeneries and medical arm Satipharm AG. Each business is strategically located in favourable jurisdictions with supportive regulatory frameworks in place. United Greeneries has received a Canadian medicinal cannabis cultivation licence, making Harvest One one of only a few companies globally with the capacity to commercially cultivate cannabis in a federally regulated environment.

The Hash Corporation (CSE:REZN) is a Canadian company positioning itself to focus on the production and sale of cannabis-based hashish and other cannabis products. HashCo intends to apply its separation and curing techniques to produce a suite of high-quality cannabis resin products, which are all-natural and free of additives and carcinogenic solvents. The Company intends to tailor its product offerings to pay tribute to historic traditions, fragrances and tastes, while upholding the highest health and safety standards.

Healthier Choices Management Corp. (OTC:HCMC) Formerly Vapor Corp. – is a U.S. based retailer of vaporizers, e-liquids and electronic cigarettes, operating thirteen stores in the Southeast and online. Through its subsidiary, Healthy Choice Markets, Inc., the Company also operates natural and organic grocery operations. The initial store acquired for these operations in June 2016 is Ada’s Natural Market in Ft. Myers, Florida.

HealthSpace Data Systems Ltd. (CSE:HS) is an industry leading technology company currently providing inspection, information, communication and data management systems for federal, state, county and municipal governments. Over the last decade, HealthSpace has successfully developed both enterprise and mobile internet-based applications currently serving over 300 state and local government organizations across North America. HealthSpace currently offers the only integrated inspection, administration and analytics product suite across all platforms in North America. Further, HealthSpace now delivers its government grade technologies to private businesses enabling them to gain visibility and predictability into their own organizations and move from a reactive to a proactive operational status. HealthSpace continues to deliver focused service and innovative solutions to government organizations, while expanding into commercial enterprise verticals to enable new customers with proactive environmental health best practices and policies. Cannabis: With all eyes on the emerging cannabis industry, it is important to ensure that you are able to comply with regulatory requirements. Whether you are cultivating, processing or dispensing, HealthSpace CS Pro manages internal auditing, licensing and inspection of all business areas.

Heliospectra AB ADR (OTC:HLSPY; FirstNorth: HELIO) specializes in intelligent lighting technology for plant research and greenhouse cultivation. The Company’s lighting system provides an effective and durable technology for cultivating greenhouse and indoor plants by combining several different groups of versatile light emitting diodes (LEDs) with optics, remote sensing techniques, and a robust heat dissipation solution. This proprietary setup gives growers the ability to control the intensity and wavelengths of the light emitted, creating a spectrum specifically adjusted to different plant species and growth stages to better facilitate photosynthesis. The complete, highly-engineered lamp produces crops that look better, taste better, and have a longer shelf-life than those grown under HID lamps. The technology not only reduces energy consumption by up to 50%, but also helps stimulate growth characteristics and improve plant quality. Other benefits include reduced light pollution, lower mercury use due to the avoidance of traditional HID/HPS bulbs, and less HVAC investment and monthly expense requirements. Heliospectra products are based on in-depth knowledge in plant physiology and photosynthesis along with a unique way to utilize modern LED technology. After six years of development in Sweden, the company has now begun to expand into the international market. The company has raised more than $ 21 million in capital and has received more than $2.6 million through academic scholarships and grants. It has also received numerous awards for its forward thinking technology.

Helix TCS (OTC:HLIX) is the premier provider of essential Technology, Compliance, and Security (TCS) services for the legal cannabis industry. Helix TCS’s mission is to provide clients with the most powerful and cutting-edge integrated operating environments in the market, helping them to better manage and mitigate risk while they focus on their core business.

Hemp, Inc. (OTC:HEMP) focuses on the provision of products made from industrial hemp. The company also offers products and services to the medical and recreational marijuana industries. It also develops and operates a website providing entertainment and news related to medical marijuana industry.

Hemp for Health Inc. (CSE:HFH; Frankfurt: 9HH) is a cultivator and distributor of premium CBD products. The company has an exclusive, long-term contract for land with farmers in the Tuscan region of Italy to achieve their purpose of yielding high quality CBD extracts. The company’s goal is to offer superior natural and organic CBD products, starting with pristine soil, seeds and sun.

Hempacco (NASDAQ:HPCO) goal is Disrupting Tobacco’s™ nearly $1 trillion industry with herb and hemp-based alternatives to nicotine cigarettes by manufacturing and marketing herb, spice, and cannabinoid smokables and rolling paper. Hempacco owns The Real Stuff™ functional hemp cigarette and rolling paper brand.

Hempco Food and Fiber Inc (TSX:HEMP.V; HMPPF) manufactures and distributes hemp food products for human and animal consumption in the United States, Canada, Mexico/Latin America, Asia/Pacific, and Europe. It produces bulk hulled hemp seeds, hemp protein powders, and hemp seed oil under the PlanetHemp brand name. The company is headquartered in Burnaby, Canada.

Hempsana Holdings Ltd. (CSE: HMPS) is a cannabis derivatives extraction and purification and cannabis infused end-product manufacturing company. It offers cannabinoid derivatives for medical and retail sales channels, end-product formulations, and service offerings for Extraction and Post-Processing

Hempstract, Inc. (OTC PINK:HPST) is a Nevada registered publicly-traded company. Hempstract production operations located in Warden, Washington offers business partners premium CBD Solutions they can trust at competitive prices. Hempstract and its laboratories go to great lengths to ensure that all of its solutions are of the highest quality and control standards and provides pure, high-quality, and safe, CBD isolate and oil to its customers

Heritage Cannabis Holdings Corp. (CSE:CANN) formerly Umbral Energy Corp. (CSE:UMB.C) – has an interest in PhyeinMed, who has applied for a license from Health Canada to legally grow and sell medical marijuana.

High Tide Inc. (CSE:HITI) is an Alberta-based, retail-focused cannabis corporation. It is a vertically-integrated company in the Canadian cannabis market, with portfolio subsidiaries including RGR Canada Inc., Smoker’s Corner Ltd., Famous Brandz Inc., Canna Cabana Inc. and the majority of KushBar Inc. High Tide’s strategy as a parent company is to extend and strengthen its retail-focused integrated value chain, while providing a complete customer experience and maximizing shareholder value.

Hollister Biosciences Inc. (CSE:HOLL) s a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Homeland Security Corporation (OTC:HSCC) engages in consulting and implementing advanced security driven technologies that can be deployed in various environments to meet a client’s security or regulatory needs. It focuses on protecting people, property, infrastructure, and client’s high value assets by mitigating threats, guiding regulatory agencies, and integrating new and novel technologies. The company offers various visual and audio surveillance systems, high speed process monitoring, and counter surveillance products. In addition, the company is evolving the innovation of the MMJ/MJ compliance and security systems for the cannabis and hemp industry. Homeland Security Corporation also provides integrated hardware and proprietary software, such as biometric and access control tools targeting the transportation, pharmaceutical, law enforcement, healthcare, travel and tourism, time and attendance, and medical marijuana industries, including various state marijuana security/compliance markets.

Horizons Medical Marijuana Life Sciences ETF (TSX:HMMJ.TO) seeks to replicate, to the extent possible, the performance of the North American Medical Marijuana Index, net of expenses. The North American Medical Marijuana Index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry.

HQ Global Education (OTC: HQGE) is a Delaware corporation dedicated to becoming the industry leader in data gathering, intelligence and education for the industrial CBD industry in America, and to playing a major role in helping to fill the enormous global demand for CBD oil and related products, the market for which is exploding since it has been proven to provide enormous health and medical benefits for a wide range of ailments and illnesses. HQ Global Education acquired Hempsession in June 2019 and Green Sky Solutions, Inc. in September 2019

HYTN Innovations Inc (CSE:HYTN) formulates, manufactures, markets, and sells premium cannabis goods. With the mission to be the leading provider of consistent, natural, and delicious cannabis products, HYTN focuses its efforts on identifying category opportunities and takes an innovative approach to delivering elevated cannabis experiences to a discerning customer base.

iAnthus Capital Holdings, Inc., (CSE: IAN) through its 100% owned subsidiary, iAnthus Capital Management, LLC, delivers a comprehensive solution for financing and managing licensed cannabis cultivators, processors and dispensaries throughout the United States, in accordance with applicable state law. Founded by entrepreneurs with decades of experience in investment banking, corporate finance, law and healthcare services, iAnthus provides a unique combination of capital and hands-on operating and management expertise. The Company harnesses these skills to support a diversified portfolio of cannabis industry investments for our shareholders, including direct equity investments in for-profit license holders and associated management and intellectual property holding companies, and lending facilities coupled with management services to not-for-profit license holders.

ICC International Cannabis Corp. (CSE:KBB) focuses on the production of cannabis, and other biomedical and therapeutic plants in Canada. The company also offers BioCanna ADM system, an automated cannabis retail system for the dispensing of Cannabis and related products. In addition, it provides engineering, procurement, and construction services for cannabis entrepreneurs.

ICC Labs Inc. (TSX:ICC.V) has operations in Uruguay, and is focused on the licensed production, development and sale of recreational cannabis, cannabinoid extracts and by-products for medicinal uses and industrial hemp.

Ignite International Brands, Ltd. (CSE: BILZ; OTCQX: BILZF) is operating in permissible CBD and cannabis sectors. Ignite intends to expand its business, which currently includes branding, marketing, licensing, sales and distribution, across the United States, Canada and into international jurisdictions such as the United Kingdom and Mexico by leveraging multiple product platforms. The Company intends to effect this expansion through brand leverage, product development, targeted marketing and strategic supply chain partnerships in each of its active and target jurisdictions.

Ikänik Farms (CSE:IKNK) – Formerly Canadian Imperial Venture Corp.- is a California based, Multi-National Operator who is building a dynamic portfolio of brands, inspired by its passion for health and wellness, action sports, and supported by cultivations and laboratories which operate at medical standard. Through its Colombian operations (Pideka), Ikänik has entered the global pharmaceutical cannabis market and will look to support the European Union and Latin American markets with flower and finished ingredient cannabis oil, produced in its Casa Flores facility. The company made history as the first in Colombia to export THC for commercial sale and the first to export THC to Mexico, legalizing the process in both respective countries, when it was completed. The company has expanded its product offerings to the hemp CBD space through (Ikänik Life) and will be serving the US and 8 additional countries across Latin America and Europe. Ikänik’s leadership team brings decades of expertise in cultivation, research and development, retail, branding, and corporate finance with the ambition to build the most efficient and iconic “seed-to-sale”, “MNO” Multi-National Operation in the world. Ikänik Farms’ operations are currently located in Colombia and California.

IM Cannabis Corp (CSE:IMCC) is an international medical cannabis company, and a well-known Israeli brand of medical cannabis products. In Europe, IMCC is establishing a fully operational, vertically integrated medical cannabis business spearheaded by its distribution arm in Germany and augmented by strategic agreements with certified EU-GMP Standard suppliers, making it one of the only medical cannabis companies with fully integrated operations in Europe. IMCC intends to leverage IMCC’s brand to establish a foothold in emerging medical cannabis markets including Germany, Portugal and Greece.

India Globalization Capital, Inc. (NYSE MKT:IGC) has articulated a strategy to become a company with diverse operating businesses including medical marijuana, and specialty pharmaceuticals. We are currently engaged in trading, vertical farming and rental of heavy equipment in India, China and the United States.

INDIVA Limited (TSX: NDVA.V; OTC:NDVAF) Indivia’s wholly owned subsidiary is a Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulation (“ACMPR”). INDIVA’s mission is to offer cannabis products that have a positive impact, improving lives and communities.

Indoor Harvest Corp (OTCQB:INQD) through its brand name Indoor Harvest®, is a full service, state of the art design-build engineering firm for the indoor farming industry. Providing production platforms and complete custom designed build outs for both greenhouse and building integrated agriculture (BIA) grows, tailored to the specific needs of virtually any cultivar. Our patent pending aeroponic fixtures are based upon a modular concept in which primary components are interchangeable.

INDVR Brands Inc. (CSE:IDVR) formerly Cannabis One Holdings Inc. is focused on aggregating and optimizing popular cannabis brands throughout North America. With its unique, franchise-ready retail brand, The JointTM, and through targeted acquisition and partnership opportunities, INDVR Brands intends to become the premier, globally-recognized, “House of Brands”, holding a client portfolio of award-winning products with an extensive market footprint. Through the Company’s The JointTM retail concept, INDVR Brands intends to leverage the consumer and brand data harvested from its retail locations to bring data-driven analytics to an emerging, branded industry. For consumers, INDVR Brands desires to become the definitive source for unparalleled product selection and renowned service in an otherwise fragmented market.

InMed Pharmaceuticals Inc. (TSX:IN.TO; OTCQX:IMLFF) is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed’s proprietary bioinformatics database drug/disease targeting tool, cannabinoid biosynthesis technology and drug development pipeline are the fundamental value drivers of the Company.

Inner Spirit Holdings Ltd. (CSE:ISH) is establishing a chain of recreational cannabis dispensaries under its Spiritleaf brand. Supporting local entrepreneurs by applying its award-winning franchise and retail models, Inner Spirit has more than 100 partnerships in place for Spiritleaf locations across BC, Alberta and Saskatchewan. Inner Spirit will also operate multiple corporate dispensaries. With a diverse portfolio of quality and curated lifestyle cannabis products – including Spiritleaf’s own locally and sustainably sourced lines – Inner Spirit’s Spiritleaf is positioned to be an iconic Canadian brand and the most trusted source for recreational cannabis

InnoCan Pharma Corporation (CSE:INNO) business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales.

Innovative Industrial Properties, Inc. (NYSE: IIPR) is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities. Innovative Industrial Properties intends to elect to be taxed as a real estate investment trust.

INSYS Therapeutics, Inc. (NasdaqGM: INSY) is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of life of patients. Using proprietary sublingual spray technology and capabilities to develop pharmaceutical cannabinoids, Insys addresses the clinical shortcomings of existing commercial products. Insys currently markets one product, Subsys® (fentanyl sublingual spray) but has received approval for the marketing of Syndros™ (dronabinol oral solution), a proprietary, orally administered liquid formulation of dronabinol that Insys believes has distinct advantages over the current formulation of dronabinol in soft gel capsule. Insys is developing a pipeline of sublingual sprays, as well as pharmaceutical cannabidiol. Insys is committed to developing medications for potentially treating addiction to opioids, opioid overdose, epilepsy and other disease areas with high unmet need. Subsys® and Syndros™ are trademarks of Insys Therapeutics, Inc.

Intec Pharma Ltd. (NasdaqCM:NTEC) is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company’s Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism. The Company’s product pipeline currently includes three product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa, or AP-CDLD, is being developed for the indication of treatment of Parkinson’s disease symptoms in advanced Parkinson’s disease patients Accordion Pill Zaleplon, or AP-ZP, for the indication of the treatment of insomnia, including sleep induction and the improvement of sleep maintenance, is our second pipeline product. We are also developing a third Accordion Pill for the treatment of gastoduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug induced ulcers. Cannabis: Intec is developing an Accordion Pill to deliver either or both of the primary cannabinoids contained in Cannabis sativa, cannabidiol (CBD) and tetrahydrocannabinol (THC) for various indications including low back pain, neuropathic pain and fibromyalgia.

Icanic Brands Company Inc (CSE:ICAN) – formerly Integrated Cannabis Company, Inc. is a leading cannabis branded products manufacturer based in California & Nevada, the largest and most competitive cannabis markets in the world. The company’s mission is to make cannabis safe and approachable – that starts with manufacturing high-quality products delivering consistent experiences.

InterCure (Nasdaq: INCR TASE: INCR.TA) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated “seed-to-sale” model to lead the fastest growing cannabis global market outside of North America.

International Spirits and Beverage Group Inc. (OTCQB: ISBG) is a Nevada-based alcoholic beverage company specializing in the development, marketing and global sales of innovative wine and spirits brands. The Company’s expertise lies in the strategic development and aggressive early growth of its brands and establishing these brands as viable and profitable. ISBG intends to build its own brands while seeking out individual acquisition candidates to continue to develop its pipeline of new brands into the ISBG portfolio. CANNABIS: October 2018 – signed a Production and Distribution (the “Agreement”) with Canbiola, Inc. (“Canbiola”), a U.S. Company specializing in the sale of premium CBD-based products. The Agreement provides for CANB to produce, package and distribute the Company’s new line of CBD infused fruit chews and non-alcoholic beverages (the “Products”).

International Wastewater Systems Inc. (CSE:IWS; OTC: INTWF; Frankfurt:IWI.F) (and its wholly owned subsidiary SHARC Energy Systems (UK) Ltd.) is a world leader in thermal heat recovery. IWS systems recycle thermal energy from wastewater, generating the most energy efficient and economical systems for heating, cooling & hot water for commercial, residential and industrial buildings. – currently collaborating with a licensed marijuana cultivator operating an industrial growing facility in the United States (“Cannabis Cultivation Facility”).

Invictus MD Strategies Corp. (TSX:GENE.V; OTC: IVITF) is focused on three main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the ACMPR; Fertilizer and Nutrients through Future Harvest Development Ltd.; and Cannabis Data and Delivery, with its wholly owned subsidiary Poda Technologies Ltd.

IONIC BRANDS CORP. (CSE: IONC; OTC: IONKF) (FRA: 1B3) is focused on building a multi-state consumer-focused cannabis concentrate brand portfolio focusing on the premium and luxury segments. The cornerstone Brand of the portfolio, IONIC, is the #1 vaporizer brand in Washington State and has aggressively expanded throughout the West Coast of the United States. The brand is currently operating in Washington, Nevada, Oregon and California. IONIC BRANDS’ strategy is to be the leader of the highest-value segments of the cannabis market and expand nationally.

Isodiol International Inc. (CSE:ISOL; OTC:LAGBF) is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol’s nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products. Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.

Isracann Biosciences Inc. (CSE:IPOT; OTC:ISCNF) is an Israeli-based company focused on becoming a premier cannabis producer offering low-cost production targeting undersupplied major European marketplaces. Based in Israel’s agricultural sector, Isracann will leverage its development within the most experienced country in the world with respect to cannabis research.

James E. Wagner Cultivation Corporation (TSX:JWCA.V) which is licensed to cultivate and to sell, is based in Ontario and produces aeroponically grown cannabis, using its GrowthStorm cultivation platform. Its current facility is 15K sq. ft. and produces 1.5 million grams annually in 7 grow rooms, and the company is targeting 28.5 million grams in its second facility under development, a 345K sq. ft. retrofit that it expects to complete in the second quarter of 2019. The company has a strategic relationship with Canopy Growth through its CraftGrow and Tweed Main Street programs, its genetics and its extraction infrastructure and Canopy Rivers, which provides it with capital and owns 13.7% of the company on a fully-diluted basis

Jazz Pharmaceuticals (Nasdaq: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. We actively explore new options for patients including novel compounds, small molecules and biologics, and through cannabinoid science and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. May 2021, JAZZ completed acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) , a leader in the science, development and commercialization of cannabinoid-based prescription medicines.

Jenex Corporation, The (TSX:JEN-H.V) is a progressive medical device technology company focused on providing consumers with quality medical devices that address their dermatological needs. Clear and healthy skin for all is at the core of Jenex’s philosophy as is the belief that such outcomes should not be a privilege for only those who can afford costly procedures and treatments. The Company’s breakthrough proprietary technology delivers effective, non-invasive and pain free skin care. Cannabis: Reports the testing of a topical cannabidiol (“CBD”) oil from hemp with Jenex’s platform technology, including Jenex’s TherOZap™ device. The topical cannabidiol oil will be included in the lab tests, to be conducted through University Health Network and coordinated through Techna Institute at UHN located in Toronto, Ontario. Jenex will work with partners in the medical marijuana industry to license a topical CBD oil or working through formulators Jenex will create its own topical CBD oil to be used with the TherOZap™ device. Several natural health products in topical formulations with unique delivery systems could be developed.

Jetblack Corp. (OTCMKTS: JTBK) is a company focused on commercializing innovative ideas for the benefit of shareholders and the community. The focus of the company is to spend a small amount of capital on each innovative product, with the potential to benefit society and or the environment. Distributing risk across a variety of products and sectors, reducing the risk for shareholders while enhancing the chance for success. The company also gives the investor the ability to put their capital to work for a good cause. We are continually identifying how we can make an impact for the better. CANNABIS: EndoCleanse™ is a product that will give the daily consumer of cannabis, the

ability to feel like they have taken a break from consuming cannabis, flushing the receptors (CB1 and CB2), which will make the intake of marijuana and its desired effects more efficient. Additional benefits of EndoCleanse™ would be, saving a consumer time and money. Taking away the need to constantly seek out different strains, along with consuming less marijuana in general. The company believes that regular daily consumers of marijuana will benefit greatly from this product. Daily consumers often need to seek out different strains to feel a strong effect or seek out concentrates.

Jupiter Wellness, Inc. (NasdaqCM:JUPW) is a functional wellness and natural health products company. With a tireless devotion to quality, sourcing, and customer care, our goal is to harness the scientifically-backed health benefits of CBD like arthritis relief and muscle relaxation to help the population live a more fulfilling life through a variety of forthcoming products.

Jushi Holdings Inc. (NEO: JUSH-B.NE) led by its industry leading management team, is seeking to be a vertically integrated multi-state cannabis and hemp operator across the United States. Jushi is focused on building a diverse multi-state portfolio of branded cannabis and hemp-derived assets through opportunistic investments and by internally pursuing licenses in attractive jurisdictions. Jushi strives to maximize shareholder value while delivering high-quality products and service across all levels of the cannabis and hemp ecosystem.

Juva Life Inc. (CSE:JUVA) is a vertically-integrated cannabis company with deep roots in California cannabis culture and extensive expertise in all areas of cannabis production and sales, from cultivation through research and manufacturing to walk-in and delivery retail.

Kalytera Therapeutics, Inc. (TSX: KALY.V) is pioneering the development of a next generation of cannabinoid therapeutics. Through its proven leadership, drug development expertise, and intellectual property portfolio, Kalytera seeks to establish a leading position in the development of novel cannabinoid medicines for a range of important unmet medical needs. Kalytera is focused first on developing a new class of proprietary cannabidiol (“CBD”) therapeutics. CBD is a remarkable compound that has shown activity against a number of pharmacological targets. However, there are limitations associated with natural CBD, including its poor oral bioavailability and short half-life. Kalytera is developing innovative CBD formulations and prodrugs in an effort to overcome these limitations, and to target specific disease sites within the body. Kalytera intends to file composition of matter and method of use patents covering its novel inventions, with the goal of limiting future competition.

Kaya Holdings Inc (OTCQB:KAYS) is a “mind care” company with operations in medical/recreational cannabis and pending operations in the emerging psilocybin sector. In 2014 KAYS became the first US public company to own and operate a medical cannabis dispensary (in Portland, Oregon). The Company still operates the original Kaya Shack™ cannabis dispensary while seeking to shift our cannabis operations to serve the European Union. KAYS has interests in three medical cannabis licenses (2 in Greece, 1 in Israel) to advance this effort. Resuming its role as innovator and trend setter, the Company is again breaking ground in the United States with the planned introduction of psilocybin treatment centers through our majority-owned subsidiary, Fifth Dimension Therapeutics, Inc. (“FDT”). KAYS subsidiaries include: Fifth Dimension Therapeutics, Inc, Marijuana Holdings Americas, Inc., Kaya Brands International, Inc., Kaya Brands USA, Inc.

Khiron Life Sciences Corp.(TSX:KHRN.V) is a Canadian integrated medical cannabis company with its core operations in Colombia, and is fully licenced in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. Khiron combines leading international scientific expertise, agricultural advantages, and branded product market entrance experience to address the unmet medical needs in a market of over 620 million people in Latin America.

Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF) through its wholly-owned subsidiary Koios, Inc., is an emerging functional beverage company which has an available distribution network of more than 2,000 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Together these distributors represent more than 80,000 bricks and mortar locations across the United States – from sports nutrition stores to large natural grocery chains including Whole Foods and Sunflower markets. Through its partnership with Wishing-U-Well, Koios also enjoys a large presence online, including being an Amazon choice product. Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products can enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain. Koios is one of the only drinks in the world to infuse its products with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. Cannabis: June 2018 – Cannavated Beverage Co., a wholly-owned subsidiary of Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF), is pleased to announce it has entered into an exclusive licensing agreement with CanCore Concepts Ltd (www.keefbrands.com) for a line of cannabis-infused beverages.

Kona Gold Solutions Inc. (OTC: KGKG) has created Kona Gold LLC, a Delaware Corporation, which has developed a premier Hemp Infused Energy Drink, Energy shots, and Apparel; please visit the Company’s new website to view updates and new products at www.konagoldhemp.com. The Company announced it has moved its Corporate Headquarters to Rockledge, FL. Kona’s new warehouse and office space gives the Company the space needed to expand rapidly.

Kush Bottles, Inc. (OTCQB: KSHB) provides packaging products and solutions to producers, processers and retailers operating in the regulated medical and recreational cannabis industry. Founded in 2010, Kush Bottles has sold more than 100 million bottles and regularly services more than 1,000 customers across the United States and Canada. The company primarily services the business-to-business market, which includes legally operated medical and adult-use dispensaries, growers and marijuana-infused product (MIP) manufacturers. Kush Bottles aims to be the gold standard for responsible branding and packaging in the cannabis industry. Kush Bottles has no direct involvement with cannabis plants or extracts

Leef Brands Inc. (CSE: LEEF) formerly Icanic Brands Company Inc. – is a leading California based extraction and manufacturing cannabis company. LEEF is owned and managed by some of the best legacy operators in the industry and is one of California’s largest and most sophisticated cannabis companies. Our platform consists of an integrated supply chain, state of the art manufacturing, industry leading brands, and a robust white labeling service offering that powers some of the largest brands in California. Our vision is simple and is centered around providing the end consumer with best-in-class products. Leef Brands, Inc. is based in California, the largest cannabis market in the world. The Company’s mission is to build a great cannabis company with great people and great results.

Leafbuyer Technologies, Inc. (OTC: LBUY) The most comprehensive online source for cannabis deals and specials, Leafbuyer.com connects consumers with dispensaries. Leafbuyer works alongside businesses to showcase their unique products and build a network of loyal patrons. Leafbuyer’s national network of cannabis deals and information reaches millions of consumers monthly. Leafbuyer is the official cannabis deals platform of thecannabist.co (owned by the Denver Post) and westword.com.

Leef Brands Inc. (CSE: LEEF) formerly Icanic Brands Company Inc. – is a leading California based extraction and manufacturing cannabis company. LEEF is owned and managed by some of the best legacy operators in the industry and is one of California’s largest and most sophisticated cannabis companies. Our platform consists of an integrated supply chain, state of the art manufacturing, industry leading brands, and a robust white labeling service offering that powers some of the largest brands in California. Our vision is simple and is centered around providing the end consumer with best-in-class products. Leef Brands, Inc. is based in California, the largest cannabis market in the world. The Company’s mission is to build a great cannabis company with great people and great results.

Level Brands (NYSE American: LEVB) is an innovative marketing and licensing company that provides bold, unconventional, and socially responsible branding for leading businesses. The focus of LEVB is licensing and corporate brand management for consumer products, including art, beauty, fashion, the beverage space, health and wellness, and entertainment. License brand marketing is at the core of the Level Brands businesses: kathy ireland® Health & Wellness; Ireland Men One (I’M1), a men’s lifestyle brand established to capitalize on potentially lucrative licensing and co-branding opportunities with brands focused on millennials; Encore Endeavor One (EE1), a provider of corporate brand-management services and producer of experiential entertainment events and products across multiple platforms. CANNABIS: Through its licensing agreement with Isodiol International, Inc. (CSE: ISOL) (ISOLF) (FSE: LB6A.F) is pleased to announce the online launch of five new cannabidiol (CBD) products under the kathy ireland® Health & Wellness brand.

Leviathan Natural Products Inc. (CSE:EPIC) Formerly Leviation Cannabis Group Inc – The Company is focused on the cannabis sector and encompasses a full service North American consumer engagement/marketing services agency and a supporting cannabis media platform

Lexaria Bioscience Corp. (CSE:LXX; OTC:LXRP) is a food sciences company focused on the delivery of active compounds that can behave as superfoods through its proprietary infusion technologies. Lexaria’s technology enables higher bioavailability rates for CBD; THC; NSAIDs; Nicotine and other molecules than is possible without lipophilic enhancement technology. This can allow for lower overall dosing requirements and/or higher effectiveness in active molecule delivery. Lexaria hopes to reduce other common but less healthy ingestion methods such as smoking as it embraces the benefits of public health.

Lexston Life Sciences Corp. (CSE:LEXT) is a Canadian biotechnology company providing cannabis testing and research services. Lexston is also in the process of securing licensing under the exemptions prescribed by section 56 of the Controlled Drugs and Substances Act (Canada) to enable the expansion of its services into the psychedelic industry with an initial focus on the detection and quantification of psychedelic molecules in the lab and point of care. Lexston intends to develop and validate methods for standardized manufacturing of plant derived psychedelics in support of burgeoning trials in the field of mental health and wellness

Liberty Health Sciences Inc. (CSE:LHS) is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in the United States. Liberty’s stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near and midterm opportunities. Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer. Liberty leverages commercial greenhouse knowledge to deliver highquality, clean and safe pharmaceutical grade cannabis to patients.

Liberty Leaf Holdings (CSE:LIB) is a new Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis sector businesses, including cultivation, value added CBD/THC products, biotech research, and supply chain products within this dynamic and fast growing sector.

Lifeloc Technologies Inc (OTC:LCTC) is a trusted U.S. manufacturer of evidential breath alcohol testers and related training and supplies for Workplace, Law Enforcement, Corrections and International customers. Marijuana Testing Equipment: Dipcards/Goggles

Lift & Co. (TSX: LIFT.V) is a platform that helps Canadians explore, understand, and make better-informed decisions around cannabis through superior information and data. Lift & Co. operates Canada’s most comprehensive product-comparison resource of federally legal cannabis products; provides customized marketing solutions and data-backed insights into consumer and product trends; and connects businesses and consumers through its digital platform, and at its leading events, the Lift & Co. Expos and the Canadian Cannabis Awards. Lift & Co. Cannabis Retail Training Certification, developed in an exclusive partnership with MADD Canada, is available to both government and private clients.

Lighting Science Group Corp. (OTC:LSCG) is a global leader in innovative LED lighting solutions that designs, manufactures and brings to market advanced, intelligent products for consumer and commercial applications. Our breakthrough technologies save energy and reduce the carbon footprint of the traditional light bulb by up to 80%. Lighting Science’s innovative lighting solutions are also building a better, brighter future by aiding the growth of nutrient-dense crops, creating safer highways, and protecting endangered wildlife.

Lineage Grow Company Ltd. (CSE:BUDD) is focused on establishing, either directly or through joint venture with licenced producers, state-of-the-art cultivation facilities and a view towards developing a dominant brand of premium quality craft cannabis. Lineage is seeking to deploy advanced cultivation techniques and best-of-breed genetics to develop brands of craft cannabis known for emphasizing the unique flavors, smells, and potencies of each individual strain. By leveraging innovative agricultural and technological solutions, Lineage intends to optimize the variable costs associated with cannabis cultivation and successfully produce craft cannabis at a commercially viable industrial scale.

Link Reservations Inc. (OTC: LRSV) is CBD Petcare provider dedicated to improving the health and life conditions of pets worldwide. Developing and marketing hemp-based CBD products for cats, dogs and horses, the Company is currently present in Europe and in the US. A pioneer in the area, Linkreservations Inc products can be found under its brand LinkResPets (www.linkrespet.com).

Little Green Pharma Ltd. (ASX: LGP) is a global, vertically integrated and geographically diverse medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution.

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) is a life sciences company focused on psychedelic medicines. The Company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness.

Lotus Ventures Inc. (CSE: J) is a Vancouver-based medical marijuana company. As a Licensed Producer applicant under The Marihuana for Medical Purposes Regulations (MMPR) we plan to build and operate a 28,000 square foot facility in Armstrong British Columbia. Utilizing a community-based marketing model Lotus will focus on providing medical users with quality-assured dried marijuana. There is an emerging consensus on the benefits of a normalized well-regulated market place and consumer protections on product quality and community safety. Lotus Ventures is an active industry participant and engages with government regulators to shape the regulatory system and extending the scientific knowledge base of the medical uses.

Lowell Farms Inc. (CSE:LOWL) Formerly Indus Holdings, Inc. is California-based vertically-integrated cannabis company with advanced production capabilities supporting every step of the supply chain; including cultivation, extraction, manufacturing, brand sales, marketing, and distribution. Founded in 2014 as Indus Holdings, Inc, Lowell Farms grows artisan craft cannabis with a deep love and respect for the plant and prides itself on using sustainable materials – from seed to sale – to produce an extensive portfolio of award-winning original and licensed brands, including Lowell Herb Co, Cypress Cannabis, MOON, Humble Flower, and Kaizen Medicinals, for licensed retailers statewide.

ManifestSeven Holdings Corporation (CSE: MSVN) formerly P & P Ventures Inc – is the first integrated omnichannel platform for legal cannabis, merging compliant distribution with a retail superhighway. M7 services the needs of lawful operators across the supply chain, from the cultivator to the consumer, through an expansive network of four facilities stretching from the San Francisco Bay Area to San Diego. M7 further augments its business-to-business value proposition with a growing portfolio of owned and operated retail operations located in major metro markets, including brick-and-mortar dispensaries, local on-demand delivery services, e-commerce, and subscription offerings.

Maple Leaf Green World (TSX:MGW.V) Maple Leaf Green World Inc. is a public Canadian company that focuses on the cannabis industry in North America. With over 10 years of extensive greenhouse management experience, it applies its eco- agriculture knowledge and cultivation technology to produce contaminant -free organic cannabis products. The Company is currently involved in three cannabis projects:1.Canada – The Company has applied for an ACMPR license for an 80,000 sq ft greenhouse complex in B.C. in August 2014 and is now in Stage 5 (Review) with Health Canada. 2.California – The Company is in a joint venture with a Non- Profit Co-Op to cultivate cannabis for its members. The Company owns 20 acres of land and has 2 greenhouses in production since September 2016. The site on which the joint venture operates has capacity for additional greenhouses. Maple Leaf is also applying for a cultivation license in the San Diego area. 3.Nevada – The Company is in the process of acquiring a cultivation permit for a 33,500 sq ft facility from an existing licensee and has plans for a facility operating in the city of Henderson, 15 miles from Las Vegas. Maple Leaf’s long-term objective is to produce cannabis oil and export its products to approved countries.

MariJ Pharmaceuticals – division of Acacia Diversified Holdings, Inc (OTC:ACCA) The MariJ Group of companies was launched in 2014, quickly finding an opportunity to fill industry niches by offering state-of-the-art equipment and services to the emerging cannabis industry. Its activities have included mobile extraction and blending of high-quality oils, launching a line of high-CBD 0-THC dietary supplements for the pediatrics sector, private label packaging of numerous products, RFID and cannabis-tracking technologies, with a unique proprietary POS system for retailers that includes HIPPA compliant technology. MariJ, through its TropiFlora subsidiary, has also applied for a cannabis growers license in Florida, and the Company is in discussions to acquire or joint venture with licensed growers in other venues.

Marijuana Company of America Inc (OTC:MCOA) is a publicly traded company headquartered in Southern California. MCOA will distribute marijuana and products related to marijuana as well as CBD and hemp, using a variety of marketing approaches to distribute on a global basis.

MariMed Inc. (OTCQB:MRMD; CSE:MRMD) a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty’s Eddies, Nature’s Heritage, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy

Marrone Bio Innovations, Inc. (NasdaqGM:MBII) strives to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for pest management and plant health. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have four products for agriculture on the market (Regalia®, Grandevo®, Venerate® and Majestene®), and also distribute Bio-tam 2.0® for Isagro USA in the western U.S. MBI also markets Zequanox® for invasive mussels for water markets. We also have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. Cannabis: January 2019 – Appoints manager to oversee cannabis agri sector

Mary Agrotechnologies Inc. (CSE:MARY) is in the business of developing affordable, automated, yet aesthetically appealing technologies for communities to grow all kinds of produce regardless of local climate. The Company’s signature product, Mary Model Z (“Model Z”), is a grow box, which is a small enclosed system for growing plants indoors or in small areas. Model Z is designed for consumers, takes advantage of the legalization of cannabis, and features a stylish Wi-Fi connected growing system that is automated by cloud-based artificial intelligence, with built-in air conditioning, active filtering system to control odour and mould, immersive multidirectional lighting, pre-made nutrient packs, and a smartphone app that can monitor and control the unit from virtually anywhere. It has been developed specifically for growing cannabis and takes the guesswork out of the process allowing anybody to grow at home.

MassRoots, Inc. (OTC:MSRT) is one of the largest technology platforms for the regulated cannabis industry. It is proud to be affiliated with the leading businesses and organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. MassRoots has been covered by The Hill, Denver Post, Fortune, Forbes, and CNBC.

Matica Enterprises Inc. (CSE: MMJ) is a Canadian company intending to enter the medical marijuana sector. Our focus will be on supplying high quality marijuana to patients and distributors across Canada and related industries and products. Recently Matica has completed an Agreement with THC Dispensaries Inc. (“THCD”) a Nova Scotia Company with ” Right to Build ” status awaiting it’s Marijuana for Medical Purposes Regulation (” MMPR”) License .Matica and THCD are currently completing a brand new State of the Art free standing Facility and anticipate the final Inspection in the near future.

MCIG INC. (OTC:MCIG) is a leading manufacturer and marketer of portable and home vaporizers, THC extracts and related equipment, CBD Rich Hemp Oil-derived products, and related nutraceuticals based on natural compounds found in Cannabis and Hemp plants. The company owns the mCig and Vapolution brands, and has a 47% stake in VitaCig (VTCQ), makers of the VitaStik, a disposable, vitamin vaporizer. The company believes that a well-regulated marijuana industry is emerging as more states follow the lead of Alaska, Colorado, Oregon, and Washington in legalizing marijuana. A similar trend is developing within the CBD and Hemp industries following overwhelming consumer demand.

Medcolcanna Organics Inc. (CSE:MCCN) is a Canadian vertically-integrated medical hemp company, whose fully licensed operations are based in Colombia. Led by a proven and successful management team, Medcolcanna has a growing number of facilities in optimal growing locations, which positions the Company to become a global leader in the medical cannabis market.

Mediatechnics Corp (OTC:MEDT) and our wholly owned subsidiary BlazeNow Inc, specialize in providing ancillary products and services to the medical and recreational Cannabis industries. Our management will utilize industry experience to target the areas of the market with the highest profit potentials. We believe in the future legitimacy and profitability of the industry based on recent studies showing bi-partisan support and demand of Cannabis. We believe that Cannabis provides a healthier alternative to conventional pharmaceutical and recreational drugs and will play an important role in the future of our country’s health care. We are determined to be a dominant force in defining this emerging market.

Medical Cannabis Payment Solutions (OTC:REFG) Our mission is to provide end-to-end management, across multiple management systems, for medicinal marijuana operations. Many medicinal marijuana companies have experienced such rapid growth that they are finding it difficult to manage all aspects of their operation. In order to become a successful and compliant medicinal marijuana operation, effective management must depend on many different systems. REFG solves the fragmentation problem by identifying tools that are important to dispensaries, and customizing those tools specifically catered to the industry. We strive to create awareness within the medicinal marijuana industry and to develop an environmentally friendly, economically sustainable business while increasing shareholder value.

MEDICAN ENTERPRISES INC. (OTC:MDCN) is a company seeking promising pharmaceutical and other business opportunities in the emerging medical and recreational marijuana sector. Through its subsidiaries, Medican is seeking to invest in businesses associated with the growing, marketing, research and development, training, distribution and retail sale of medical and recreational marijuana, both in the United States and Canada.

Medical Marijuana Inc. (OTC: MJNA) Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

Medicine Man Technologies, Inc. (OTC:MDCL) Established in March 2014, the Company secured its first client/licensee in April 2014. To date, they have provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state. It currently has twenty-seven active clients in 13 states (including Puerto Rico), focusing on working with licensees and clients to 1) utilize its experience, technology, and training to help secure a license, 2) deploy the Company’s highly effective variable capacity constant harvest cultivation practices through its deployment of Cultivation MAX and eliminate the liability of single grower dependence, 3) avoid the costly mistakes generally made in start-up, and 4) stay engaged with an ever expanding team of licensees and partners all focused on quality and safety that will ‘share’ the ever improving experience and knowledge of the network.

Medlab Clinical Ltd. (ASX:MDC.AX) l is an Australian based medical life science company, with a certified biologics facility in Sydney and sales arms in Australia and California. Medlab’s research relates to five health areas – obesity, chronic kidney disease, depression, ageing and muscular skeletal health and pain management. A lot of Medlab’s research is on the role bacteria in the gastrointestinal tract play in health and disease, leading to drug discovery and development of new medicines involving bacteria (pharmacobiotics) as well as nutritional products. Medlab is also about to commence a human trial of a cannabis-based medicine for oncology patients with intractable pain, utilising its small particle medicine delivery system, Nanocelle™. Medlab has a growing patent portfolio, multiple published research papers and conference presentations and the Pharmacobiotic trademark – a therapeutic term referring to both probiotics and biologics.

MedMen Enterprises Inc (CSE:MMEN; OTCQX: MMNFF) is the preeminent cannabis company in the United States with multiple assets and operations in California, Nevada and New York, which combined account for nearly half of North America’s addressable legal market. MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing and retail, and is one of the most well recognized cannabis brands in the world today. Headquartered in Los Angeles, MedMen Enterprises employs more than 800 people across the United States. The predecessor to MedMen Enterprises was founded in 2010 by Adam Bierman and Andrew Modlin, two visionary entrepreneurs who saw not just a tremendous business opportunity in the growing legalization of marijuana, but a chance to re-define our society’s relationship with cannabis. MedMen supports sensible, clear and just drug laws. The Company is the single largest financial supporter of progressive marijuana laws at the local, state and federal levels, giving directly to pro-legalization groups, industry organizations and political candidates.

MENTOR CAPITAL INC. (OTC:MNTR) The company seeks to take significant positions in medical marijuana and cannabis companies to both provide public market liquidity for founders and to incubate private cannabis companies that have the potential to be spun off as stand-alone pubic companies.

MGC Pharmaceuticals (ASX: MXC.AX) operates as a medical and cosmetic cannabis company in Australia and Slovenia. It is developing phytocannabinoid as active pharmaceutical ingredients containing medicinal cannabis products. The company is also developing product formulation groups, including MGCND00EP1 for neurological disorders; MGCON00CA1 for oncology treatment and side effects; and MGCAU00SD1 for autoimmune treatments in inflammatory cases, as well as deep skin relief products under the DermaPlus brand. In addition, it provides the raw materials and matched genetics to treat patients that live with various diseases.

MJardin Group, Inc (CSE: MJAR) (OTCQX: MJARF) is a cannabis management platform with extensive experience in cultivation, processing, distribution and retail. For over 10 years, MJardin has refined cultivation methodologies, developed state of the art facilities and implemented vertical integration for and on behalf of license owners. MJardin is based in Denver, Colorado and Toronto, Canada.

MMJ Phytotech Medical (ASX:MMJ.AX) is focused on becoming a large-scale cannabis producer, targeting direct supply to the growing Canadian medical and recreational markets which will have an estimated combined value of C$8-9 billion by 2024. The Company controls operations across the entire medicinal cannabis value chain through three business units, strategically located in favourable jurisdictions with supportive regulatory frameworks in place.

MJ Holdings, Inc. (OTC:MJNE) is developing business opportunities in both the recreational and medical marijuana space. Our focus is in digital assets, education and tools to enable physicians in incorporating marijuana treatment into their practices. Our fist product is the Toker App and is expected to launch in Q2 of 2017.

Mojave Brands Inc. (CSE: JANE) is a Canadian-based cannabis sector brand and distribution company emerging as a true vertical integrator in California’s legal cannabis space serving recreational and wellness markets. The Company’s U.S. holdings are comprised of assets set up as a vertical stack including cultivation to scale, branding, packaging, manufacturing & processing, as well as, a distribution arm and the edibles brand CALIGOLD. Operating out of licensed strategic locations within the state, Mojave Jane is leveraging its consumer and brand-focused business model to generate sustainable profits delivering quality product by recognized brands

Molecule Holdings Inc. (CSE:MLCL) formerly Everton Resources Inc works with client-partners to engage in the production of cannabis-infused beverages and edibles. We provide the infrastructure, know-how, technology, and licenses for craft producers to create consumable cannabis products. Molecule’s goal is to be the on-ramp for companies wishing to enter into the cannabis beverage and edibles market, but who choose not to go through the significant process of obtaining the required cannabis licences.

Mountain High Acquisitions Corp (OTC:MYHI) is a holding company focused on the commercial hemp and CBD products industries. Our first acquisition in this sector is GreenLife BotaniX, Inc.

MPX International Corporation (CSE:MPXI) formerly Canadian Bioceutical Corporation – an Ontario corporation, through its wholly owned subsidiaries in the U.S., provides substantial management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannabis enterprises in Arizona operating under the Health for Life (dispensaries) and the award-winning Melting Point Extracts (high-margin concentrates wholesale) brands. The successful Health for Life brand operates in the rapidly growing Phoenix Metropolitan Statistical Area (MSA). The Company also owns assets in Massachusetts, supporting cultivation, production and up to three dispensaries in Massachusetts, as well as is supporting development of a third licensed dispensary in Arizona. MPX continues to expand its U.S. footprint, being in the process of acquiring a cultivation and production wholesale business in Las Vegas, Nevada, and three dispensaries and a production license in Maryland.

The Company also leases a property in Owen Sound, Ontario, for which an application to Health Canada has been made for a cannabis production and sales license. In addition, the Company will continue its efforts to develop its legacy nutraceuticals business.

MTL Cannabis Corp. (CSE: MTLC) Formerly Canada House Wellness Group Inc.- is the parent company of Montréal Medical Cannabis Inc., a licensed producer headquartered in Montréal, Québec and operating from a 57,000 sq ft licensed indoor grow facility in Pointe Claire, Québec; Abba Medix Corp., a licensed producer in Pickering, Ontario that operates a leading medical cannabis marketplace; IsoCanMed Inc., a licensed producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility; and Canada House Clinics Inc., with clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions.

MYM Nuetraceuticals Inc (CSE:MYM) is a west-coast based medical marijuana company focused on production, distribution, innovation and technologies related to the Marijuana industry. Our executive team has built many successful companies from the ground up and are striving to make MYM a world class brand.

MyDx, Inc. (OTC:MYDX) is a chemical detection and sensor technology company based in San Diego, California whose mission is to help people Trust & Verify® what they put into their minds and bodies. The Company developed MyDx®, a patented, affordable portable analyzer that provides real-time chemical analysis and fits in the palm of the user’s hand. The multi-use MyDx analyzer leverages over a decade of established chemical detection technology to measure chemicals of interest. The Company owns a substantial and growing intellectual property portfolio of patents covering its technology. The MyDx CannaDx™, AquaDx™ and OrganaDx™ sensors are now commercialized, and the AeroDx™ application is next in line. All Sensors will be compatible with a MyDx App that empowers consumers to test the chemical composition of what they eat, drink and inhale.

Nabis Holdings (CSE:NAB) (OTCQB: NABIF) is a Canadian investment issuer that invests in high quality cash flowing assets across multiple industries, including real property, securities, cryptocurrency, and all aspects of the U.S. and international cannabis sector. The Company is focused on investing across the entire vertically integrated aspects of the space with a focus on revenue generation, EBITDA and growth

Namaste Technologies Inc. (TSX:N.V; OTC:NXTTF) Formerly Next Gen Metals, Inc. – is an emerging leader in vaporizer and accessories space. Namaste has over 30 e-commerce retail stores in 20 countries, offers the largest range of brand name vaporizers products on the market and is actively manufacturing and launching multiple unique proprietary products for retail and wholesale distribution. The Company is currently focused on expanding its product offering, acquisitions and strategic partnerships, and entering new markets globally.

NanoSphere Health Sciences Inc. (CSE:NSHS) is a biotechnology firm specializing in the creation of a NanoSphere Delivery System™ (NDS) for the supplement, nutraceutical, over-the-counter pharmaceutical industries, and beyond. Its patent-pending NanoSphere Delivery System and industry-first line of bioavailable NanoSphere Gels, represent a significant milestone and one of the most important developments for advancing the non-invasive delivery of biological agents in over 25 years. As an innovative biotechnology company, we are developing a robust and growing portfolio of novel product candidates generated by our patent-pending NanoSphere Delivery System. We address multiple areas including dietary supplements, pharmaceutical and OTC medications, cannabinoids, skin care, animal health, etc.

National Access Cannabis Corp (TSX:META.V) is Canada’s best practices leader in delivering secure, safe, and responsible access to legal cannabis. Through its Canada-wide network of care centres, NAC enables patients and the public to gain knowledge and access to Canada’s network of authorized Licensed Producers of Cannabis.

Naturally Splendid Enterprises Ltd (TSX:NSP.V) has an exclusive licensing agreement to market and distribute, the full complement of patent pending, plant-based omega products created by Boreal Technologies. The products include HempOmega(TM) and H2Omega(TM), as well as the AlgaeOmega(TM) FlaxOmega(TM), CanolaOmega(TM), and ChiaOmega(TM) plant based omega products. These novel products utilize microencapsulation and are available in both a powder format and an aqueous solution for increased flexibility in ingredient applications and stand-alone products. Additionally, the Company has licensed from FSL progressive cannabinoid extraction and formulation technologies including the world’s first water soluble cannabinoid patent. Naturally Splendid’s 100% owned NATERA(TM) line of hemp-based superfood products are carried nationwide by Canada’s leading health food distributors and a network of retail stores across Canada including major retailers and specialty stores. Naturally Splendid’s recently rebranded “NATERA(TM)” line of products includes natural and flavored shelled hemp seeds as well as natural and flavored hemp protein powders.

nDatalyze Corp. (CSE:NDAT) Formerly MedXtracator Corp – is a Calgary-based company that generates technical solutions. It’s extraction division manufactures proprietary small-scale carbon dioxide-based and alcohol-based extractors that are used to extract essential oils and compounds from a variety of botanical materials. The Corporation owns the US and Canadian patents on its CO2 Extractors. The Corporation is developing the SHAMAN project, an AI-assisted, predictive probability engine initially targeting the effectiveness of psychedelic compounds when applied to a variety of mental afflictions.

Nemus Bioscience Inc. (OTC:NMUS) is a biopharmaceutical company, headquartered in Costa Mesa, California, focused on the discovery, development, and commercialization of cannabinoid-based therapeutics for significant unmet medical needs in global markets. Utilizing certain proprietary technology licensed from the University of Mississippi, NEMUS is working to develop novel ways to deliver cannabinoid-based drugs for specific indications, with the aim of optimizing the clinical effects of such drugs, while limiting the potential adverse events. NEMUS’ strategy will explore the use of natural and synthetic compounds, alone or in combination. The Company is led by a highly qualified team of executives with decades of biopharmaceutical experience and significant background in early-stage drug development.

Neptune Technologies & Bioressources Inc. (NasdaqCM:NEPT; TSX:NTB.TO) is a nutrition products company focused on the business of customized unique nutrition solutions, specialty ingredients and consumer brands. The company develops turnkey solutions available in various unique delivery forms. Neptune also offers premium krill oil manufactured in its state-of-the art facility and a variety of other specialty ingredients such as marine and seed oils. Neptune sells its premium krill oil under the OCEANO3® brand directly to consumers in Canada and the United States through web sales at www.oceano3.com. OCEANO3 is also sold as a turnkey solution to distributors. The Company’s head office is located in Laval, Quebec. Cannabis: Groupe DJB and Neptune Technologies & Bioressources (NASDAQ:NEPT)(TSX:NEPT), in collaboration with the Université de Sherbrooke, are proud to announce the creation of the Sherbrooke-based Green Valley Consortium, a strategic partnership that combines the strengths and expertise of three industry stakeholders to carry out medical cannabis production and research and development activities: an industry first.

Net Element, Inc. (NasdaqCM:NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the US and selected emerging markets. In the US we are growing transactional revenue by innovating SME productivity services such as its cloud based, restaurant point-of-sale solution Aptito. Internationally, Net Element’s strategy is to leverage its omni-channel platform in emerging markets with diverse banking, regulatory and demographic conditions such as UAE, Kazakhstan, Kyrgyzstan and Azerbaijan where initiatives have been recently launched. Cannabis: Oct 22, .2018 – (Unified Payments) launch of a secure and compliant payment processing offering aimed at the legal cannabis industry.

NEUTRA CORPORATION (OTC:NTRR) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products.

NeutriSci International Inc. (TSX:NU.V; OTC:NRXCF) specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy®, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. Bleuenergy® contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine, and is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products. With the recent formation of Ambarii, a joint venture partnership with Lexaria Bioscience Corp., NeutriSci is expanding its reach into the burgeoning cannabinoid industry.

New Age Brands Inc. (CSE: NF; OTC: NWGFF) is in the business of providing fully built out turnkey farming solutions for growers of high value luxury crops. We have operations in Washington State and British Columbia and are interested in bringing our innovative model to other jurisdictions with legalized medical and/or recreational marijuana.

New Colombia Resources Inc (OTC:NEWC) is a two-pronged company with not only premium coking coal but medical marijuana operations, two of the hottest sectors in today’s market. The Company has a joint venture in Colombia, Sannabis, producing medical marijuana products since 2014. New Colombia has hired a production company in Miami and teamed up with a retired World Series MVP to begin marketing some of these products in the U.S. where legal.

New Leaf Ventures Inc. (CSE:NLV) provides consulting services, real property, intellectual property, equipment for lease and enhanced ancillary services to a licensed cannabis producer and processor.

NewGen Concepts, Inc. (OTC:VPOR) acquires and develops commercially viable intellectual property. Formerly Vapor Group, it focused on the manufacture and marketing of vaporizers, e-cigarettes and e-liquids. Through its subsidiary, Smart Wheels, Inc., it markets “Whizboard” scooters. The Company’s subsidiary, Total Vapor, Inc., is the worldwide distributor of the revolutionary, hand-held automatic Easy Grinder™, designed for the MJ market.

NewLake Capital Partners, Inc. (OTCQX:NLCP) is an internally-managed real estate investment trust that provides real estate capital to state-licensed cannabis operators through sale-leaseback transactions and third-party purchases and funding for build-to-suit projects. NewLake owns a portfolio of 28 cultivation facilities and dispensaries that are leased to single tenants on a triple-net basis, and has provided one loan collateralized by a cultivation facility structured to convert to a sale-leaseback unless specific provisions are met by July 29, 2022.

Newstrike (TSX:HIP.V) is a publicly traded Canadian medical cannabis company licensed to produce cannabis through its wholly-owned subsidiary. Newstrike Resources owns, operates or has identified a diversified network of growing platforms in Ontario.

Next Generation Management Corp (OTC:NGMC) focuses, primarily, on the acquisition of retail and cultivation licenses in the medical marijuana industry. The Company’s overarching strategy is to acquire lines of business that have high intrinsic future value and to generate existing, reliable revenue streams, with the medical marijuana industry being its most recent and promising direction. With this expanded direction, the Company has formed a wholly owned subsidiary, NextGen Cannabis Consulting LLC to provide management services to the high growth, high profit medical marijuana industry. NextGen Cannabis Consulting is intent on the development of a national brand that encompasses every aspect of the medical marijuana industry, including collectives, dispensaries, and grow-ops. NextGen Holdings, LLC: Next Generation Management Corporation’s wholly-owned subsidiary was formed to hold its Oregon cannabis assets.

Next Green Wave Holdings Inc. (CSE: NGW; OTCQB: NXGWF) (formerly Crossgate Capital Corp.) is a vertically integrated premium medicinal and recreational cannabis company operating in the State of California, the world’s largest cannabis market. Led by award-winning cannabis industry veteran Mike Jennings, an Industry innovator specializing in premium cannabis products. With 15.5 acres and plans for four facilities centrally located in Coalinga, California – allowing for state-wide reach across the lucrative California market.

Nextleaf Solutions (CSE: OILS) (OTCQB: OILFF) is the first publicly traded company to be issued a U.S. patent for the industrial-scale extraction and purification of cannabinoids. OILS owns a portfolio of five (5) issued and 25 pending patents pertaining to the production of high-purity, cannabinoid rich distillate, a key ingredient used in the manufacturing of standardized THC and CBD infused products. Once cannabis concentrates become legal across Canada on October 17, 2019, the company plans to commercialize its intellectual property portfolio through IP licensing and B2B processing services.

NightFood Holdings, Inc. (OTCQB: NGTF) “The Nighttime Snack Company”, is a snack food company dedicated to providing consumers delicious, better-for-you, sleep-friendly choices for evening snacking. According to IRI Worldwide, 44% of snack consumption occurs at night, representing a consumer spend of over $1B weekly on nighttime snacks. Currently, consumer’s most popular choices are cookies, chips, ice cream, and candy. These options are generally understood to be unhealthy, and often contain ingredients and nutritional profiles that can impair sleep quality. NightFood creates, manufactures, and distributes snacks formulated to help consumers satisfy nighttime cravings in a better, healthier, more sleep friendly way. Cannabis: November 2017 – Company is researching introducing a line of snacks with cannabidiol (also known as CBD) to promote the medicinal benefits of CBD, including better sleep.

North American Cannabis Holdings, Inc. (OTC: USMJ) is founded on the core belief that cannabis makes people’s lives better. Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner. North American Cannabis Holdings is dedicated to developing the best possible applications for cannabis to serve consumers. North American Cannabis Holdings is introducing the AmeriCanna Café, a destination beverage company where consumers can interface with trained staff to learn about the specific benefits of cannabis and select healthy and refreshing cannabis infused beverages. The AmeriCanna Café subsidiary is expected to enjoy a rapid rate of growth accelerated by North American’s current DuBe Hemp Energy drink distribution business and the previously announced pending acquisition of an existing, ten year old fitness café operation. The AmeriCanna Café will initially include custom blended hemp infused coffee, cold pressed juices and smoothies in addition to carrying raw hemp seeds and other hemp infused foods. As state and federal law permits, THC infused beverages and foods will be added to the menu. North American Cannabis Holdings launched its cannabis business late in 2013 with the introduction of The American Seed & Oil Company, a subsidiary founded to conduct various pilots in the legal cannabis sector in order to explore a variety of high growth potential business opportunities. The Company will continue to develop existing and new pilot initiatives under the American Seed & Oil Company subsidiary.

North Bud Farms Inc. (CSE:NBUD) through its wholly-owned subsidiary GrowPros MMP Inc. which was acquired from Tetra Bio-Pharma Inc. (TSX-V: TBP) (OTCQB: TBPMF) in February 2018, is pursuing a license under the Access to Cannabis for Medical Purposes Regulations (ACMPR). North Bud Farms will be constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of Agricultural Land in Low, Quebec. North Bud Farms will be focused on Pharmaceutical and Food Grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October 2019.

Northern Lights Acquisition Corp (Nasdaq:NLIT) is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Formed to effect a Business Combination with a company in the cannabis industry with a particular focus on financing, branded products, branded retail, cultivation and processing and technology sub-sectors.

Northsight Capital Inc. (OTC:NCAP) is comprised of a portfolio of online marijuana-related websites that are being developed and operated by the company. These sites incorporate many aspects of the marijuana industry. The company provides its audience with a means to stay informed on the industry’s most cutting edge marijuana-related innovations and legislation. The company’s most dynamic concept, WeedDepot.com, provides consumers with a geo-targeted map directory of medical and recreational dispensaries, head shops, doctors, attorneys and more within the marijuana industry. The Weed Depot app can be downloaded for free at the iTunes Store and Google Play. Weed Depot has an entire platform of content suited for every aspect of advertising and marketing to consumers from all businesses in the cannabis industry. Northsight’s current websites include: www.Weeddepot.com, www.420careers.com, www.MJBizwire.com, www.MarijuanaRecipes.com, www.RateMyStrain.com, www.WikiWeed.com, www.MarijuanaMd.com, and www.MarijuanaHealthTips.com

Nova Cannabis Inc. (TSX:NOVC; OTCQB: NVACF) is one of Canada’s largest and fastest growing cannabis retailers with a goal to disrupt the cannabis retail market by offering a wide range of high-quality cannabis products at every-day best value prices. The Company currently operates 80 locations across Alberta, Ontario, and Saskatchewan primarily under its Value Buds banner. The Company is majority owned by Sundial Growers Inc. (NASDAQ: SNDL).

Nova Net Lease REIT (CSE:NNL.U) was formed to acquire specialized industrial and retail properties leased to experienced, top-tier, creditworthy, state-licensed operators in the legal U.S. cannabis industry

NOVUS Acquisition & Development Corp. (OTC:NDEV) through its subsidiary WCIG Insurance, Services, Inc. provides health insurance and related insurance solutions within the wellness and medical marijuana industries in states where legal programs exist. Novus has developed its infrastructure within many lines of the insurance business such as health, life, and fixed annuities. As a carrier Novus relies on two key indicators to measure value and performance. The Benefit Monetization Ratio is defined as the total number of policies, monetized annually, which is offset by the operating cost ratio which is a Balance Sheet line item computed as Net Asset Value. Novus’ medical cannabis benefits package will work as outside developers and will not cultivate, handle, transport grow, extract, dispense, put up for sale, put on the market, vend, deliver, supply, circulate, or trade cannabis or any substances that violate the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent disease. All information provided on these press releases, or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional. All cannabis transaction is solely between the state-licensed dispensary and the registered patient. The state laws conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state-designated laws, allowing the use and distribution of medical marijuana. Changes in consolidation may affect the provider network. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government’s enforcement of current federal laws could cause significant financial changes. While we do not intend to harvest, distribute, or sell cannabis or cannabis-related products, we may be harmed by a change in enforcement by federal or state governments.

NUGL Inc. (OTC: NUGL) is the world’s first cannabis search app built for the people, by the people. Our goal is to build the most user-friendly app experience in the cannabis industry by listening to our users and giving them what they want. NUGL is the only cannabis search app that offers equal and unbiased search results. We don’t sell top-spot listings or fake reviews, so our data stays true. Use NUGL to search for genuine user-rated dispensaries, strains, doctors, lawyers, cannabis service providers, vape shops, hydro stores, brands and more. NUGL’s flexible web app has no geographic limitations and can rapidly connect cannabis companies, related vertical services and users. The NUGL iOS and Android app brings a powerful cannabis search tool within reach of anyone, anytime, anywhere with the ease of a smartphone.

NutraLife Biosciences, Inc. (OTCQB: NLBS) Formerly NutraFuels, Inc. was founded in 2010 by Edgar Ward, the Company’s Chief Executive Officer, President and Director to engage in the development, manufacturing and distribution of unique and effective nutritional products. Since then the Company has evolved into a successful developer, manufacturer and distributor of more than 50 nutraceutical, wellness, and CBD products.

Nutritional High International Inc. (CSE:EAT; OTCQB:SPLIF; FRANKFURT:2NU.F) is focused on developing, manufacturing and distributing products and nationally recognized brands in the hemp and marijuana-infused products industries, including edibles and oil extracts for nutritional, medical and adult recreational use. The Company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law.

Omnicanna Health (formerly Endocan) (OTC:ENDO) is currently developing new natural cannabis-based products based on innovative formulations to utilize the unique and potent benefits of the cannabis and hemp plants. Medicinal properties of cannabis and hemp have been known and applied for thousands of years. With the aid of scientific research, OmniCanna Health Solutions is translating such knowledge into development of effective cannabinoid formulation-based health and wellness solutions as well as cosmeceutical, nutraceutical, and food brands throughout the world. The Company’s health and wellness, nutritional, and cosmetics lines will address personal needs and will evolve with the introduction of new formulations and products, advancing the Company within the expanding multibillion-dollar global market.

One World Pharma (OTCQB: OWPC) through its wholly-owned subsidiary One World Pharma SAS, is a fully licensed cannabis and hemp producer committed to supplying the highest quality cannabis and hemp ingredients to the world. One World Pharma was formed in 2017 to participate in the vast potential of the Colombian market created by the recent MMJ legislation of 2015 and 2017. Colombia is positioned to be a significant supplier of cannabis-based ingredients and products to the world based on its ideal climate, rich agricultural traditions, supportive legislation, and medical cannabis quotas.

Optima Medical Innovations Corp. (CSE:OMIC) Formerly Tree of Knowledge International Corp. -is a public company that delivers pathways to innovative, science-based health and wellness solutions. The Company is a leader in pain management, spanning from seed to patient. Built upon an extensive network of scientific and medical research, TOK is an advanced leader in the development, processing, and distribution of focused products and treatments for pain relief. Tree of Knowledge spans the globe with its multidisciplinary pain clinics, research partners, consumer CBD products, and education and advocacy programs – all working in harmony to bring health and wellness to the world while creating value for shareholders and partners.

Optimind Pharma Corp. (CSE:OMND) specializes in prescribing medical cannabis and other alternative treatments for various medical ailments. The Issuer prides itself on providing quality education and health care to patients. The Issuer is also an emerging provider of psychedelic therapies at its clinic, helping people suffering from PTSD, anxiety, depression, and other mental illnesses and disabilities by providing ketamine assisted treatment and other psychedelic enhanced psychotherapy modalities.

Orchid Ventures Inc. (CSE:ORCD) is an award-winning cannabis brand with THC and CBD product lines currently sold in 250+ dispensaries across California and Oregon. Orchid plans to expand its brand into new markets such as Nevada, New York, Puerto Rico, Canada and other global markets. With a continued focus on brand and intellectual property development, Orchid will execute strategic acquisitions to solidify an integrated cannabis manufacturing and distribution infrastructure with the goal of becoming a dominant premium cannabis brand in the United States. Orchid’s management brings significant branding, product development, manufacturing, and distribution experience with a proven track record of scaling revenues, building value generating partnerships, and creating enterprise value.

OrganiGram Holdings Inc. (NASDAQGS:OGI; TSXV:OGI.V) is a NASDAQ Global Select and TSX Venture Exchange-listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Co., Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

Origin House (CSE: OH; OH.WT; OTCQB:ORHOF) – Formerly CannaRoyalty Corp. – is a growing cannabis products and brands company operating across key markets in the U.S. and Canada, with a strategic focus on becoming a preeminent global house of cannabisbrands. The Company’s foundation is in California, the world’s largest regulated cannabis market, where it delivers over 130 branded cannabis products to the majority of licensed dispensaries. Origin House’s brand development platform is operated out of five licensed facilities located across California, and provides distribution, manufacturing, cultivation and marketing services for its brand partners. The Company is actively developing infrastructure to support the proliferation of its brands internationally, initially through its acquisition of Canadian retailer 180 Smoke. Origin House is the registered business name of CannaRoyalty Corp.

Orion Nutraceuticals Inc. (CSE:ORI) produces and develops innovative products with key strategic partners in the cannabis life science industry. In conjunction with its professional sports strategic alliances, the company intends to advance research and development in the plant science sector, deliver science-based products and services, and market CBD therapies to the mainstream with proprietary brands and products.

Ovation Science Inc. (CSE: OVAT) is engaged in the business of sublicensing rights to use Invisicare a patented drug delivery technology used in topical and transdermal skin products containing hemp seed oil and cannabis products.

OWC Pharmaceutical Research Corp. (OTC:OWCP) through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., (collectively \”OWC\” or the \”Company\”) conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. OWC is also developing unique delivery systems for the effective delivery and dosage of medical cannabis. All OWC research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators. The Company’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids for the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks.

Oxford Investments Holdings Inc. (OTC Pink: OXIHF) through its Florida-based subsidiary, FloraCana Consultants Inc. is marketing the sale of CBD store franchises and license agreements throughout the United States under the Pioneer Green USA brand. The Company currently has three licensed stores operating in Florida and plans to expand into Canada once Health Canada legislation around CBD is established.

OXIS International, Inc. (OTC:OXIS) is a biotech company that develops and commercializes innovative drugs of therapeutic molecules including cannabinoids, which are focused on several cancer indications. Oxis address the clinical shortcomings of existing commercial products in related fields. OXIS has formed relationships with some of the world’s leading cannabinoid researchers and institutions to advance its technologies.

ParcelPal (OTC:PTNYF; CSE: PKG) s a technology driven logistics company that connects consumers to the goods they love. Customers can shop at partner businesses and through the ParcelPal technology receive their purchased goods within an hour. The Company offers on-demand delivery of merchandise from leading retailers, restaurants, medical marijuana dispensaries and liquor stores in Vancouver and soon in major cities Canada-wide.

Pascal Biosciences Inc. (TSX.:PAS.V) is a biotechnology company focused on advancing innovative approaches for the treatment of cancer including cannabinoid-based therapeutics and targeted therapies. The company’s leading cannabinoid portfolio comprises a small molecule therapeutic, ST-403, that is advancing into clinical trials for the treatment of glioblastoma, and an immuno-stimulatory molecule. In addition, Pascal Biosciences is developing a B-cell targeted antibody for acute lymphoblastic leukemia and an antibody for calcium channels expressed by the immune system

Pazoo, Inc. (OTC:PZOO) is a company focused on health, wellness and safety. Our focus is to provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly owned subsidiary, Harris Lee, and our partnership with MA & Associates, Pazoo provides industry leading laboratory testing of cannabis. Pazoo’s license agreement with Steep Hill Labs Inc. allows us to use their best-in-market testing protocols on a right of first refusal basis as we expand throughout the USA. Pazoo is licensed to test cannabis in Nevada and Oregon, with a focus on expansion into other states. Additionally, Pazoo delivers a comprehensive array of health and wellness information on its website www.pazoo.com, and features industry experts from both the health and wellness arena and the pet industry.

Petrone Worldwide, Inc. (OTCQB: PFWI) is a leader in the hospitality industry with global operations capabilities. Now providing third party logistics for overseas manufacturing companies attempting to sell their goods in North America, PFWI sells and markets products under its own proprietary name and acts as distributor for a wide variety of companies to the hospitality trade. Cannabis: 2-21-17 – Company has formally signed a Letter of Intent with Twisted Lab, LLC to become the exclusive distributor for their cannabis products throughout Europe. In addition, PFWI will facilitate the building of a premier international sales and marketing distribution network throughout the sovereign states of Europe that will be mutually beneficial for both Petrone Worldwide and Twisted Lab. Twisted Lab is a leader in the cannabis market with their silicone water pipe line which will be distributed by PFWI.

Pharmacyte Bioetch (OTC:PMCB) (Formerly Nuvilex, Inc) is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box® This unique and patented technology will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. PharmaCyte Biotech’s treatment for pancreatic cancer involves low doses of the well-known anticancer prodrug ifosfamide, together with encapsulated live cells, which convert ifosfamide into its active or “cancer-killing” form. These capsules are placed as close to the cancerous tumor as possible to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. This “targeted chemotherapy” has proven remarkably effective in past clinical trials. In addition, PharmaCyte Biotech is working towards improving the quality of life for patients with advanced pancreatic cancer and on treatments for other types of solid cancerous tumors. PharmaCyte Biotech is also developing treatments for cancer based upon chemical constituents of marijuana known as cannabinoids. In doing so, PharmaCyte Biotech is examining ways to exploit the benefits of Cell-in-a-Box® technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects usually associated with cancer treatments. This provides PharmaCyte Biotech the rare opportunity to develop “green” approaches to fighting deadly diseases, such as cancer of the pancreas, brain and breast, which affect hundreds of thousands of individuals worldwide every year.

PharmaDrug Inc. (CSE:PHRX) is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs. The Company owns 80% of Pharmadrug Production GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license and German EuGMP certification allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU. The Company also owns 100% of Super Smart, a Dutch company building a modern adult use psychedelic retail business with an elevated and educational focus. PharmaDrug recently acquired Sairiyo Therapeutics, a biotech company that specializes in researching and reformulating established natural medicines with a goal of bringing them through regulatory and research driven clinical trials.such as psychedelics, cannabis and naturally-derived approved drugs. The Company owns 80% of Pharmadrug Production GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license and German EuGMP certification allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU. The Company also owns 100% of Super Smart, a Dutch company building a modern adult use psychedelic retail business with an elevated and educational focus. PharmaDrug recently acquired Sairiyo Therapeutics, a biotech company that specializes in researching and reformulating established natural medicines with a goal of bringing them through regulatory and research driven clinical trials.

Pharmagreen Biotech, Inc. (OTC Pink: PHBI) WFS Pharmagreen Inc. is a wholly owned Canadian based subsidiary of Pharmagreen Biotech, Inc., a publicly traded (OTC Pink: PHBI) company. WFS Pharmagreen Inc. is a tissue culture company that is becoming one of the largest producers of hemp plantlets through a proprietary tissue culture process with opportunity to become one of the largest players globally. Pharmagreen’s mission is to advance the technology of tissue culture science and to provide the highest quality 100% germ free, disease free and all genetically the same hemp plantlets with high Cannabinoids content and with less than 0.3% THC and other flora while offering full spectrum DNA testing for plant identification, live genetics preservation using low temperature storage for various plant species.

Phivida (CSE:VIDA) is a premiere brand of cannabidiol (“CBD”) infused functional foods and beverages and clinical CBD products, poised for global distribution. Using nanoencapsulation technology, Phivida converts lipid based cannabinoids into water soluble delivery format enhancing bioavailability and timed released within the body. Phivida’s nanoencapsulated CBD is infused into CBD beverages, foods and supplements which contain a proprietary blend of phytonutraceuticals targeting a range of key health conditions, from chronic pain to terminal diseases. Celebrating; Health and Wellness, In Harmony™, Phivida’s mission is to lead the alternative health care sector as the global benchmark standard in premium cannabinoid infused foods, beverages and clinical products.

Pineapple Express Inc. (OTC:PNPL) Headquartered in Los Angeles, Calif., Pineapple Express is a publicly traded company that invests in, expands, and brands existing and newly established canna-businesses through expert consulting and cutting-edge technology. We provide capital to our canna- business clientele, lease real properties to canna-businesses, and provide consulting and technology to operators within the cannabis industry. We intend to create a nationally branded chain of company owned cannabis retail stores under the “Pineapple Express” name, as soon as federal laws allow. As long as cannabis remains federally illegal our operations will be limited to consulting, product licensing, leasing to and investing in existing and new canna-businesses, selling industry specific technology, and branding/retail concept support services. Home to some of the most experienced and well-connected minds in the business, Pineapple Express is at the forefront of the legal cannabis industry.

Plandaí Biotechnology, Inc. (OTC:PLPL) and its subsidiaries develop highly bioavailable, phytonutrient rich extracts which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare™ extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company’s products include beverage, cosmeceutical, wellness, nutriceutical, anti-aging, and pharmaceutical.

Planet 13 Holdings Inc. (CSE:PLTH) is committed to providing an array of international award-winning cannabis products available through its strategically located licensed operations. Planet 13 Holdings, Inc. is focused on providing an unparalleled dispensary experience and optimizing cultivation efficiencies through its best-in-class technology, as the vanguard of cannabis.

Platinex Inc. (CSE:PTX) has a long history of resource exploration and continues to focus efforts in this area. Platinex is also currently focusing efforts on the timely and strategic development of an online platform for the cannabis industry: www.cannabismall.org launched on July 1, 2017 and the new site will receive regular updates.

Players Network Inc (OTC:PNTV) is a diversified company with holdings in Media and Medical Marijuana. The Company uses its proprietary Enterprise Web Platform to develop Branded Digital Lifestyle Television Networks for itself and its partners in a wide range of lifestyle categories. Player’s Network’s current original channels, “Player’s Network,” “Vegas on Demand,” “Real Vegas TV,” focus on the Las Vegas and Gaming Lifestyles. These channels are distributed over PNTV’s owned and operated VOD Channels over its Broadband Network and Mobile Platforms. The Medical Marijuana assets are primarily through the Company’s 86% ownership in Greenleaf Farms Holdings, and PNTV’s newest channel, WeedTV.com, which focuses on the rapidly expanding cannabis community.

Poko Innovations Inc. (CSE: POKO) Formerly Brunswick Resources Inc.- is an award winning European-based company that leverages its strong portfolio of CBD brands, including financial services platform Lumipay, news and media sites, The Extract and Candid Magazine and consumer brands Poko and Canndid. These brands form a complete ecosystem that brings innovative solutions to the CBD industry-from supplying businesses with high-quality CBD-derived products and other natural health supplements to offering a reliable payment gateway service for high-risk industries and providing a CBD-focused marketplace for buyers and sellers to connect and trade. The Company has leadership teams located in Ireland, United Kingdom, Canada and the United States.

Polaris Northstar Capital Corp. (CSE: POLE) Formerly Global Care Capital Inc. – is a global investment company which specializes in providing early-stage financing to private and public companies. The Company engages in new, early-stage investment opportunities in previously underdeveloped assets and obtaining positions in early-stage investment opportunities that adequately reflect the risk profile.

POSaBIT Systems Corporation (CSE: PBIT) is a financial technology company that delivers unique and innovative, blockchain-enabled payment processing and point-of-sale systems for cash-only businesses. POSaBIT specializes in resolving pain points for complex, high-risk, emerging industries like cannabis with an all-in-one solution that is compliant, user-friendly and utilizes top-of-the-line hardware. POSaBIT’s unique solution provides a safer and transparent environment for merchants while creating a better overall experience for the consumer.

PotNetwork Holding Inc. (OTC:POTN) is a publicly traded company with two wholly owned subsidiaries, Sunrise Auto Mall Inc. and First Capital Venture Co. and its wholly owned subsidiary Diamond CBD. First Capital Venture Co. through its wholly owned subsidiary, Diamond CBD, is a progressive organization focused on the advanced research and development of the industry’s finest premium hemp extracts and making them available to the global marketplace. The Company’s notable team, consisting of hemp industry pioneers and natural product experts, chemists, and scientists, is dedicated to producing the finest and purest CBD oil.

Predictmedix Inc. (CSE: PMED) Formerly Cultivar Holdings Inc is an early stage cannabis company. The Issuer has a variety of offerings in the cannabis industry, including a proprietary artificial intelligence technology for workplace and law enforcement to detect cannabis and alcohol impairment along with the cultivation of cannabis (in Jamaica), the manufacture of natural, consumable health products, as well as the development of genetic tools for opioids and cannabis dependency.

PreveCeutical Medical Inc. (CSE:PREV.C) is a biomedical company that coined the platform for preventive health sciences. PreveCeutical’s innovative research and development department advances organic and nature identical products for both prevention and curative therapies.

Primo Nutraceuticals Inc. (CSE:PRMO) formerly Bougainville Ventures Inc – provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Cultivators lease these facilities and pay affordable fee-based management costs to accelerate market entry and scalability. The first 10,000 square feet of greenhouse space in Oroville, Washington has been completed and is ready for occupancy. Our facilities remove financial barriers for cannabis cultivators as traditional funding is limited due to United States federal laws and current lending practices.

Profile Solutions, Inc. (OTC:PSIQ) through its subsidiary Elite Products International, Inc., is a leading distributor and manufacturer in the cannabinoid (CBD) industry. The Company’s products contain cutting-edge CBD industrial hemp extracts in the form of edibles, creams, oils, salves and others. Financial information can be found at www.otcmarkets.com/stock/PSIQ/profile . Please visit the Company website at www.profilesolutionsinc.com

Psychemedics Corp. (NasdaqCM:PMD) is the world’s largest provider of hair testing for the detection of drugs of abuse. The Company’s patented process is used by thousands of U.S. and international clients, including over 10% of the Fortune 500 companies, for pre-employment and random drug testing. Major police departments, Federal Reserve Banks, schools, and other public entities also rely on our unique patented drug testing process. We strongly believe our drug testing method to be superior to any other product currently in use, including traditional urine testing and other hair testing methods. Cannabis Testing

Puration, Inc. (OTC: PURA) is engaged in the development of standardized and repeatable cannabis extraction processes that can deliver a consistent and high-quality concentrate for infusion into consumer food and beverage products that appeal to the recreational and wellness market segments. The Company recently released details regarding the upcoming launch of an extraction facility in the State of Colorado where the extraction process can be utilized for both the ongoing development of cannabis treatments at the same time benefiting from the extraction and selling oil from marijuana into the legal recreational market in Colorado.

Pure Extracts Technologies Corp. (CSE:PULL) is an integrated Canadian plant-based extraction company specializing in the processing of cannabis, hemp and functional mushrooms to produce oils and various derivative products. The company is involved in white labeling activities as well as selling branded oil based products under the Pure Extracts brand. The Company features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. On September 25, 2020, Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act

Pure Global Cannabis Inc. (TSX:PURE.V; OTC: PRCNF) is a vertically-integrated, growth-oriented life sciences cannabis company led by experienced pharma-industry, horticultural, consumer packaged goods (CPG), and supply chain experts. The Company’s wholly owned subsidiary, PureSinse Inc., is a licensed producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR) focused on producing cannabis products for medical, wellness, health & beauty, natural health, and future legal adult use markets.

Pure Harvest Cannabis Group, Inc. (OTC PINK: PHCG) is a development stage science-based medical cannabis company with a commitment to the highest quality products, ethical growing standards, environmental awareness, and corporate integrity. Pure Harvest intends to develop into a large scale vertically integrated producer and distributor in large, established, and growing markets. Pure Harvest is focused on developing precision dosed cannabinoid health and wellness consumer products. The Company’s goals include establishing Pure Harvest Cannabis as an iconic consumer product brand offering a wide variety of cannabis/CBD products that can be sold in multiple international markets that have legalized cannabis and hemp-derived products. Pure Harvest recently merged with The Pocket Shot Company and plans to transition into a vertically integrated multi-state operator (MSO) and purveyor of the finest quality cannabis and hemp derived products for active life styles, and to support patient health and well-being.

Pyxus International, Inc. (NYSE: PYX) is a global agricultural company united behind a common purpose – to transform people’s lives so that together we can grow a better world. With 145 years’ experience delivering value-added products and services to businesses and customers, we are a trusted provider of responsibly-sourced, independently-verified, sustainable and traceable products and ingredients. Pyxus International offers high-quality, distinct brands and products on the cutting edge of innovation and entrepreneurship in the E-Liquids, industrial hemp, legal cannabis and leaf tobacco industries.

Quadron Cannatech Corporation (CSE: QCC) focuses on ancillary equipment, products and services for the authorized cannabis industry, providing automated extraction and processing solutions, and sales of end user delivery solutions such as vape pens, capsules and other safer consumption solutions for patients.

Quanta, Inc. (OTC: QNTA) an applied science company, focused on enhancing energy levels in plant matter (including cannabis) to increase performance within the human body. Its proprietary technology uses quantum mechanics to increase the bio-activity of targeted molecules to enhance the desired effects. The Company specializes in potentiating rare naturally occurring elements to create impactful and sustainable healing solutions that are as powerful and predictable as pharmaceutical drugs. Quanta offers its technology as a platform to product makers through distribution channels, as well as consumer products. The Company serves brands in cannabis, anti-aging, health and wellness, stress management, pain management, fitness, and brain performance enhancement. Quanta’s flagship product is a CBD pain relief rub. This all-natural topical consists of 13 natural elements including turmeric, arnica and polarized cannabidiol (CBD), designed to provide relief from pain, inflammation, and stiffness in muscles and joints. The Company was founded in 2016 and is headquartered in Los Angeles, California.

Queensland Bauxite (ASX: QBL.AX) engages in the exploration and development of bauxite tenements in Queensland and New South Wales. It operates through three segments: Mining Exploration and Evaluation, Medical Cannabis, and Corporate. The company’s flagship project is the South Johnstone bauxite deposit located in Northern Queensland. It also holds 100% interest in the Pilbara gold project that covers an area of approximately 200 square kilometers in Queensland. In addition, Queensland Bauxite Limited engages in the hemp and medical cannabis business.

Quinsam Capital Corporation (CSE:QCA) is a merchant bank based in Canada that is focusing on cannabis-related investments. Our merchant banking business may encompass a range of activities including acquisitions, advisory services, lending activities and portfolio investments. Quinsam invests its capital for its own account in assets, companies or projects which we believe are undervalued and where we see a viable plan for unlocking such value. We do not invest on behalf of any third party and we do not offer investment advice.

Radient Technologies Inc. (TSX:RTI.V) extracts natural compounds from a range of biological materials using microwave assisted processing (“MAP™”), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield, and cost. From its 20,000 square foot manufacturing plant in Edmonton, Alberta, Radient serves market leaders in industries that include pharmaceutical, food, beverage, natural health, personal care and biofuel markets. Marijuana – November 14 press release announces foray in the fast emerging cannabinoids medical market.

Radiko Holdings (CSE:RDKO) formerly International Cannabrands Inc., dba Radiko Holdings (Radiko) is a CBD and cannabis focused brand portfolio, leveraging the potential of the plant by offering best of breed products that naturally complement today’s consumer lifestyles. The Company’s mission is to build and market a diversified portfolio of cannabis and CBD brands, with strategic manufacturing and distribution partnerships to support better EBITDA and margins. Radiko markets products with THC content where that practice has been legalized at the state level through either medicinal or full recreational use. Radiko also markets products containing CBD in the US and internationally. The Company believes as the legal cannabis and CBD markets evolve, high-quality, unique products will increasingly capture market share and provide a valuable platform for growth.

RAMM Pharma Corp (CSE:RAMM) through its wholly-owned operating subsidiaries, is engaged in the pharmaceutical and medical product business, and is a leader in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. With RAMM’s large scale cultivation facility, the combined operations are expected to provide for complete vertical integration. Further to its industry leading activities in the cannabis sector, RAMM operates a pharmaceutical, cosmetic and nutraceutical product development and medical services business which has been servicing the local market for 30 years.

Rapid Dose Therapeutics (CSE: DOSE) is a publicly-traded Canadian biotechnology company that provides innovative, proprietary drug delivery technologies designed to improve outcomes and quality of lives. Through its wholly-owned subsidiary, Rapid Dose Therapeutics Inc., RDT offers Quick, Convenient, Precise and Discreet™ choices to consumers. RDT is focused and committed to clinical research and product development for the healthcare manufacturing industry – including nutraceutical, pharmaceutical and cannabis industries. Within the cannabis sector, RDT provides a turn-key Managed Strip Service Program which enables RDT’s QuickStrip™ proprietary drug delivery technology to be licensed by select partners. RDT’s service based annuity contracts drive recurring revenue which enables rapid expansion into emerging markets – generating value for consumers and shareholders. Rapid Dose Therapeutics is committed to continually create innovative solutions aimed at multiple consumer segments and future market needs.

Rapid Fire Marketing, Inc. (OTC:RFMK) is a developer and reseller of herbal vaporizers. The core strategy is to maximize revenues in the rapidly expanding medical cannabis and vaporizer industries. Rapid Fire Marketing also looks to invest and do joint ventures with companies in the vaporizer and medical cannabis industries as well as working with other companies with established revenue streams that are looking to grow their businesses. Rapid Fire Marketing is also looking to grow through acquisitions of companies or technologies that are synergistic with our business plan.

RavenQuest Biomed Inc. (CSE:RQB) is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.

REAC Group Inc. (OTC: REAC) On January 4, 2017, Real Estate Contacts, Inc. (the “Company”) closed the Asset Purchase Agreement (“APA”) with Patriot Bioenergy Corporation, a Kentucky corporation (“Patriot”), for the purchase of all of the assets related to the business of operating a hemp processing and growth operation and selling hemp related products (the “Business”). Patriot Bioenergy Corporation is an alternative energy agriculture biofuel company specializing in the utilization of hemp.

Red White and Bloom Brands (CSE:RWB; OTC: TDRYD) Formerly Tidal Royalty Corp.- is positioning itself to be one of the top three multi-state cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominately focusing its investments on major markets in the United States, including Michigan, Illinois, Massachusetts, California, and Florida in respect to cannabis and the entire US for legal hemp CBD based products.

Redfund Capital Corp. (CSE: LOAN) intends to provide debt and equity funding in the mid-to-late stages of a target company’s development, or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related, healthcare-related target companies.

Relevium Technologies Inc. (TSX.:RLV.V) (OTCQB:RLLVF) (Frankfurt:6BX) is a TSXV-listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices. Biocannabix, a wholly-owned subsidiary will focus on organic products and on the development of specialty genetic strains targeting primarily cannabidiol (CBD) and cannabigerol (CBG) for use in medical applications as well as consumer packaged goods.

Reliq Health Technologies Inc. (TSX:RHT.V) is a Vancouver, BC based healthcare technology company that specializes in developing innovative, secure mobile software solutions for the $20 Billion Community Care market. Reliq’s iUGO Health technology platform is a comprehensive hardware and software solution that allows complex patients to receive high quality care in the home, improving health outcomes, enhancing quality of life for patients & families and reducing the cost of care delivery. February 2017: Collaborating on App for Cannabis Industry

RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) is a leader in the development of medicines for respiratory disorders, with a focus on sleep apneas and drug-induced respiratory depression. The Company holds exclusive licenses and owns patents and patent applications or rights thereto for certain families of chemical compounds that claim the chemical structures and their uses in the treatment of a variety of disorders, as well as claims for novel uses of known drugs. RespireRx has a pipeline of medicines in Phase 2 clinical development focused on pharmaceutical treatments for a variety of breathing disorders. Clinical development in the area of respiratory disorders, particularly drug-induced respiratory depression and sleep apnea, has created opportunities for the development and commercialization of the Company’s compounds. Cannabinoids. One platform being developed by RespireRx is the class of compounds known as cannabinoids, including dronabinol. Under a license agreement with the University of Illinois, the Company has rights to patents claiming the use of cannabinoids for the treatment of sleep-related breathing disorders. Ampakines. The other platform of proprietary medicines being developed by RespireRx are ampakines, which act to enhance the actions of the excitatory neurotransmitter glutamate at AMPA glutamate receptors. Several ampakines, in both oral and injectable forms, are being developed by the Company for the treatment of a variety of breathing disorders. In clinical studies, select ampakines have shown preliminary efficacy in central sleep apnea and in the control of respiratory depression produced by opioids, without altering the opioid analgesic effects. In animal models of orphan disorders, such as Pompe Disease, spinal cord injury and perinatal respiratory distress, it has been demonstrated that certain ampakines improve breathing function. The Company’s compounds belong to a new class that does not display the undesirable side effects previously reported for other ampakines.

Revive Therapeutics Ltd. (CSE:RVV) is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of infectious diseases, with an initial focus on severe influenza strains including COVID-19. With its recent acquisition of Psilocin Pharma Corp., Revive is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the company was granted FDA orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.

Right on Brands (OTC:RTON) formerly HealthTalk Live, is a Santa Monica California-based consumer and media company specializing in brand development of health conscious, hemp-infused food and beverage products. Humbly Hemp is a product line of delicious hemp based products. The snack line will feature hemp powered foods that will delight the palette of consumers and thrill retailers with America’s fastest growing food category.

RISE Life Science Corp. ( CSE:RLSC) formerly Luminor Medical Technologies Inc – develop cutting-edge cannabis consumer products for both medical and adult-use markets around the world. All products are based on patent-pending formulations and processes to produce specific targeted effects. A key area of focus for RISE is evidence-based formulations to address adult sexual health and wellness for both men and women.

Rising Biosciences (OTC:RSII) is a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry. Cannabis: Rising BioSciences seeks to fulfill a yet-to-be-met market demand with a first to market approach so that patients across the U.S. get the treatment they so desperately need without falling subject to the dangers of opiates, whose long-term effects can include liver damage, dependence/addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.

RIV Capital Inc. (CSE: RIV) is an investment and acquisition company specializing in cannabis with a portfolio of 13 companies across various segments of the cannabis value chain. We believe that bringing together people, capital, and ideas raises the potential of the entire cannabis industry. By leveraging our industry insights, in-house expertise, and thesis-driven approach to investing, we aim to provide shareholders with exposure to specialized and disruptive cannabis companies.

Rocky Mountain High Brands Inc (OTC:RMHB) is a consumer goods company specializing in brand development of health conscious, hemp-infused food and beverage products. The Company currently markets a lineup of four naturally flavored hemp-infused beverages (Citrus Energy, Black Tea, Mango Energy and Lemonade) and a low-calorie Coconut Lime Energy drink. Rocky Mountain High Brands also offers hemp-infused 2oz. Mango Energy Shots and Mixed Berry Energy Shots, as well as a new Relaxation Brownie. The Company recently launched a naturally high alkaline spring water, Eagle Spirit Spring Water™.

Roto-Gro International (ASX: RGI.AX) holds license for and sells automated rotary hydroponic advanced garden systems (Roto-Gro System) in Australia and Canada. The Roto-Gro System is able to produce uniform high quality medicinal cannabis at a reasonable cost allowing the Company to realise the burgeoning medicinal cannabis market in the western world.

Rubicon Organics Inc. (CSE:ROMJ; (OTCQX: ROMJF) is a North American company with operations in

Canada, California, and Washington. The principal activity of the Company is within the cannabis sector.

Sante Veritas Holdings Inc (CSE:SV) owns 100% of Sante Veritas Therapeutics Inc. (SVT). At present, Sante Veritas Therapeutics Inc. (SVT) is the Company’s (SVH’s) singular asset. Sante Veritas Therapeutics Inc. (SVT) is a late stage applicant under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company (SVT) was incorporated in British Columbia in February 2012 and in August 2013, applied to Health Canada for permission under the Marihuana for Medical Purposes Regulations (MMPR) to convert an administrative office building owned by the City of Powell River, British Columbia into a facility for the cultivation, harvest and sale of adult cannabis for medical purposes. The Company (SVT) expects to complete construction of its first facility in Powell River by late spring/early summer 2018 and to be awarded its first licence to produce (LP) cannabis by Health Canada in 2018. The Company’s (SVT’s) first facility in Powell River occupies approximately 40,000 sq ft on 4-floors encompassing approximately 12,000 sq ft of indoor cultivation area. The Company (SVT) is currently negotiating plans to expand its Powell River site by 93,000 sq ft of purpose built, multi-level, indoor, cultivation facilities.

Scotts Miracle-Gro Company, The (NYSE:SMG) is the world’s largest marketer of branded consumer products for lawn and garden care. The Company’s brands are the most recognized in the industry. In the U.S., the Company’s Scotts(R), Miracle-Gro(R) and Ortho(R) brands are market-leading in their categories, as is the consumer Roundup(R) brand, which is marketed in North America and most of Europe exclusively by Scotts and owned by Monsanto. In the U.S., we operate Scotts LawnService(R), the second largest residential lawn care service business. In Europe, the Company’s brands include Weedol(R), Pathclear(R), Evergreen(R), Levington(R), Miracle-Gro(R) (R), KB(R), Fertiligene(R) and Substral(R).

Seedo Corp. (OTCQB: SEDO) is a market leading, high-tech company providing the hemp and agriculture industries with fully automated and controlled indoor growing solutions for home-grown and commercial hemp, herbs and vegetables. Seedo provides growers with the freedom to cut costs while generating high yields of lab-grade, pesticide-free herbs and vegetables. Seedo’s artificial intelligence (AI)-powered, turnkey systems enable anyone, from the average consumers to large-scale producers, the ability to grow without prior experience or ample space. The Seedo solution minimizes cultivation costs by delivering maximum daylight illumination, built-in carbon filters, automated air conditioning, and a smart post-harvest drying system to users. Even in the harshest environments or with limited space, cultivators can use Seedo’s intelligent technology to harvest the next generation of precision agriculture.

Simlatus Corporation (OTC PINK:SIML) develops, manufactures, markets, and owns broadcast equipment and software for broadcast studios worldwide. The company also provides DirecTV services to high-rise apartments, condominiums, and large commercial office buildings in the San Francisco metropolitan area, as well as Internet services. develops, manufactures, markets, and owns broadcast equipment and software for broadcast studios worldwide. The company also provides DirecTV services to high-rise apartments, condominiums, and large commercial office buildings in the San Francisco metropolitan area, as well as Internet services. Simlatus is also heavily invested in the $150 Billion Digital Media and Augmented/Virtual Reality device industry. Their SocialCast AR and Augmented/Virtual Reality Content Server products will enable the company to expand into high-growth digital television and over-the-top (OTT) markets. We are developing technologies in Virtual Reality, Augmented Reality, Audio/Video Codecs, Audio Content Recognition, and OTT API Integration. Our Market Analysis and IP Portfolio will include new patents specifically developed for these products and owned by the Company. CANNABIS: In addition, the company manufactures and sells cold- water/alcohol CBD extraction systems for medical grade CBD utilization, as well as climate controlled grow containers for government food-safety programs, and commercial and medical grade CBD. Simlatus Corporation is based in Grass Valley, California.

SINGLEPOINT INC. (OTCQB:SING) is a technology company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company portfolio includes mobile payments, daily fantasy sports, ancillary cannabis services and blockchain solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base. Through its subsidiary company SingleSeed, the company is providing products and services to the cannabis industry.

Sipp Industries Inc (OTC:SIPC) is a multifaceted corporation that specializes in technology, manufacturing and distribution of commercial and consumer products. Through its wholly owned subsidiary, Major Hemp, the Company provides high quality and competitively priced hemp based products, bulk hemp, CBD supply, co-packing and private labeling services, including “Major Hemp Brown Ale” brewed by Sleeping Giant Brewing of Colorado

Sixth Wave Innovations Inc. (CSE:SIXW) is a nanotechnology company focused on extraction and detection of target substances at the molecular level. The company’s products provide significant advantages in cost and performance. These advantages are derived from application of the company’s patented technologies in the highly specialized field of molecularly imprinted polymers (MIPs). Sixth Wave is commercializing IXOS®, a line of extraction polymers for the gold mining industry and Affinity™ for the Cannabis Industry.

SLANG Worldwide Inc. (CSE:SLNG) is a leading global cannabis consumer packaged goods company with a robust portfolio of renowned brands distributed across 2,600 stores in 12 US states. The Company is focused on acquiring and developing market-proven regional brands as well as creating new brands to meet the needs of cannabis consumers worldwide.

Smart Cannabis Corp. (OTC: SCNA) is a public equity corporation focused on the advanced agriculture and cannabis industries with plans to grow through acquisition, strategic alliances, and proprietary intellectual property. The company’s wholly owned subsidiary Next Generation Farming Inc. provides turnkey commercial SMART greenhouse and automation systems that improve yields and decrease water consumption for cultivators of organic food and cannabis crops.

SNDL Inc (NasdaqGS: SNDL) is the largest private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. SNDL is a licensed cannabis producer and one of the largest vertically integrated cannabis companies in Canada specializing in low-cost biomass sourcing, premium indoor cultivation, product innovation, low-cost manufacturing facilities, and a cannabis brand portfolio that includes Top Leaf, Contraband, Citizen Stash, Sundial Cannabis, Palmetto, Bon Jak, Spiritleaf Selects, Versus Cannabis, Value Buds, Vacay and Grasslands. SNDL’s investment portfolio seeks to deploy strategic capital through direct and indirect investments and partnerships throughout the global cannabis industry.

SOL Global Investments Corp. (CSE:SOL) formerly Scythian Biosciences Inc.- is an international cannabis company with a focus on legal U.S. states. Its strategic investments and partnerships across cultivation, distribution and retail complement the company’s R&D program with the University of Miami. It is this comprehensive approach that is positioning Scythian as a future frontrunner in the United States medical cannabis industry

Solis Tek Inc. (OTC:SLTK) is an importer, distributor and marketer of digital lighting equipment for the hydroponics industry with specific focus on the research, design, development and manufacturing of advanced, energy efficient indoor/greenhouse horticulture lighting and ancillary equipment. Using certain of its proprietary technologies, the Company provides innovative aptitudes with its ballast, reflector and lamp products. Our vision is to apply the latest advances in high efficiency lighting and controls technology as well as effective manufacturing techniques to deliver highly differentiated products with clear benefits at competitive prices to the greenhouse and indoor horticulture markets. The Company’s customers include retail stores, distributors and commercial growers in the United States and abroad.

Solo Growth Corp. (TSX:SOLO.V) – formerly Aldershot Resources Ltd – Operating as YSS by Solo™, Solo Growth Corp.™ is a cannabis retailer with the vision to become a premier retailer and the trusted destination for cannabis in Canada. Since launch in June of 2018, Solo Growth has leveraged management’s expertise in commercial real estate to build a strategic portfolio of future locations while managing financial commitments and has completed construction of three stores in Alberta. With over 22 years experience gained through profitably operating the Solo Liquor retail brand, YSS management brings operational excellence in responsible controlled-substance retail to the newly legalized cannabis industry. The YSS by Solo retail experience is built on our five fundamental pillars: convenience, value, selection, team, and above all else, trust.

South American Gold Corp. (OTC: SAGD) had previously been focused on supplying goods and services to the cultivators (farmers) in the emerging cannabis market in the country of Uruguay. Under our new leadership the company has moved from tools and supplies to the cultivators in Uruguay, on to a whole new realm of the cannabis industry. Our company is now focused on the LIFESTYLE of the cannabis industry through our soon to be released cannabis social network, “PotCircles”; which is our first step towards our new company strategy.

SpeakEasy Cannabis Club Ltd. (CSE:EASY) represents a collective of the top cannabis growers in Canada, sharing decades of knowledge and experience to produce the finest product in the world. As the only licensed producer applicant in British Columbia’s renowned ‘Golden Mile’, our 290-acre facility in the South Okanagan Valley is celebrated for its ideal climate conditions, honoring this region’s tradition of excellence and a family legacy that has grown here for more than 120 years. We embrace the finest elements of a proud cannabis culture and years of agricultural expertise to do what we know best.

Springbig Holdings Inc. (NasdaqGM:SBIG) is a market-leading software platform providing customer loyalty and marketing automation solutions to cannabis retailers and brands in the U.S. and Canada. springbig’s platform connects consumers with retailers and brands, primarily through SMS marketing, as well as emails, customer feedback system, and loyalty programs, to support retailers’ and brands’ customer engagement and retention. springbig offers marketing automation solutions that provide for consistency of customer communication, thereby driving customer retention and retail foot traffic. Additionally, springbig’s reporting and analytics offerings deliver valuable insights that clients utilize to better understand their customer base, purchasing habits and trends.

Sproutly Canada Inc (CSE:SPR) (formerly Stone Ridge Exploration Corp.) is an ACMPR Licensed Producer of cannabis that strives to meet the evolving needs of cannabis consumers across Canada. Its mission is to become a vertically integrated cannabis consumer products company, bringing together best-in-class cultivation, secured distribution solutions, and advanced technologies to redefine the cannabis industry. Sproutly currently owns and operates a 16,600 sq. ft. production facility located centrally in the GTA utilizing state-of-the-art production technology and methods designed to pharma-grade standards. Sproutly’s strategy is focused on developing and deploying novel technologies to formulate and market unique cannabis products in a rapidly evolving consumer market.

Spyder Cannabis Inc. (TSX: SPDR.V) is an established chain of three high-end vape stores in Ontario, with stores located in Woodbridge, Scarborough and Burlington. The Spyder brand is defined by its high-quality proprietary line of e-juice, liquids and exclusive retail deals, dispensed in uniquely designed stores creating the optimal customer experience. Spyder is building off this leading retail, distribution and branding eCig and vapes company and expanding into the legal cannabis and hemp derived market. Spyder has developed a scalable retail model with aggressive expansion plan to create a significant retail footprint with targeted and disciplined retail distribution strategy focusing on Canadian retail and U.S. hemp kiosks in high traffic peripheral areas.

Stem Holdings Inc. (CSE: STEM; OTCQB: STMH) was formed to purchase, lease and improve certain real estate properties, initially in the State of Oregon and the State of Nevada, which are or will be utilized as either cannabis selling retail establishments or cannabis growing facilities. In July 2017, Stem Holdings, Inc. commenced rental operations through real estate leases with entities engaged in the cultivation, processing and sale of cannabis.

StereoVision Entertainment, Inc. (OTC:SVSN) is a publicly traded Nevada company focused on creating, acquiring, and producing multimedia content with its media subsidiaries the majority owned family entertainment company Inspirational Vision Media and the wholly owned 9 time Emmy Award winning production company REZN8, and the majority owned medical cannabis and organic hemp subsidiary, MediCannaVision Inc., dba CannaVision.

Stevia Corp (OTC:STEV) is a farm management company and healthcare company focused on developing highly nutritional, high value products through proprietary plant breeding (including the stevia plant) and hemp, excellent agricultural methodologies and innovative post-harvest techniques. Stevia Corp invests in R&D and IP acquisition and manages its own propagation, nursery and plantations as well as provides services to contract growers and other industry growers. Stevia Corp was founded on the principal of implementing socially responsible, sustainable, quality agribusiness solutions to maximize the long-term efficient production of nutritional crops.

StillCanna Inc. (CSE:STIL) formerly EVI Global Group Development – is a Canadian early-stage life sciences company, based in Vancouver, British Columbia, that is focused on large scale CBD extraction in Europe. The Company feels its proprietary intellectual property allows it to extract CBD at a lower cost. The Company has signed an initial extraction contract in Europe to be the exclusive extractor for Dragonfly BioSciences LLC, a UK based supplier of CBD. The Company continues to look for other industry acquisitions that will enhance shareholder value.

Stony Hill Corp. (OTC:STNY) is a diversified company focused on multiples areas of cannabis, hemp and CBD industry. The company is focused on select investment, branding, real estate, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

SugarBud Craft Growers Corp. (TSX:RRL.V) – formerly Relentless Resources Ltd – is a Calgary based emerging cannabis and oil and natural gas company engaged in the development, acquisition and production of cannabis and natural gas and crude oil reserves in Alberta.

Sugarmade Inc (OTC:SGMD) is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include CarryOutSupplies.com, Sugarmade Tree Free Paper, FreeHand ThumbTray and CannaShroud™. During early 2017, the company will be launching Sriracha Stix, a revolutionary culinary seasoning product under official license from Irwindale, California-based Huy Fong Foods, Inc., the maker of Sriracha Hot Chili Sauce.

Sun Kissed Industries Inc. (OTCMKTS: SKDI) is an emerging leader in the CBD-based products marketplace. The Company is pursuing meaningful acquisitions as part of an aggressive M&A strategy designed to position Sun Kissed as a dominant player in a well-defined, high-growth niche within the rapidly expanding CBD sector.

Sunniva Inc. (CSE:SNN) through its subsidiaries, is a vertically integrated medical cannabis company operating in the two largest markets – California and Canada. Sunniva is committed to becoming one of the lowest cost producers delivering safe, high-quality products and services at scale free of pesticides and/or other contaminants.

SUPREME Cannabis Company (TSX: FIRE.TO; OTC:SPRWF) is a Canadian-owned and operated company whose mission is to enhance the quality of life of our patients and clients by producing sun-grown medical marijuana of the highest standards, quality and value. Supreme Pharmaceuticals Inc. acquired marijuana grow operations in June 2014, with the purchase of Advanced Medical Marijuana Canada (“AMMCan”), a Canadian corporation, which is now a wholly (100%) owned subsidiary and operating as Supreme Medical Marijuana (AMMCAN Supreme). AMMCan Supreme is preapproved by Health Canada to grow produce and distribute 24,000 kilograms of marijuana per annum.

SURNA INC. (OTC:SRNA) develops innovative technologies and products that monitor, control or address the energy and resource intensive nature of indoor cannabis cultivation. Currently, the Company’s revenue stream is based on its main product offerings – supplying industrial technology and products to commercial indoor cannabis grow facilities. Headquartered in Boulder, CO, Surna’s diverse engineering team is tasked with creating novel energy and resource efficient solutions, including the Company’s signature water-cooled climate control platform. The Company’s engineers continuously seek to create technology that solve the highly specific demands of the cannabis industry for temperature, humidity, light and process control. Surna’s goal is to provide intelligent solutions to improve the quality, the control and the overall yield and efficiency of indoor cannabis cultivation. The Company’s operations exclude the production or sale of marijuana.

Sweet Earth Holdings Corporation (CSE:SE) is a vertically integrated and award-winning company focused on hemp production and CBD related products. A member of the American National Hemp Association and Leaping Bunny accredited, the Company maintains a complete “farm to shelf” platform. The Company’s American and European farms focus on pure organic hemp growing while production specializes on high-end CBD products that can be purchased on its website and distributors in the United States.

Target Group Inc. (OTCQB: CBDY) is a progressive, diversified, and vertically integrated cannabis acquisition company. Target Group is curating an iconic brand portfolio, leveraging product diversification, innovation, and operational expertise to solidify long-term growth and stability. The Company owns and operates Canary Rx Inc, a final-stage Canadian cannabis license applicant, and CannaKorp, makers of the pod-based Wisp™ Vapor technology. Target Group is expanding its global operations to build an international network of manufacturing, distribution, production, and sales operations.

TAURIGA SCIENCES INC. (OTC:TAUG) is a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology. The mission of the Company is to acquire and build a diversified portfolio of life science assets that is capital efficient and has the potential to generate meaningful profitable revenues. The Company’s business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. Tauriga has developed and is preparing to launch its own proprietary line of cannabis creams under the TopiCanna brand name in the first quarter of 2015. There are two distinct TopiCanna products: one which will contain ingredients to better penetrate to the joints, and one that will contain ingredients that have been successfully used for dermatological conditions. Tauriga’s TopiCanna products will be offered in the United States (under compliance with all applicable medical marijuana regulations} as well as in Japan. Medical marijuana law in Japan requires that products use oil that has been extracted from the stalk of the cannabis plant and that is necessarily higher in CBD and low in THC, hence providing wellness and healing properties without psychoactive effects

Tecogen Inc. (NasdaqCM:TGEN) designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including natural gas engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company is known for cost efficient, environmentally friendly and reliable products for energy production that, through patented technology, nearly eliminate criteria pollutants and significantly reduce a customer’s carbon footprint. In business for over 20 years, Tecogen has shipped more than 2,300 units, supported by an established network of engineering, sales, and service personnel across the United States. CANNABIS: Tecochill model STx water chillers sold to an indoor cannabis cultivation facility in central Massachusetts. This order is independent of and separate from another order for two model DTx chillers announced in June and marks the third sale that the company has closed into the nascent cannabis industry of Massachusetts. It is Tecogen’s fifth sale to the cannabis industry overall. The three units will be able to provide the new 30,000 Sq. ft. growing facility with 450 refrigeration tons of year-round cooling.

Terra Tech Corp (OTC: TRTC) through its wholly-owned subsidiary GrowOp Technology, specializes in controlled environment agricultural technologies. The company integrates best-of-breed hydroponic equipment with proprietary software and hardware to provide sustainable solutions for indoor agriculture enterprises and home practitioners. Our complete product line is available at specialty retailers throughout the United States, and via our website. TRTC, through its wholly-owned subsidiary, Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as Shoprite, Walmart, Krogers, and others throughout New Jersey, New York, Delaware, Maryland, Connecticut, Pennsylvania and the Midwest. The Company’s MediFarm LLC subsidiaries are focused on medical cannabis businesses throughout Nevada. IVXX LLC is a wholly-owned subsidiary that produces medical cannabis-extracted products for regulated medical cannabis dispensaries

Terranueva Corporation (CSE: TEQ) and its subsidiary are licenses applicant under the Cannabis Act and the Cannabis Regulations. Once the licenses have been obtained from Health Canada, the focus of Terranueva is to produce medicinal and recreational cannabis in an environment inspired by GMP pharma standards at its indoor facility located in province of Québec. In doing so, Terranueva will strive to deliver the highest standards of efficiency, quality and stability to its products for related therapeutic cannabis treatments such as chronic pains, migraines, sleeping disorders or anxiety.

TerrAscend (CSE: TER) is a biopharmaceutical and wellness company that is committed to quality products, brands and services for the global cannabinoid market. The Company provides support to medical consumers through its wholly-owned subsidiaries, Solace Health Inc., a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations and Solace Health Network Inc., a clinical support program and education platform led by healthcare professionals.

Tetra BioPharma Inc. (TSX:TBP.V; OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies

THC Biomed Intl Ltd. (CSE:THC) THC is an ACMPR Licensed Producer and Canada’s largest supplier of legal Cannabis Genetics. THC also produces and sells dried and fresh marijuana and cannabis oil for medical purposes. THC is on the leading edge of scientific research and the development of products and services related to the medical cannabis industry. Management believes THC is well-positioned to be in the forefront of this rapidly growing industry.

The Cannabis ETF (NYSEArca:THCX) tracks the Innovation Labs Cannabis Index, which is a modified market capitalization weighted index, with a portfolio of 36 stocks that are expected to benefit from growth of the legal marijuana, CBD and hemp industries. Valens’ inclusion is part of THCX’s expansion to include various cannabis industry sub-themes, such those at the crossroads of science and technology, which is intended to appeal to investors who are looking for differentiated exposure outside of a traditional seed-to-sale story. The index rebalances on a monthly basis and it is currently considered the lowest cost passively managed US-listed cannabis ETF.

The Hydroponics Company (ASX: THC.AX) focuses on the manufacture and distribution of hydroponics equipment, materials, and nutrients for cannabis cultivation and processing worldwide. Its products include extraction bags to filter plant resins without using chemicals; horticultural lighting products; lighting relays; trimmers for the removal of protruding leaves and roots, as well as for the preparation of plants for essential oils; multi-directional oscillating wall-mount fans for air circulation and coverage; ceramic metal halide lamps; elemental controls for temperature control for commercial hydroponic systems; and rack drying systems. It also engages in the hydroponic greenhouse design and construction activities; and development and delivery of medicinal cannabis.

Therapix Biosciences Ltd. (NasadqCM:TRPX) Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of Senior Executives and Scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based on repurposing an FDA-approved cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain

Thoughtful Brands Inc (CSE:TBI) .- Formerly Mota Ventures, is an established eCommerce technology company that researches, develops, markets and sells natural health products in North America and Europe. The Company has a strong focus on the CBD market, as well as the burgeoning psychedelic medicine sector. Through its direct-to-consumer digital platform, the Company offers multiple well-established hemp-CBD brands, including Nature’s Exclusive, Sativida and Franchise. The Company also owns and operates a 110,000 square foot manufacturing

facility in Radebeul, Germany, where its highly skilled team is currently conducting clinical studies utilizing naturally occurring psilocybin and other compounds found in psychedelics for the treatment of opiate addiction. The Company anticipates future opportunities to create proprietary psilocybin products as legislation related to psychedelics evolves. The Company continues to pursue the acquisition of additional revenue-producing natural health product brands and operations in both Europe and North America with the goal of establishing an international distribution network utilizing its powerful eCommerce technology platform.

Tilray (NasdaqGS:TLRY; TSX:TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.

Tilt Holdings Inc. (CSE: TILT) (OTCQB: TLLTF) serves cannabis brands worldwide through a strong network of portfolio companies committed to technological innovations that support long-term success. TILT services more than 2,000 brands and cannabis retailers across 33 states in the U.S., as well as in Canada, Israel, Mexico, South America and the European Union. As a market leader in cannabis technology and related products and services, the Company’s core assets include wholly-owned subsidiaries Jupiter, a company that focuses on the vast potential of inhalation through innovative design, development and manufacturing; Blackbird, a company that provides operations and software solutions for wholesale and retail distribution; and Baker, a CRM platform helping dispensaries grow their business. The Company also owns cannabis operations in states including Massachusetts, led by Commonwealth Alternative Care, Inc.; and in Pennsylvania, led by Standard Farms, LLC. Headquartered in Cambridge, Massachusetts, with offices throughout the U.S., and London, TILT has over 400 employees and has sales in the U.S., Canada and Europe

Tinley Beverage Company Inc, The (CSE:TNY) manufactures and sells liquor-inspired, non-alcoholic, and cannabis-infused beverages in the United States. It also offers Hemplify and Tinley’s Tonics line of products through retail locations in California; and online in the United States.

Top Strike Resources Corp. (CSE:VENI) dba “Vencanna Ventures Inc.” (“Vencanna”), aims to be a go-to capital provider for early-stage global cannabis initiatives with an emphasis on state compliant opportunities in limited licenced jurisdictions in the United States. We look to provide our investors with a diversified, high-growth, cannabis investment strategy through our strategic investments focused though-out the value chain (cultivation, processing and distribution, and including ancillary businesses).

Tracker Ventures Corp. (CSE:TKR) – formerly TrackLoop – is an analytics software company that is leveraging digital asset technology to transform and modernize multiple industries. TrackLoop is taking a diversified approach to the analytics and technology space, delivering practical solutions in the finance, logistics, cannabis, and pharmaceutical industries. The Company’s turnkey real-time tracking solutions offer the very latest in IoT and AI, providing valuable data and business intelligence to some of the world’s leading brands.

Transcanna Holdings Inc. (CSE:TCAN) is a Canadian based company providing branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.

Trichome Financial Corp. (CSE:TFC) is a specialty finance company focused on providing flexible and creative credit solutions to the global legal cannabis market. Trichome Financial was created to address the lack of credit availability in the large, growing and increasingly complex cannabis market. Founded by industry leaders Origin House and Stoic Advisory, Trichome Financial’s experienced management team has a unique edge to capitalize on proprietary deal flow and industry insight while developing a first mover advantage as a global cannabis focused specialty finance company. Trichome Financial provides customized financing solutions across the industry value chain to support growth, capital expenditures, mergers, acquisitions, working capital and other needs. Leveraging the combined resources and knowledge of its founders, it is able to offer significant value-added financial, product, market and operational support to its partner companies. Trichome Financial’s current assets are all based in Canada and it currently has no operations or assets in the United States.

True Leaf Brands Inc. (CSE:MJ) True Leaf is a plant-forward wellness brand for people and their pets. Founded in 2013, True Leaf has two main operating divisions: True Leaf Medicine Inc. and True Leaf Pet Inc. True Leaf Medicine Inc. is in the final stages of approval to become a licensed producer of federally-approved medicinal cannabis for the Canadian market. The license is subject to a Health Canada inspection to allow for the production, manufacture, and distribution of cannabis products upon the completion of the Company’s cannabis cultivation facility being built in Lumby, British Columbia. The facility is expected to be completed in fall 2018. Established in 2015, True Leaf Pet Inc. is one of the first companies to market hemp-based products for pets worldwide. The Company is initially marketing a line of hemp-seed based supplements for pets. True Hemp™ chews, dental sticks, and supplement oils are sold in more than 2,000 stores across North America and Europe.

Trulieve Cannabis Corp. (CSE: TRUL; OTC: TCNNF) is a vertically integrated “seed to sale” company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery.

TruTrace Technologies Inc. (CSE:TTT) Formerly BLOCKStrain Technology Corp – has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry. TruTrace’s technology allows cannabis growers and breeders to identify and secure rights to their intellectual property. It also streamlines the administrative process and reduces the costs of genetic and mandatory quality-control testing for legal cannabis. TruTrace’s technology is proprietary, immutable and cryptographically secure, thereby establishing a single-source, accurate, validated and permanent account for cannabis strains from ownership to market.

TWO RIVERS WATER & FARMING (OTC:TURV) is building a new water paradigm for the arid regions of the southwestern United States. Two Rivers assembles its water assets by acquiring irrigated farmland with senior water rights because 85% of water rights in the arid southwest are owned by agricultural interests. Two Rivers transforms the value of its water rights and farmland by continually developing operations that generate higher revenues and better profit margins. Two Rivers current farm operations convert feed crop farmland into fruit and vegetable crop production in Pueblo County Colorado, which generates six times more revenue with better profit margins. In December 2012, Colorado legalized the personal use and cultivation of marijuana. As a result, Two Rivers is providing greenhouses and processing facilities for licensed marijuana growers in Colorado on land with water rights not used for fruit and vegetable crop production. Two Rivers also develops Metropolitan Districts to serve underserved communities in rural areas in which Two Rivers’ farmland and water rights are located. GrowCo Subsidiary: GrowCo was formed for the purpose of constructing state-of-the-art computer-controlled greenhouses for licensed marijuana growers. GrowCo is not a licensed marijuana grower or retailer. GrowCo does not “touch the plant” and only provides growing infrastructure, growing materials and consulting services for licensed marijuana tenants.

Ubiquitech Software Corp (OTC:UBQU) through its subsidiaries is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, Direct Response (DRTV) Television, Radio, and traditional marketing, to drive traffic to the new and emerging multi-billion dollar industries like its subsidiary HempLifeToday™. HempLifeToday™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers HempLifeToday.com™ has developed multiple and proprietary CannazALL™ CBD oil products that include; It’s popular CBD Tinctures, Oils, GelCaps, CBD Powder, Skin Salve, Wax Honey, and e-liquid, all offered @ www.HempLifeToday.com

United Cannabis Corp (OTC:CNAB) The Company’s Prana Bio Medicinal products provide patients a way to mix/match cannabinoids for therapeutic purpose. These products, licensed to regulated marijuana dispensaries, are broken into 5 categories that are available in capsules, sublingual’s, and topical delivery methods. The Company uses a patent-pending infusion process utilizing select fatty acids, lipids, and specific combination of cannabis derived terpenes to increase bioavailability.

Upper Street Marketing Inc. (OTC UPPR) Growing Springs is established and entrenched in the Colorado cannabis marketplace with significant opportunities for organic expansion and synergistic mergers and acquisitions. The business is well-officiated by an experienced c-level suite of officers and highly specialized cannabis operational personnel. Until a name change is completed and approved, Growing Springs trades under the name and ticker of its recent merger partner, Upper Street Marketing (OTC:UPPR).

urban-gro, Inc. (Nasdaq:UGRO) is a fully integrated architectural, engineering and cultivation systems integration company for commercial cannabis and food-focused Controlled Environment Agriculture (“CEA”) facilities. With experience in hundreds of CEA facilities spanning millions of square feet across the globe, we design, engineer and integrate complex environmental equipment systems into high-performance facilities. urban-gro’s gro-care® Managed Services Platform leverages the company’s expertise to reduce downtime, provide continuity, and drive facility optimization. Operating as a crop-agnostic solutions provider in both food and cannabis CEA sectors, our crop-focused end-to-end approach provides a single point of accountability across all aspects of growing operations.

Vape Holdings Inc (OTC:VAPE) focuses on designing, marketing, and distributing various vaporization products. The company offers medical and food grade ceramic products primarily under the HIVE Ceramics brand throughout North America, Europe and South America. HIVE offers a nonporous, non-corrosive, chemically inert ceramic vaporization element, which can be used for a range of applications, including stand-alone vaporization products and electronic cigarettes. The company is based in Agoura Hills, California.

Vapir Enterprises Inc (OTC:VAPI) vaporizer products are intended to integrate elite technology with sophisticated design. We believe that our scientific background may give us the insight necessary to create a cutting-edge convection system that gently massages the active compounds from any herb, flower, or essential oil into a delicious and healthy vapor cloud.

Vega Biofuels, Inc. (OTC:VGPR) is a cutting-edge energy company that manufactures and markets a renewable energy product called Bio-Coal and a soil enhancement called Biochar, both made from timber waste using unique technology called torrefaction. Torrefaction is the treatment of biomass at high temperatures under low oxygen conditions.

Vemanti Group, Inc. (OTC:VMNT) is a diversified holding corporation that’s looking to be active in high-growth and technology-driven markets. The company plans to grow by adding value-added and fundamentally-sound businesses to their portfolio The Company intends to provide a technology platform empowering the legal cannabis industry to transact safely, securely, and remain fully-compliant via a cash-free mobile payments service. The Company recently signed a Memorandum of Understanding (MOU) with a well-established payment processor whose services mainly target clients with unique and special needs to co-develop a sustainable electronic payment service for the cannabis industry. It is also in active talks to partner with potential acquiring and merchant banks in a closed-loop banking program designed to help both financial institutions and dispensary owners create a legitimate business banking relationship that is fully compliant with current and future governmental regulations. The Company intends to first roll this service out in California which recently, with the passing of Proposition 64, has become potentially the single biggest recreational cannabis market in the world.

Verano Holdings Corp. (CSE:VRNO; OTC:VRNOF) Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano™, Avexia™, Encore™, and MÜV™. Verano’s portfolio encompasses 14 U.S. states, with active operations in 13, including 13 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf™ and MÜV™, delivering a superior cannabis shopping experience in both medical and adult-use markets. Learn more at www.verano.com.

Verde Science (OTC:VRDI) is focused on Medical Research and Development, which includes medical marijuana research and the development of effective treatments for emerging and contemporary health issues that have been inadequately addressed.

Veritas Farms, Inc. (OTCQB: VFRM) is a vertically integrated agribusiness focused on producing superior quality, whole plant, full spectrum hemp oils and extracts containing naturally occurring cannabinoids. The Company currently owns and operates a 140-acre farm and production facilities in Pueblo, Colorado, and is registered with the Colorado Department of Agriculture to grow industrial hemp. The Company markets and sells products under its Veritas Farms™ brand and manufactures private label products for a number of leading distributors and retailers. Veritas Farms™ brand full spectrum hemp extract products include vegan capsules, tinctures, formulations for sublingual applications and infused edibles, lotions, salves, and oral syringes in a variety of size formats and flavors. All Veritas Farms™ brand products are third-party laboratory tested for strength and purity.

VeritasPharma Inc. (CSE:VRT) mission is to develop the most effective cannabis strains for specific disease conditions, and to provide doctors and patients with conclusive scientific evidence to recommend and use medical marijuana with confidence.

Vert Infrastructure Ltd. (CSE: VVV) Formerly Crop Infrastructure Corp. is engaged in the business of branding, investing, constructing, owning and leasing turnkey greenhouse projects to licensed cannabis producers and processors. The company’s first project and core asset is its Greenhouse project currently under construction in the State of Washington.

VEXT Science, Inc. (CSE:VEXT; OTC: VEXTF) s a US-based cannabis THC and Hemp cannabinoid products company manufacturing THC cartridges, concentrates, edibles and accessories under the Vapen Brand, and Hemp based products under the Pure Touch Botanicals brand as well as the Vapen CBD brand. Based in Arizona, Vext Science has one of the leading THC concentrates, edibles, and distillate cartridge brands sold in the majority of the state’s 100+ dispensaries. Herbal Wellness Center is one of Arizona’s leading dispensaries and we execute all aspects of the cultivation, extraction, edibles infusion and manufacturing processes which insures a product of the highest quality and purity. Product quality and purity are core to our marketing strategy. Vext Science is executing its business growth by leveraging experience and expertise in extraction, product manufacturing, and marketing to expand in the U.S. and internationally through revenue and profit-sharing joint venture partnerships

Vibe Growth Corporation (CSE:VIBE) is a vertically integrated cannabis company whose mission is to become a dominant California cannabis retailer and multi-state operator. The company delivers exceptional retail experiences with its Vibe by California brand and ethos, premier cultivation product, and high-efficiency delivery and distribution. Vibe’s management team brings expertise in retail, cannabis cultivation, and mergers and acquisitions to support its U.S. expansion through accretive acquisitions and organic growth.

Village Farms (NasdaqGS: VFF: TSX:VFF.TO) is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from more than nine million square feet of Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in British Columbia, Ontario, and Mexico. The Company is now leveraging its 30 years of experience as a vertically integrated grower for the rapidly emerging global cannabis opportunity through a 50% ownership of British Columbia-based Pure Sunfarms, Corp., one of the single largest cannabis growing operations in the world.

Virtual Crypto Technologies Inc. (OTCQB:VRCP) is a technology company dedicated to making cryptocurrency accessible to the public on a global basis. Virtual Crypto specifically develops payment solutions for businesses and consumers, which combine Application Programming Interfaces and Mobile Applications for implementation via ATM’s, PCs, tablets and other mobile devices. CANNABIS: September 2018 – announced today that they will unveil their proprietary cannabis-centric crypto payment solution in October 2018 ahead of schedule. The company is setting-up private demos with dispensary owners, investors, partners, and associated stakeholders during the Cannabis World Congress & Exposition in Boston on October 17th-20th.

Vitality Biopharma, Inc. (OTC:VBIO) is dedicated to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders.

VODIS PHARMACEUTICALS (CSE:VP) is positioned to be among the first pharmaceutical corporations in Canada to produce and market medical marijuana under license from Health Canada in accordance with the existing Narcotic Control Regulations (“NCR”) and the new Marihuana for Medical Purposes Regulations (“MMPR”) that came into effect on April 1st, 2014. Vodis filed its MMPR in August of 2013 and in January of 2014 received a ‘ready to build’ letter from Health Canada. IT IS CURRENTLY AWAITING FINAL INSPECTION FROM HEALTH CANADA. The company has been operating under the MMAR regulations at its 12,000 square foot production facility, consisting of six rooms. This was recently upgraded to eight rooms, consisting of between 40 and 50 lights per room. The estimated production when fully operational under the MMPR license is between 150-200 pounds per month of award winning cannabis.

VPR Brands, LP (OTC:VPRB) is a technology company, whose assets include issued U.S. and Chinese patents for atomization related products including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market, including e-liquids, vaporizers and electronic cigarettes (also known as e-cigarettes) which are devices which deliver nicotine and or cannabis through atomization or vaping, and without smoke and other chemical constituents typically found in traditional products.

Wayland Group. (CSE:WAYL) – Formerly Maricann Group Inc is a vertically integrated producer and distributor of marijuana for medical purposes. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany and Regensdorf, Switzerland.

Wayland is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) footprint upon full buildout, and will continue to pursue new opportunities in Europe.

WEED INC. (OTC:BUDZ) focuses on purchasing land and building commercial grade cultivation centers for the legal and medical marijuana sector in the United States. The company intends to consult, assist, manage, and lease its cultivation centers to licensed dispensary owners and organic grow operators.

WeedMD Inc. (TSX WMD.V) is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer and distributor of medical cannabis and oils under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company operates a 26,000 sq. ft. indoor facility in Aylmer, Ontario, and is awaiting its second-site cultivation license for its greenhouse facility located in Strathroy, Ontario, representing 610,000 sq. ft. or 14 acres under glass. WeedMD has entered into supply agreements in addition to strategic relationships with established cannabis brands. The Company is focused on providing medical cannabis to the seniors’ markets in Canada through its proprietary seniors care program. It is dedicated to educating healthcare practitioners and furthering public understanding of the role that medical cannabis plays – including as it pertains to regulatory requirements, indications and potential side effects.

Weekend Unlimited Industries Inc. (CSE:POT) is capitalizing on vast industry relationships to establish a portfolio of cannabis brands throughout North America and internationally. Weekend Unlimited’s brand portfolio includes geographic footholds in California, Washington State, British Columbia and Las Vegas, establishing a strong, versatile foundation for substantial growth. The product portfolio will be focused under the headings of flower, edibles and extracts.

Westleaf Inc. (TSXV:WL.V) (OTCQB:WSLFF) is a vertically integrated cannabis company focused on innovative retail experiences and engaging cannabis brands as well as cultivation, production and extraction of cannabis products. Westleaf is rolling out a national retail footprint for its retail concept Prairie Records, with stores planned for British Columbia, Alberta, Saskatchewan and potentially Ontario. The retail concept leverages the instinctual tie between recreational cannabis and music and redefines the cannabis purchasing experience. The Company also has two significant production facilities under construction and scheduled for completion in 2019.

Wikileaf Technologies Inc. (CSE: WIKI) is a price comparison platform for recreational and medicinal cannabis consumers. Wikileaf provides consumers with instant price comparison among dispensaries in their immediate vicinity. It is a portfolio company of Nesta Holding Co. Ltd. (“Nesta”), a private equity firm focused on the global cannabis industry. Nesta was founded in 2015 by Chuck Rifici, Chair of Auxly Cannabis Group and co-founder of Canopy Growth Corporation.

Wildflower Brands Inc. (CSE:SUN) is a cannabis company focused on developing and designing branded products in the marijuana sector. In this regard, Wildflower works exclusively in Washington State where such activity is permitted and regulated by State law, through entities which hold licenses for such activities. Further, Wildflower is advancing two applications to grow and distribute medical marijuana under an MMPR license with Health Canada. Wildflower’s proprietary growing system is designed to maximize crop yields and consistently produce pure clean pharmaceutical grade BC cannabis for patients and cannabinoid research.

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) and its team of scientists are leaders in the field of biosynthetic production of high value plant-derived compounds. Willow has applied its integrated suite of technologies to develop manufacturing processes for numerous active pharmaceutical ingredients with various therapeutic benefits, including cancer treatment, pain management, and CNS disorders. In the cannabinoid field, Willow owns proprietary yeast-based lab strains that produce CBD, tetrahydrocannabinol (THC), and cannabigerol (CBG), as well as certain minor and novel cannabinoids.

World Class Extractions Inc. (CSE:PUMP; OTC: WCEXF) is a Canadian based developer of an innovative extraction process for both the hemp and cannabis industry. The Corporation intends to provide single step continuous flow extraction services to the hemp and cannabis industry. Using patent pending technology, the Corporation’s results produce higher yields and better quality crude hemp oil at faster rates. The technology allows the extraction of CBD Oil and other related extracts from wet or dried natural plants. The Corporation can save its clients floor space, utility drying costs, equipment and processing labour costs.

Xebra Brands Ltd. (CSE: XBRA) is an international cannabis cultivation and product company with global brands and intellectual property. Xebra’s products range from wellness to leisure, and include beverages.

XPhyto Therapeutics Corp (CSE:XPHY) is a science-based cannabis company focused on formulation, clinical validation, and emerging European markets. XPhyto’s 100% owned German subsidiary, Bunker Pflanzenextrakte GmbH, has been granted a unique German cannabis cultivation and extraction licence for scientific purposes by the German Federal Institute for Drugs and Medical Devices (BfArM). XPhyto is pursuing additional opportunities in Germany including cultivation, processing, manufacturing, import, and distribution. In Canada, two exclusive 5-year engagements with the Faculty of Pharmacy at a major Canadian university provide certified extraction, isolation, and formulation facilities, drug research and development expertise, as well as commercial analytical testing capability.

XS Financial Inc. (CSE:XSF) Formerly Xtraction Services Holdings Corp – specializes in providing equipment leasing solutions in the United States to owner/operators of cannabis and hemp companies, including cultivators, oil processors, manufacturers, testing laboratories, among others. In addition, XS provides a full range of consulting services including equipment selection and procurement, through its network of preferred vendor partnerships with original equipment manufacturers and equipment distributors. This powerful dynamic provides an end-to-end solution for customers, which results in recurring revenues, strong profit margins, and a proven business model for XS stakeholders.

Xtacy Therapeutics Corp (CSE:XTCY) Formerly Global Wellness Strategies Inc.- is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products. The present focus of the company is in hemp and CBD-related, psilocybin and functional mushrooms, and health-care related industries.

YaSheng Group (OTC:HERB) is a U.S. company and conducts business operations in China in three major segments: agriculture, livestocks, and biotechnology. The company specializes in developing, processing, marketing, and distributing a variety of food products processed primarily from premium specialty agriculture products grown in North West China in 6 agricultural segments: field crops, vegetables, fruits, special crops, seeds and poultry. We have been producing our premium specialty agriculture products over 20 years and some of our entities were founded over 40 years ago, to become a top agriculture company in China. Our major customers include world class conglomerates such as Tsingtao Beer, KFC and McDonalds. Priorities from Yasheng’s inception have been to acquire a vast amount of land long-term for large scale industrial agro bases, with the necessary natural resources to provide a long-term infrastructure for people to work these basic ingredients to create high-end agriculture products. Products include: Langfang poplars, peaches, and saplings, durum wheat (flower), cotton, cotton processing, hemp, corn seeds and processing, dried fruit packages, garlic extract gels, feed materials, flowers, fruits, potato, hops extracts, pellet and compressed hops, Chinese TCM herbs, seeds, and many other agro products.

Yooma Wellness Inc. (CSE:YOOM) Through its subsidiaries in China, Japan and the United States, Yooma intends to leverage the success and experience of its senior management and board of directors to build Yooma’s business into a global leader in the marketing, distribution and sale of wellness products including hemp seed oil and hemp-derived and cannabinoid (CBD) products through strategically curated network of sales channels. Yooma has assembled a strong international team of multicultural industry professionals with extensive experience in digital marketing, ecommerce and social media in EU, North America, and the pan-Asian region with particular depth in the Chinese ecommerce market.

Youngevity International (OTC:YGYI) is a fast-growing, innovative, multi-dimensional company that offers a wide range of consumer products and services, primarily through person-to-person selling relationships that comprise a “network of networks.” The Company also is a vertically-integrated producer of the finest coffees for the commercial, retail and direct sales channels. The Company was formed after the merger of Youngevity Essential Life Sciences and Javalution Coffee Company in the summer of 2011, and changed its name to Youngevity International Inc. from AL International, Inc. in July 2013. Cannabis: HEMP FX: proprietary hemp plant and production practice results in full spectrum hemp oil. It contains not only cannabinoids but also a rich source of terpenes and other phytonutrients in their natural matrix. Our formula also includes other botanicals and natural ingredients. All these ingredients work synergistically. Combine this with our patent-pending nanoemulsion technology and water soluble technology for higher absorption and bioavailabity, and the results are highly effective products. We call this the “Entourage FX.”

Zelda Therapeutics Limited (ASX:ZLD.AX) has been formed to bring together some of the world’s leading researchers and clinicians active in the study and use of medicinal cannabis to treat a variety of ailments.

Zenabis Global Inc. (TSXV: ZENA) is a significant licensed cannabis cultivator of medical and adult use cannabis, and employs staff coast-to-coast, across facilities in Atholville, New Brunswick ; Delta and Langley, B.C. ; and Stellarton, Nova Scotia . In addition to gaining technologically advanced knowledge of plant propagation, the recent addition of state-of-the-art greenhouses in Langley provides Zenabis with 3.5 million square feet of facility space that can, upon full conversion, be dedicated to cannabis production. If all facility space is fully built out and dedicated to production, Zenabis will own, and have access to, 660,000 square feet of high quality indoor cannabis production space, as well as 2.1 million square feet of greenhouse space at its Langley facility (an additional 700,000 square feet of greenhouse space will be used to continue the existing propagation business, to be converted at such a time that is beneficial to the strategic position of the company), strategically positioned on Canada’s coasts. These facilities, if fully converted for cannabis production, would have the design capacity to yield 479,300 kg of dried cannabis annually, for both national and international market distribution. The Zenabis brand name is used among the medical market, while Namaste is used to service the adult use market. The management team at Zenabis has significant experience in finance, agriculture, technology, pharmaceutical sales, consumer packaged goods, international distribution and brand marketing. Zenabis has established distribution relationships with provincial liquor authorities, wholesalers and licensed retailers in 9 provinces and territories ( British Columbia , Alberta , Saskatchewan , Manitoba , Quebec , New Brunswick , Nova Scotia , Prince Edward Island and the Yukon Territory ).

Zoned Properties Inc (OTC:ZDPY) is a strategic real estate development firm whose primary mission is to identify, develop, and lease sophisticated, safe, and sustainable properties in emerging industries, including the licensed marijuana industry. The Company acquires commercial properties that face unique zoning challenges and identifies solutions that can potentially have a major impact on the cash flow and value generated. Zoned Properties, Inc. targets commercial properties that can be acquired and potentially re-zoned for specific purposes. Zoned Properties does not grow, harvest, sell or distribute cannabis or any substances regulated under United States law such as the Controlled Substances Act.

Zynerba Pharmaceuticals Inc. (NasdaqGM:ZYNE) is a clinical-stage specialty pharmaceutical company focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Zynerba is developing therapeutic candidates based on proprietary transdermal technologies that, if successfully developed, may allow sustained, consistent and controlled delivery of therapeutic levels of two cannabinoids: cannabidiol (CBD), a non-psychoactive cannabinoid, and tetrahydrocannabinol (THC). Transdermal delivery has the potential to reduce adverse effects associated with oral dosing. ZYN002, the Company’s CBD gel, is the first and only synthetic CBD formulated as a patent protected permeation-enhanced gel. In June 2016, the company initiated the Phase 2 STAR1 (Synthetic Transdermal Cannabidiol for the Treatment of Epilepsy) clinical trial of ZYN002 CBD gel in adult refractory epilepsy patients with focal seizures and has also launched the STAR2 open-label extension trial which allows patients who complete STAR1 to receive treatment with ZYN002 gel for up to 52 weeks. In August 2016, the Phase 2 STOP (Synthetic Transdermal Cannabidiol for the Treatment of Knee Pain due to Osteoarthritis) clinical trial in patients with knee pain due to OA was initiated. A Phase 2 clinical trial in Fragile X syndrome (FXS) is expected to initiate in the second half of 2016. Zynerba is also developing ZYN001, which utilizes a synthetically manufactured pro-drug of THC. A Phase 1 clinical trial for ZYN001 is planned to begin in the first half of 2017.

Psychedelic Stocks

Adastra Holdings Ltd. (CSE:XTRX) Founded in 2014, Adastra Holdings Ltd. built a successful reputation as a household name in cannabis concentrates among consumers and retailers alike. Adastra Labs Inc. was founded in 2018 and is an agricultural-scale cannabis extraction, distillation, and product manufacturer, located in Langley, BC. Operating out of its 13,500 sq. ft. Health Canada Licensed Standard Processing facility, now named Adastra Holdings Ltd., produces and distributes cannabis-derived products designed for medical cannabis and forward-looking therapeutic use. Recently, the Company announced its entry into psychedelics by applying for a Controlled Substances Dealer’s License, which is under review by Health Canada. As a leading supplier, Adastra Holdings Ltd. currently distributes its product line to 1400+ adult-use retailers and a web-based medical platform, CannMart Inc., seeking to provide consistent, quality concentrate products and alternative treatment options across the country to patients.

Aion Therapeutic Inc. (CSE: AION)- Formerly Osoyoos Cannabis Inc. is an early-stage cannabinoid extraction company based in Oliver, BC. Aion has applied for a standard processing license under the Cannabis Act for its 10,410 ft2 facility and that application is currently in the review stage. The Company will offer contract tolling extraction, sale of bulk oil and development of both proprietary Aion Cannabis branded and white labelled products once licensed to do so.

Awakn Life Sciences Corp. (NEO: AWKN) (OTC:AWKNF) is a biotechnology company, researching, developing, and delivering revolutionary therapeutics to treat addiction. Awakn’s team consists of renowned research experts and world leading chemists, scientists, psychiatrists, and psychologists. Addiction is one of the biggest unmet medical needs of our time, affecting over 20% of the global population and is an industry valued at over $100bn per annum. Awakn is disrupting this underperforming industry by rapidly advancing the next generation of psychedelic drugs and therapies to be used in combination, through preclinical research and clinical stage trials.

Better Plant (CSE:PLNT) (OTC: VEGGF) formerly Yield Growth – develops and acquires intellectual property and other assets related to plant-based products and therapeutics. Through its integrated business model, Better Plant develops, manufactures, markets, sells and distributes plant-based products. It has 14 patent applications to protect its Intellectual Property, and over 200 proprietary wellness formulas at various stages of commercialization, including over 20 proprietary products that are now for sale via eCommerce or brick-and-mortar retail stores. It operates websites and oversees eCommerce and Amazon sales for over 200 JUSU plant based products for body, baby and home. Its majority-owned subsidiary NeonMind Biosciences Inc. is launching a line of coffees infused with health optimizing medicinal mushrooms including reishi, cordyceps, lion’s mane and turkey tail mushrooms. NeonMind is also engaged in research into developing a psilocybin (psychedelic mushroom) based product for weight loss and has applied for a Section 56 Exemption to begin preclinical trials to study its pending psychedelic medicine patents.

Braxia Scientific Corp. (CSE: BRAX) Formerly Champignon Brands is a research driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as major depressive disorder among others. Braxia Scientific is primarily focused on (i) owning and operating multidisciplinary clinics providing treatment for mental health disorders and (Braxia Health) and (ii) research activities related to discovering and commercializing novel drugs and delivery methods. The Company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform. Braxia Scientific, through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., currently operates multidisciplinary community-based clinics offering rapid-onset treatments for depression located in Mississauga, Toronto, Ottawa, and Montreal.

Bright Minds Biosciences Inc. (CSE:DRUG) is a pre-clinical biosciences company with a portfolio of compounds designed to precisely target abnormalities in neurocircuitry that lead to dysfunctional behaviors. Bright Minds is focused on developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders through the use of serotonergic compounds leveraging its world class scientific and drug development expertise to bring forward the next generation of safe and efficacious neuropsychiatry drugs into the clinic. Bright Minds drugs extenuate the therapeutic aspects of psychedelic and other serotonergic compounds while minimizing the side effects thereby creating superior drugs to first generation compounds, such as psilocybin. Bright Minds was selected to participate in two National Institutes of Health (“NIH”) Programs. These NIH collaborations are evaluating Bright Minds serotonin agonists for therapeutic potential in pain and in epilepsy.

Canbud Distribution Corporation (CSE: CBDX) is a science and technology company focused on both the global hemp markets inclusive of hemp cannabinoids (CBD) and psychedelic pharmaceutical and non-psychedelic nutraceutical verticals. Currently the company, through its subsidiaries, holds three industrial hemp licences for the purposes of supplying the global market with medicinal and wellness cannabidiol and other cannabinoid-based products

Champignon Brands (CSE:SHRM) is focused on the formulation and manufacturing of novel ketamine, anaesthetics, and adaptogenic delivery platforms for nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. The Company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (PTSD), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the Company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability as its medicinal mushroom-infused SKUs are organic, non-GMO, and vegan certified.

Codebase Ventures Inc. (CSE:CODE) Formerly 360 Blockchain Inc – is led by technology and business experts who invest early in great ideas in sectors that have significant upside, including the cannabis sector. We operate from the understanding that technology is always evolving, bringing early opportunities for strategic investments that can deliver the exponential returns to our shareholders. We seek out and empower the innovators who are building tomorrow’s standards with platforms, protocols and innovations – not just products. We invest early, support those founders, take their ideas to market and work tirelessly to help them realize their vision.

Compass Pathways (NASDAQ:CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA), for treatment-resistant depression (TRD), and we are currently conducting a phase IIb clinical trial of psilocybin therapy for TRD, in 20 sites across Europe and North America. We are headquartered in London, UK, with offices in New York, USA. Our vision is a world of mental wellbeing.

Cybin Inc. ( NEO:CYBN.NE) is a life sciences company advancing psychedelic pharmaceutical treatments for various psychiatric and neurological conditions. Cybin is developing technologies and delivery systems aiming to improve bioavailability to achieve the desired effects of psychedelics at low dosage levels. The new delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

EHave Inc (OTC:EHVVF) is a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients. Our primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, psychedelics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes meeting privacy and HIPAA & GDPR Compliant. Our main product is the Ehave Dashboard which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insight using Blockchain technology. The Ehave dashboard offers Offline Encrypted Digital Records Empowering Healthcare providers and patients and it’s a powerful machine learning and artificial intelligence platform using artificial intelligence to extract deep insights from audio, video and text to improve research with a growing set of advanced tools and applications developed by Ehave and its leading partners. This empowers patients, healthcare providers, and payers to address a wide range of conditions through high quality, safe, and effective data-driven involvement with intelligent and accessible tools.

Enveric Biosciences (NASDAQ: ENVB) is a neuroscience-focused pharmaceutical company developing next-generation, psychedelic-inspired mental health medicines. Enveric’s robust pipeline supports drug development from the clinic to commercialization aimed to help millions of patients in need around the world suffering from conditions that include cancer-related distress, PTSD and more.

Field Trip Health Ltd. (CSE: FTRP) -formerly Newton Energy Corporation – is the global leader in the development and delivery of psychedelic therapies. With Field Trip Discovery leading the development of the next generation of psychedelic molecules and conducting advanced research on plant-based psychedelics, Field Trip Health hubs for psychedelic therapies opening across North America, and Field Trip Digital building the digital and technological tools to support psychedelic experiences and consciousness expansion, we help people, from those in treatment to those seeking accelerated personal growth, with a simple, evidence-based way to heal and heighten engagement with the world.

Filament Health Corp (OTCQB: FLHLF; NEO: FH) is a clinical-stage natural psychedelic drug development company. We believe that safe, standardized, naturally-derived psychedelic medicines can improve the lives of many, and our mission is to see them in the hands of everyone who needs them as soon as possible. Filament’s platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines. We are paving the way with the first-ever natural psychedelic drug candidates.

Graph Blockchain Inc. (CSE:GBLC) is a leading-edge private blockchain data management and business intelligence solutions provider. Graph leverages their proprietary integration of the AgensGraph Database engine with IBM’s Hyperledger Fabric to create a transparent and immutable ledger with near real-time transactional data processing and intuitive data visualization. In addition, Graph’s hybrid approach offers greater flexibility and scalability, benefiting industries with fast-paced and constantly changing environments. The company is currently focused on developing enterprise platforms for high-growth areas including the global logistics industry, the global trade sector, the cannabis health and wellness sector, and the electric vehicle charging space

Halo Collective Inc. (NEO:HALO)(OTC:HCANF) is a leading, vertically integrated cannabis company that cultivates, extracts, manufactures and distributes quality cannabis flower, oils and concentrates, and has sold approximately eight million grams of oils and concentrates since inception. Halo continues to evolve its business and scale efficiently, partnering with trustworthy leaders in the industry, who value the Company’s operational expertise in bringing top-tier products to market. Recently, the Company has entered into a non-binding letter of intent with Red Light Holland Corp. for the purpose of creating a joint venture to become a licensed psilocybin manufacturer to supply psilocybin products to licensed service centers in the State of Oregon.

HAVN Life Sciences Inc. (CSE:HAVN) is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds.

Hollister Biosciences Inc. (CSE:HOLL) s a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Kaya Holdings Inc (OTCQB:KAYS) is a “mind care” company with operations in medical/recreational cannabis and pending operations in the emerging psilocybin sector. In 2014 KAYS became the first US public company to own and operate a medical cannabis dispensary (in Portland, Oregon). The Company still operates the original Kaya Shack™ cannabis dispensary while seeking to shift our cannabis operations to serve the European Union. KAYS has interests in three medical cannabis licenses (2 in Greece, 1 in Israel) to advance this effort. Resuming its role as innovator and trend setter, the Company is again breaking ground in the United States with the planned introduction of psilocybin treatment centers through our majority-owned subsidiary, Fifth Dimension Therapeutics, Inc. (“FDT”). KAYS subsidiaries include: Fifth Dimension Therapeutics, Inc, Marijuana Holdings Americas, Inc., Kaya Brands International, Inc., Kaya Brands USA, Inc.

Levitee Labs Inc. (CSE:LVT) is a functional mushrooms company. Within the functional mushrooms space, Levitee Labs is focused on the development and sale of high potency mushroom extract nutraceuticals and supplies and equipment for mushroom cultivation.Levitee Labs Inc. (CSE:LVT)is a functional mushrooms company. Within the functional mushrooms space, Levitee Labs is focused on the development and sale of high potency mushroom extract nutraceuticals and supplies and equipment for mushroom cultivation.

Lexston Life Sciences Corp. (CSE:LEXT) is a Canadian biotechnology company providing cannabis testing and research services. Lexston is also in the process of securing licensing under the exemptions prescribed by section 56 of the Controlled Drugs and Substances Act (Canada) to enable the expansion of its services into the psychedelic industry with an initial focus on the detection and quantification of psychedelic molecules in the lab and point of care. Lexston intends to develop and validate methods for standardized manufacturing of plant derived psychedelics in support of burgeoning trials in the field of mental health and wellness

Lophos Holdings Inc. (CSE:MESC) pertains to the cultivation and research of Lophophora williamsii (“peyote cactus”). Additionally, in the long-term, the Company is engaged in the research and development of compounds derived from peyote cactus. The company’s wholly-owned subsidiary, Lophos Pharmaceuticals Corp., is a biosciences company that specializes in peyote cactus cultivation, research, and sale. It is also licensed to possess, produce, sell/provide, send, transport and deliver the controlled substances covered by its Controlled Substances Dealers License (CSDL), namely mescaline, psilocin and psilocybin.

Mind Cure Health Inc. (CSE: MCUR) is a mental health and wellness company with a mission to identify, develop and commercialize products that ease suffering, increase productivity, and enhance mental health. It is the therapeutic potential of nootropics, psychoactive products, and psychedelic substances to treat the profound distress of a world suffering from a mental health crisis that led to the formation of Mind Cure. Mind Cure’s initial products are a branded line of organic mushroom nootropics.

MindMedicine Inc (NEO: MMED; OTC:MMEDF) is a neuro-pharmaceutical company that discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering. The company’s immediate priority is to address the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine. In addition, the company has established a microdosing division to conduct clinical trials of LSD microdosing for adult ADHD. The MindMed executive team brings extensive biopharmaceutical industry experience to this ground-breaking approach to the development of next-generation psychedelic medicines.

Mindset Pharma (CSE:MSET) is a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet needs. Mindset was established in order to develop next generation pharmaceutical assets that leverage the breakthrough therapeutic potential of psychedelic drugs. Mindset is developing several novel families of next generation psychedelic compounds, as well as an innovative process to chemically synthesize psilocybin as well as its own proprietary compounds

Minerco, Inc. (OTC Pink: MINE) was recently acquired by a psilocybin research and investment firm and is emerging as the world’s first publicly traded company focused on the research, production and distribution of psilocybin mushrooms

Mydecine Innovations Group Inc. (CSE:MYCO; OTC: MYCOF) is a publicly traded, pre-revenue biopharmaceutical company that began operations in North America and Europe in early 2020. Mydecine was founded to increase physicians’ access to serotonin-modulating medicine. Recent research has demonstrated the therapeutic potential of psychedelic substances such as psilocybin and MDMA for treating intractable conditions such as pain, anxiety, depression, addiction, and PTSD, along with neurodegenerative disorders. Mydecine believes these compounds can be safer, more effective, and more accessible for patients and medical professionals through modern drug chemistry paired with artificial intelligence (AI). Mydecine is developing innovative medications for target indications with high mortality rates that have lacked innovation for decades and are controlled by dominant corporations. Mydecine developed several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. Mydecine is also developing MYCO-006—short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. Mydecine utilizes cutting-edge artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them affordable and accessible to the general public upon Health Canada and FDA approval. The Mydecine team is enthusiastic about its mission and is dedicated to creating a positive difference in the lives of others.

MYND Life Sciences Inc. (CSE: MYND) is a leading life sciences company focused on improving mental health. The Company has confirmed access to Health Canada psilocybin research and development through licenses to Chief Science Officer, Dr. Wilfred Jefferies. Patents have been filed based on therapeutic approaches to treat diseases of the Central Nervous System using neuroactive agents including psychedelics and other compounds. Research and development is currently underway.

Neonmind Biosciences Inc. (CSE:NEON) is conducting research into potentially therapeutic uses of compounds found in psychedelic mushrooms and is commercializing edible mushroom infused beverages.

New Wave Holdings (CSE:SPOR) is an investment issuer focused on the burgeoning psychedelic and esports sectors. In the psychedelic sector, New Wave will focus on supporting research on active psychedelic compounds, creation of consumer products based on functional mushrooms, and developing an IP portfolio focusing on psilocybin, LSD, MDMA, and ketamine derived treatments for neuropsychiatric diseases.

Newscope Capital Corporation (CSE:PHRM) is focused on drug repurposing with artificial intelligence. The Company’s drug repurposing artificial intelligence platform combines multilayered processes for integrating millions of data points and performing machine learning to discover new uses of drugs. Wholly-owned subsidiary Pharmather Inc. was founded in 2020 with a particular focus on repurposing ketamine and psilocybin for neurological and pain disorders. The goal is to advance the development of panaceAI™, our drug repurposing AI platform, validate psilocybin in pre-clinical models of stroke and traumatic brain injury, and conduct clinical studies with ketamine for Parkinson’s disease and other disorders of the brain and nervous system.

Novamind Inc. (CSE:NM) is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind.

Numinus Wellness Inc (TSXV:NUMI) is a Vancouver -based health care company helping to support the universal desire to heal and be well. Through its wholly-owned subsidiary Salvation Botanicals, Numinus has a Health Canada cannabis testing licence that allows the company to test and analyze cannabis products from licensed producers. In addition, it is a late-stage applicant to receive a Health Canada standard processing licence to produce cannabis products. Numinus, through the same subsidiary, also has a dealer’s licence which allows the company to test, possess, buy and sell MDMA, psilocybin, psilocin, DMT and mescaline. It is seeking to expand the licence to include activities such as import/export, testing and R&D. The expanded licence will allow Numinus to support the growing number of studies on the potential benefits of psychedelic therapies through research projects, product development, and the supply and distribution of these substances. Numinus Wellness is dedicated to therapies that enhance and supplement existing options for people wanting lasting physical, mental and emotional health – with psychedelic treatments at its core when approved for therapeutic and research use. Psychedelics will be part of this offering but will only be available for treatment once approved by regulators and governing bodies – a process Numinus is helping to support

Nutritional High International Inc. (CSE:EAT; OTCQB:SPLIF; FRANKFURT:2NU.F) is focused on developing and manufacturing branded products in the cannabis industry, with a specific focus on edibles and oil extracts for medical and adult recreational use. The Company works exclusively in jurisdictions where such activity is permitted and regulated by state law. Nutritional High has brought its flagship FLÏ™ edibles and vape product lines from production to market in various markets including Colorado where its award winning FLÏ™ products are manufactured by Palo Verde, LLC. The Company signed a purchase agreement for Palo Verde and is awaiting regulatory approval. In California, the Company distributes products through its wholly owned distributor Calyx Brands Inc. June 2020 – Nutritional High International Inc. is pleased to announce that Kruzo LLC (“Kruzo”) has formed Psychedelic Science Corp to facilitate its previously announced acquisition by the Company on June 1, 2020

Optimi Health Corp. (CSE: OPTI; OPTI.WT) is developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness food markets. The Company also intends to cultivate, extract, process and distribute high quality strains of fungi products at its GMP certified facility located in Princeton, British Columbia.

Optimind Pharma Corp. (CSE:OMND) specializes in prescribing medical cannabis and other alternative treatments for various medical ailments. The Issuer prides itself on providing quality education and health care to patients. The Issuer is also an emerging provider of psychedelic therapies at its clinic, helping people suffering from PTSD, anxiety, depression, and other mental illnesses and disabilities by providing ketamine assisted treatment and other psychedelic enhanced psychotherapy modalities.

Origin Therapeutics Holdings Inc. (CSE:ORIG) is an actively managed investment issuer focused on making equity investments in psychedelics industry-related companies to provide investors with diverse exposure to the sector. The Company, led by a team of industry experts, leverages its management expertise, professional network, and due diligence process to identify and invest in leading and emerging companies focused on the emerging psychedelics sector.

PsyBio Therapeutics (OTCQB: PSYBF; TSXV: PSYB) is an integrated and intellectual property driven biotechnology company developing novel, bespoke psychoactive medicinal candidates targeting the potential treatment of mental health challenges, neurological disorders and other human health conditions. The team has extensive experience in drug discovery based on synthetic biology and metabolic engineering as well as clinical and regulatory expertise progressing drugs through human studies and regulatory protocols. Research and development is currently ongoing for naturally occurring psychoactive tryptamines originally discovered in different varieties of hallucinogenic mushrooms, other tryptamines and phenethylamines and combinations thereof. The Company utilizes a bio-medicinal chemistry approach to therapeutic development, in which psychoactive compounds can be utilized as a template upon which to develop precursors and analogs, both naturally and non-naturally occurring, specifically because they are already known to have an effect within the brain.

Psyched Wellness Ltd. (CSE:PSYC; OTCQB:DCNPF) is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods. The Company’s objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category. The Company is in the process of developing a line of Amanita muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: promote stress relief and relaxation, assist with sleeping and to support mood.

Pure Extracts Technologies Corp. (CSE:PULL) is an integrated Canadian plant-based extraction company specializing in the processing of cannabis, hemp and functional mushrooms to produce oils and various derivative products. The company is involved in white labeling activities as well as selling branded oil based products under the Pure Extracts brand. The Company features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. On September 25, 2020, Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis

Red Light Holland Corp. (CSE:TRIP) business revolves around the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

Reunion Neuroscience Inc.(Nasdaq: REUN) is committed to developing innovative therapeutic solutions for underserved mental health conditions. The Company’s lead asset, RE104, is a proprietary, novel serotonergic psychedelic compound being developed as a potential fast-acting and durable treatment for patients suffering from postpartum depression and other mental health conditions. RE104 is protected under US Patent No. 11,292,765 issued on April 5, 2022 (priority June 30, 2020) with claims for composition of matter, methods of manufacturing, formulations and methods of use for a genus of hemi-ester tryptamines, including RE104, which could provide protection out to June 30, 2041. Reunion is also developing the RE200 series, which includes compounds with potential for more selective serotonin receptor activity with reduced psychoactivity for potential use in more chronic treatment paradigms and indications.

Revitalist Lifestyle and Wellness Ltd. (CSE:CALM) provides patient-focused treatments for mental health and pain disorders through the operation of psychedelic-enhanced psychotherapy clinics, which guide patients through ketamine-enhanced psychotherapy. Revivalist commenced operations in 2018 at is existing location in Knoxville Tennessee and is working on a rapid expansion in the United States. Revivalist seeks to create a global brand of psychedelic-enhanced psychotherapy clinics for ketamine-enhanced psychotherapy, psychedelic-enhanced psychotherapy, ketamine infusion therapy, vitamin infusions, and transcranial magnetic stimulation focusing on mental health and pain disorders

Revive Therapeutics Ltd. (CSE:RVV) is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of infectious diseases, with an initial focus on severe influenza strains including COVID-19. With its recent acquisition of Psilocin Pharma Corp., Revive is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the company was granted FDA orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.

Roadman Investments (TSXV:LITT) is a Canadian Venture Capital and Advisory Firm that strives to actively drive innovation and accelerate growth within its portfolio holdings in order to realize alpha returns for its shareholders. Roadman invests capital into companies that offer breakthrough products, devices, treatments and health supplements.

Small Pharma Inc. (TSXV:DMT) is a neuroscience company specialized in discovering and developing novel treatments for mental health conditions, with a current focus on depression. Small Pharma initiated a clinical program into DMT-assisted therapy in February 2021. This program includes a Phase I/IIa trial on the Company’s lead candidate alongside development of a robust pipeline of proprietary preclinical assets. DMT is a naturally occurring psychedelic tryptamine found in plants and in the brain of mammals. Scientific evidence suggests DMT offers the potential for rapid-acting and long-lasting antidepressant effects.

Thoughtful Brands Inc (CSE:TBI) .- Formerly Mota Ventures, is an established eCommerce technology company that researches, develops, markets and sells natural health products in North America and Europe. The Company has a strong focus on the CBD market, as well as the burgeoning psychedelic medicine sector. Through its direct-to-consumer digital platform, the Company offers multiple well-established hemp-CBD brands, including Nature’s Exclusive, Sativida and Franchise. The Company also owns and operates a 110,000 square foot manufacturing

facility in Radebeul, Germany, where its highly skilled team is currently conducting clinical studies utilizing naturally occurring psilocybin and other compounds found in psychedelics for the treatment of opiate addiction. The Company anticipates future opportunities to create proprietary psilocybin products as legislation related to psychedelics evolves. The Company continues to pursue the acquisition of additional revenue-producing natural health product brands and operations in both Europe and North America with the goal of establishing an international distribution network utilizing its powerful eCommerce technology platform.

Tryp Therapeutics Inc. (CSE:TRYP) is a pharmaceutical company focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. The Company intends to do this through the development of compounds with known activity and/or safety profiles. The Company’s lead program is designed to address neurological disorders through the therapeutic dosing of synthetic psilocybin. The Company is currently evaluating potential lead indications for its psilocybin-for-neurology program, which it refers to as its PFN™ program, including fibromyalgia and Prader-Willi Syndrome. In addition to its PFN™ program, the Company is developing razoxane for the treatment of soft-tissue sarcomas. The Company continues to evaluate potential additional indications for its existing programs, as well as other drug candidates with known activity and/or safety profiles that may have utility in the treatment of rare diseases or other diseases with high unmet medical needs.

Wesana Health (CSE:WESA) is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury (TBI). Through extensive clinical research and academic partnerships, Wesana Health is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological and mental health ailments caused by trauma.

 

Our site does not give specific recommendations and encourages investors to complete their own due diligence. Our lists are compiled from internal and external research sources. Our lists are to be used only as a partial source of due diligence.